[
    {"ICD10Code":"E00.0","Description":"Congenital iodine-deficiency syndrome, neurological type","SearchInclusion":"Endemic cretinism, neurological type                                                                                                 Congenital iodine deficiency syndrome - neurological type\nCongenital iodine deficiency syndrome, myxedematous","ClinicalNotes":""},
    {"ICD10Code":"E00.1","Description":"Congenital iodine-deficiency syndrome, myxedematous type","SearchInclusion":"Endemic hypothyroid cretinism\nEndemic cretinism, myxedematous type                                                                                                  Congenital iodine deficiency syndrome, myxedematous ty\nEndemic congenital iodine deficiency syndrome of myxedematous type","ClinicalNotes":"Severely reduced physical and mental growth associated with pyramidal and extrapyramidal signs and symptoms, due to dietary iodine deficiency."},
    {"ICD10Code":"E00.2","Description":"Congenital iodine-deficiency syndrome, mixed type","SearchInclusion":"Endemic cretinism, mixed type                                                                                                                   Congenital iodine deficiency syndrome - mixed type\nCongenital iodine deficiency syndrome, mixed type","ClinicalNotes":""},
    {"ICD10Code":"E00.9","Description":"Congenital iodine-deficiency syndrome, unspecified","SearchInclusion":"Congenital iodine-deficiency hypothyroidism NOS\nEndemic cretinism NOS                                                                                         Congenital iodine deficiency syndrome\nEndemic cretinism","ClinicalNotes":"Severely reduced physical and mental growth associated with pyramidal and extrapyramidal signs and symptoms, due to dietary iodine deficiency."},
    {"ICD10Code":"E01.0","Description":"Iodine-deficiency related diffuse (endemic) goiter","SearchInclusion":"","ClinicalNotes":"A form of iodine deficiency disorders characterized by an enlargement of the thyroid gland in a significantly large fraction of a population group. Endemic goiter is common in mountainous and iodine-deficient areas of the world where the diet contains insufficient amount of iodine."},
    {"ICD10Code":"E01.1","Description":"Iodine-deficiency related multinodular (endemic) goiter","SearchInclusion":"Iodine deficiency related multinodular thyroid goiter\nIodine-deficiency-related multinodular endemic goiter                                                                              Iodine-deficiency related nodular goiter","ClinicalNotes":""},
    {"ICD10Code":"E01.2","Description":"Iodine-deficiency related (endemic) goiter, unspecified","SearchInclusion":"Endemic goiter NOS","ClinicalNotes":"A form of iodine deficiency disorders characterized by an enlargement of the thyroid gland in a significantly large fraction of a population group. Endemic goiter is common in mountainous and iodine-deficient areas of the world where the diet contains insufficient amount of iodine."},
    {"ICD10Code":"E01.8","Description":"Other iodine-deficiency related thyroid disorders and allied conditions                                                                                                                                                                                         Y","SearchInclusion":"Acquired iodine-deficiency hypothyroidism NOS                                               Iodine deficiency related hypothyroidism\nIodine hypothyroidism","ClinicalNotes":""},
    {"ICD10Code":"E02.","Description":"Subclinical iodine-deficiency hypothyroidism                                                                                                                                                                                                                    Y","SearchInclusion":"Subclinical iodine deficiency hypothyroidism","ClinicalNotes":""},
    {"ICD10Code":"E03.0","Description":"Congenital hypothyroidism with diffuse goiter","SearchInclusion":"Congenital parenchymatous goiter (nontoxic)\nCongenital goiter (nontoxic) NOS                                                                                                                    Congenital hypothyroidism with diffuse thyroid goiter","ClinicalNotes":""},
    {"ICD10Code":"E03.1","Description":"Congenital hypothyroidism without goiter","SearchInclusion":"Aplasia of thyroid (with myxedema)\nCongenital atrophy of thyroid\nCongenital hypothyroidism NOS                                                                                                                      Congenital hypothyroidism\nHypothyroidism, congenital","ClinicalNotes":"A condition in infancy or early childhood due to an in-utero deficiency of thyroid hormones that can be caused by genetic or environmental factors, such as thyroid dysgenesis or hypothyroidism in infants of mothers treated with thiouracil during pregnancy. Endemic cretinism is the result of iodine deficiency. Clinical symptoms include severe mental retardation, impaired skeletal development, short stature, and myxedema.\nA deficiency of thyroid hormone present at birth. The etiology can be genetic or environmental, or a combination of both; treatment is based on severity and causality.\nCondition due to congenital lack of thyroid hormone, marked by arrested physical and mental development, dystrophy of the bones and soft parts, and lowered basal metabolism; it is the congenital form of thyroid deficiency, while myxedema is the acquired form."},
    {"ICD10Code":"E03.2","Description":"Hypothyroidism due to medicaments and other exogenous substances                                                                                                                                                                                                Y","SearchInclusion":"Drug induced hypothyroidism\nDrug induced hypothyroidism, amiodarone\nHypothyroidism due to amiodarone\nHypothyroidism due to drug\nHypothyroidism due to drug or other exogenous substance\nHypothyroidism, iatrogenic\nIatrogenic hypothyroidism","ClinicalNotes":""},
    {"ICD10Code":"E03.3","Description":"Postinfectious hypothyroidism                                                                                                                                                                                                                                   Y","SearchInclusion":"Post-infectious hypothyroidism","ClinicalNotes":""},
    {"ICD10Code":"E03.4","Description":"Atrophy of thyroid (acquired)","SearchInclusion":"Acquired thyroid atrophy\nAtrophy of thyroid\nAtrophy of thyroid - acquired\nThyroid atrophy","ClinicalNotes":""},
    {"ICD10Code":"E03.5","Description":"Myxedema coma","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E03.8","Description":"Other specified hypothyroidism                                                                                                                                                                                                                                  Y","SearchInclusion":"Central hypothyroidism\nHypothyroidism due to thyroiditis\nHypothyroidism of prematurity\nHypothyroidism, secondary\nHypothyroxinemia of prematurity\nSecondary hypothyroidism\nTertiary hypothyroidism","ClinicalNotes":""},
    {"ICD10Code":"E03.9","Description":"Hypothyroidism, unspecified                                                                                                                                                                                                                                     Y","SearchInclusion":"Acquired hypothyroidism\nCerebral degeneration due to hypothyroidism\nCerebral degeneration in hypothyroidism\nHypothyroid (low level of thyroid hormone) in childbirth\nHypothyroid (low thyroid) in pregnancy\nHypothyroidism\nHypothyroidism (low thyroid)\nHypothyroidism (low thyroid), acquired\nHypothyroidism in childbirth\nHypothyroidism in pregnancy\nHypothyroidism postpartum\nMyxedema\nPostpartum (after childbirth) hypothyroidism\nSubclinical hypothyroidism","ClinicalNotes":"A condition characterized by a dry, waxy type of swelling (edema) with abnormal deposits of mucopolysaccharides in the skin and other tissues. It is caused by a deficiency of thyroid hormones. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.\nA condition in which the production of thyroid hormone by the thyroid gland is diminished. Signs and symptoms of hypothyroidism include low metabolic rate, tendency to weight gain, somnolence and sometimes myxedema. In the United States, the most common cause of hypothyroidism is hashimoto's thyroiditis, an autoimmune disorder.\nA disorder characterized by a decrease in production of thyroid hormone by the thyroid gland.\nA syndrome that results from abnormally low secretion of thyroid hormones from the thyroid gland, leading to a decrease in basal metabolic rate. In its most severe form, there is accumulation of mucopolysaccharides in the skin and edema, known as myxedema.\nCondition characterized by a dry, waxy type of swelling with abnormal deposits of mucin in the skin and other tissues; it is produced by a functional insufficiency of the thyroid gland, resulting in deficiency of thyroid hormone.\nDeficiency of thyroid gland activity; characterized by decreased basal metabolic rate, fatigue and lethargy, sensitivity to cold, and menstrual disturbances; untreated it progresses to myxedema; in infants severe hypothyroidism leads to cretinism.\nToo little thyroid hormone. Symptoms include weight gain, constipation, dry skin, and sensitivity to the cold."},
    {"ICD10Code":"E04.0","Description":"Nontoxic diffuse goiter","SearchInclusion":"Diffuse (colloid) nontoxic goiter\nSimple nontoxic goiter                                                                                             Diffuse thyroid goiter without thyrotoxicosis\nNontoxic diffuse thyroid goiter\nSimple goiter","ClinicalNotes":""},
    {"ICD10Code":"E04.1","Description":"Nontoxic single thyroid nodule","SearchInclusion":"Cyst of thyroid\nDominant nodule of thyroid\nDominant thyroid nodule\nFunctioning thyroid nodule\nNon-toxic uninodular goiter\nThyroid cyst\nThyroid goiter, nontoxic, uninodular\nThyroid nodule\nThyroid nodule, functioning                                                                                                                                        Colloid nodule (cystic) (thyroid)\nNontoxic uninodular goiter\nThyroid (cystic) nodule NOS","ClinicalNotes":""},
    {"ICD10Code":"E04.2","Description":"Nontoxic multinodular goiter","SearchInclusion":"Cystic goiter NOS\nMultinodular (cystic) goiter NOS                                                                                                                         Multinodular goiter\nNon-toxic multinodular goiter\nThyroid goiter multinodular\nThyroid goiter, nontoxic, multinodular","ClinicalNotes":""},
    {"ICD10Code":"E04.8","Description":"Other specified nontoxic goiter","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E04.9","Description":"Nontoxic goiter, unspecified","SearchInclusion":"Adenomatous goiter\nAutonomous goiter\nAutonomously functioning thyroid goiter\nEuthyroid goiter\nGoiter\nGoiter due to thyroiditis\nGoiter, euthyroid\nGoiter, substernal\nNon-toxic nodular goiter\nSubsternal goiter\nThyroid goiter\nThyroid goiter, adenomatous\nThyroid goiter, nontoxic, nodular\nThyroiditis unspecified, with goiter                                                                                                                        Goiter NOS\nNodular goiter (nontoxic) NOS","ClinicalNotes":"An enlarged thyroid. It may be caused by too little iodine in the diet or by other conditions. Most goiters are not cancer.\nEnlargement of the thyroid gland that may increase from about 20 grams to hundreds of grams in human adults. Goiter is observed in individuals with normal thyroid function (euthyroidism), thyroid deficiency (hypothyroidism), or hormone overproduction (hyperthyroidism). Goiter may be congenital or acquired, sporadic or endemic (goiter, endemic).\nEnlargement of the thyroid gland usually caused by lack of iodine in the diet, hyperthyroidism, or thyroid nodules. Symptoms include difficulty in breathing and swallowing.\nEnlargement of the thyroid gland."},
    {"ICD10Code":"E05.00","Description":"Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm","SearchInclusion":"Bilateral exophthalmic ophthalmoplegia\nExophthalmic ophthalmoplegia\nGraves disease\nGraves disease w restrictive strabismus\nGraves ophthalmopathy\nGraves ophthalmopathy (eye condition)\nGraves ophthalmoplegia\nGraves' disease\nLeft exophthalmic ophthalmoplegia\nRestrictive strabismus due to grave's disease\nRestrictive strabismus due to graves disease\nRight exophthalmic ophthalmoplegia\nThyroid eye disease\nThyroid goiter toxic diffuse\nThyrotoxic exophthalmos\nThyrotoxic exophthalmos without crisis or storm\nThyrotoxic exophthalmos without thyrotoxic crisis or storm\nToxic diffuse goiter","ClinicalNotes":""},
    {"ICD10Code":"E05.01","Description":"Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm","SearchInclusion":"Graves disease with crisis\nToxic diffuse goiter with thyrotoxic crisis","ClinicalNotes":""},
    {"ICD10Code":"E05.10","Description":"Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm","SearchInclusion":"Thyroid goiter, toxic, uninodular\nToxic uninodular goiter","ClinicalNotes":""},
    {"ICD10Code":"E05.11","Description":"Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm","SearchInclusion":"Toxic uninodular goiter with thyrotoxic crisis\nToxic uninodular thyroid goiter with thyrotoxic crisis","ClinicalNotes":""},
    {"ICD10Code":"E05.20","Description":"Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm","SearchInclusion":"Thyroid goiter, toxic, multinodular\nThyroid goiter, toxic, nodular\nToxic multinodular goiter\nToxic nodular goiter","ClinicalNotes":""},
    {"ICD10Code":"E05.21","Description":"Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm","SearchInclusion":"Thyroid goiter, toxic, nodular, with crisis\nToxic multinodular goiter with thyrotoxic crisis\nToxic multinodular thyroid goiter, thyrotoxic crisis\nToxic nodular goiter with thyrotoxic storm","ClinicalNotes":""},
    {"ICD10Code":"E05.30","Description":"Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm","SearchInclusion":"Hyperthyroidism due to ectopic thyroid nodule\nHyperthyroidism due to ectopic thyroid tissue\nThyrotoxicosis from ectopic thyroid nodule with no crisis","ClinicalNotes":""},
    {"ICD10Code":"E05.31","Description":"Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm","SearchInclusion":"Hyperthyroidism with thyrotoxic crisis\nThyrotoxicosis from ectopic thyroid nodule with crisis","ClinicalNotes":""},
    {"ICD10Code":"E05.40","Description":"Thyrotoxicosis factitia without thyrotoxic crisis or storm","SearchInclusion":"Thyrotoxicosis factitia\nThyrotoxicosis factitia without thyrotoxic crisis","ClinicalNotes":""},
    {"ICD10Code":"E05.41","Description":"Thyrotoxicosis factitia with thyrotoxic crisis or storm","SearchInclusion":"Thyrotoxicosis factitia with thyrotoxic crisis","ClinicalNotes":""},
    {"ICD10Code":"E05.80","Description":"Other thyrotoxicosis without thyrotoxic crisis or storm","SearchInclusion":"Hyperthyroidism due to thyroiditis\nHyperthyroidism, iatrogenic\nIatrogenic thyrotoxicosis\nIodine-induced hyperthyroidism\nJod basedow iodine induced hyperthyroidism","ClinicalNotes":""},
    {"ICD10Code":"E05.81","Description":"Other thyrotoxicosis with thyrotoxic crisis or storm","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E05.90","Description":"Thyrotoxicosis, unspecified without thyrotoxic crisis or storm","SearchInclusion":"Amiodarone induced hyperthyroidism\nHyperthyroid (high level of thyroid hormone) in childbirth\nHyperthyroid in pregnancy\nHyperthyroidism\nHyperthyroidism (high thyroid)\nHyperthyroidism due to amiodarone\nHyperthyroidism in childbirth\nHyperthyroidism in pregnancy\nHyperthyroidism postpartum\nPostpartum (after childbirth) hyperthyroidism\nPretibial myxedema\nPretibial myxedema without thyrotoxic crisis or storm\nSubclinical hyperthyroidism\nSubclinical hyperthyroidism (high thyroid no symptoms)\nThyrotoxicosis","ClinicalNotes":""},
    {"ICD10Code":"E05.91","Description":"Thyrotoxicosis, unspecified with thyrotoxic crisis or storm","SearchInclusion":"Thyrotoxic crisis\nThyrotoxicosis with crisis","ClinicalNotes":""},
    {"ICD10Code":"E06.0","Description":"Acute thyroiditis","SearchInclusion":"Abscess of thyroid\nPyogenic thyroiditis\nSuppurative thyroiditis  ","ClinicalNotes":"Acute inflammatory disease of the thyroid gland due to infections by bacteria; fungi; or other microorganisms. Symptoms include tender swelling, fever, and often with leukocytosis."},
    {"ICD10Code":"E06.1","Description":"Subacute thyroiditis","SearchInclusion":"de Quervain thyroiditis\nGiant-cell thyroiditis\nGranulomatous thyroiditis\nNonsuppurative thyroiditis\nViral thyroiditis","ClinicalNotes":"Self-limited inflammation of the thyroid gland characterized by the presence of multinucleated giant cells. Patients present with neck pain, often associated with fever and dysphagia. The clinical course includes an initial phase of hyperthyroidism, followed by a phase of hypothyroidism, and eventually a return to normal thyroid function.\nSpontaneously remitting inflammatory condition of the thyroid gland, characterized by fever; muscle weakness; sore throat; severe thyroid pain; and an enlarged damaged gland containing giant cells. The disease frequently follows a viral infection."},
    {"ICD10Code":"E06.2","Description":"Chronic thyroiditis with transient thyrotoxicosis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E06.3","Description":"Autoimmune thyroiditis","SearchInclusion":"Hashimoto's thyroiditis\nHashitoxicosis (transient)\nLymphadenoid goiter\nLymphocytic thyroiditis\nStruma lymphomatosa                                                                                                                                                     Fibrous autoimmune thyroiditis\nHashimoto thyroiditis\nThyroiditis (inflammation of thyroid), hashimotos\nThyroiditis, autoimmune\nThyroiditis, fibrous autoimmune","ClinicalNotes":"An autoimmune condition of the thyroid gland (a gland located beneath the larynx). It is caused by the formation of antibodies that attack the thyroid gland and it usually causes hypothyroidism (too little thyroid hormone). Symptoms include fatigue, weight gain, constipation, dry skin, depression, and the inability to exercise. It is more common in females and can run in families.\nAn autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.\nAn inflammatory disorder that affects the thyroid gland. It is characterized by the infiltration of the thyroid parenchyma by lymphocytes. It includes hashimoto thyroiditis and subacute lymphocytic thyroiditis.\nChronic autoimmune thyroiditis, characterized by the presence of high serum thyroid autoantibodies; goiter; and hypothyroidism.\nDiffuse infiltration of the thyroid gland with lymphocytes, resulting in diffuse goiter, progressive destruction of the parenchyma and hypothyroidism.\nInflammatory disease of the thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific t-cells and thyroid autoantibodies. The clinical signs can range from hypothyroidism to thyrotoxicosis depending on the type of autoimmune thyroiditis.\nProgressive enlargement of the thyroid gland, often associated with hypothyroidism."},
    {"ICD10Code":"E06.4","Description":"Drug-induced thyroiditis","SearchInclusion":"Amiodarone induced thyroiditis\nDrug induced thyroiditis\nIatrogenic thyroiditis\nThyroiditis due to amiodarone\nThyroiditis, iatrogenic","ClinicalNotes":""},
    {"ICD10Code":"E06.5","Description":"Other chronic thyroiditis","SearchInclusion":"Chronic fibrous thyroiditis\nChronic thyroiditis NOS\nLigneous thyroiditis\nChronic thyroiditis\nFibrous autoimmune thyroiditis\nRiedel's thyroiditis\nThyroiditis, chronic\nThyroiditis, chronic fibrous\nThyroiditis, fibrous autoimmune","ClinicalNotes":"An inflammation of the thyroid gland that frequently results in hypothyroidism (lowered thyroid function)"},
    {"ICD10Code":"E06.9","Description":"Thyroiditis, unspecified","SearchInclusion":"Euthyroid thyroiditis\nGoiter due to thyroiditis\nHyperthyroidism due to thyroiditis\nHypothyroidism due to thyroiditis\nInfectious thyroiditis\nSilent thyroiditis\nThyroiditis\nThyroiditis (inflammation of thyroid)\nThyroiditis (inflammation of thyroid) in childbirth\nThyroiditis (inflammation of thyroid) in pregnancy\nThyroiditis in childbirth\nThyroiditis in pregnancy\nThyroiditis unspecified, with goiter\nThyroiditis, euthyroid\nThyroiditis, infectious\nThyroiditis, painless","ClinicalNotes":"Inflammation of the thyroid gland\nInflammation of the thyroid gland.\nInflammation of the thyroid gland. Thyroiditis may be an autoimmune disease that affects the thyroid gland over time, causing hypothyroidism (too little thyroid hormone). A temporary form of thyroiditis may also occur after the birth of a baby, or when viral or bacterial infections spread to the thyroid.\nInflammatory diseases of the thyroid gland. Thyroiditis can be classified into acute (thyroiditis, suppurative), subacute (granulomatous and lymphocytic), chronic fibrous (riedel's), chronic lymphocytic (hashimoto disease), transient (postpartum thyroiditis), and other autoimmune thyroiditis subtypes."},
    {"ICD10Code":"E07.0","Description":"Hypersecretion of calcitonin","SearchInclusion":"C-cell hyperplasia of thyroid\nHypersecretion of thyrocalcitonin","ClinicalNotes":""},
    {"ICD10Code":"E07.1","Description":"Dyshormogenetic goiter","SearchInclusion":"Familial dyshormogenetic goiter\nPendred's syndrome                                                                                 Dyshormonogenic goiter\nGoiter, dyshormonogenic","ClinicalNotes":""},
    {"ICD10Code":"E07.81","Description":"Sick-euthyroid syndrome","SearchInclusion":"Euthyroid sick-syndrome","ClinicalNotes":"Conditions of abnormal thyroid hormones release in patients with apparently normal thyroid gland during severe systemic illness, physical trauma, and psychiatric disturbances. It can be caused by the loss of endogenous hypothalamic input or by exogenous drug effects. The most common abnormality results in low t3 thyroid hormone with progressive decrease in thyroxine; (t4) and tsh. Elevated t4 with normal t3 may be seen in diseases in which thyroxine-binding globulin synthesis and release are increased."},
    {"ICD10Code":"E07.89","Description":"Other specified disorders of thyroid","SearchInclusion":"Nodular thyroid disease\nThyroid binding protein disorder\nThyroid hemorrhage and infarction\nThyroid hormone resistance syndrome\nThyroid hormone responsiveness defect\nThyroid-binding globulin abnormality                                                                Abnormality of thyroid-binding globulin\nHemorrhage of thyroid\nInfarction of thyroid","ClinicalNotes":""},
    {"ICD10Code":"E07.9","Description":"Disorder of thyroid, unspecified","SearchInclusion":"Disorder of thyroid gland\nMass of thyroid gland\nMaternal thyroid disease in pregnancy\nPostpartum (after childbirth) thyroid disease\nPostpartum thyroid disease\nThyroid disease in childbirth\nThyroid disease in pregnancy\nThyroid disorder\nThyroid mass","ClinicalNotes":"Condition in which there is a deviation from or interruption of the normal structure or function of the thyroid gland, which is a highly vascular endocrine gland that produces the thyroid hormones which are concerned in regulating the metabolic rate of the body.\nPathological processes involving the thyroid gland.\nYour thyroid is a butterfly-shaped gland in your neck, just above your collarbone. It is one of your endocrine glands, which make hormones. The thyroid helps set your metabolism - how your body gets energy from the foods you eat.millions of people in the United States Have thyroid diseases. Most of them are women. If you have a thyroid disease, your body uses energy more slowly or quickly than it should. A thyroid gland that is not active enough, called hypothyroidism, is far more common. It can make you gain weight, feel fatigued and have difficulty dealing with cold temperatures. If your thyroid is too active, it makes more thyroid hormones than your body needs. That condition is hyperthyroidism. Too much thyroid hormone can make you lose weight, speed up your heart rate and make you very sensitive to heat. There are many causes for both conditions. Treatment involves trying to reset your body's metabolism to a normal rate."},
    {"ICD10Code":"E08.00","Description":"Diabetes mellitus due to underlying condition with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.01","Description":"Diabetes mellitus due to underlying condition with hyperosmolarity with coma","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.10","Description":"Diabetes mellitus due to underlying condition with ketoacidosis without coma","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.11","Description":"Diabetes mellitus due to underlying condition with ketoacidosis with coma","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.21","Description":"Diabetes mellitus due to underlying condition with diabetic nephropathy","SearchInclusion":"Diabetes mellitus due to underlying condition with intercapillary glomerulosclerosis\nDiabetes mellitus due to underlying condition with intracapillary glomerulonephrosis\nDiabetes mellitus due to underlying condition with Kimmelstiel-Wilson disease","ClinicalNotes":""},
    {"ICD10Code":"E08.22","Description":"Diabetes mellitus due to underlying condition with diabetic chronic kidney disease","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.29","Description":"Diabetes mellitus due to underlying condition with other diabetic kidney complication","SearchInclusion":"Renal tubular degeneration in diabetes mellitus due to underlying condition","ClinicalNotes":""},
    {"ICD10Code":"E08.311","Description":"Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.319","Description":"Diabetes mellitus due to underlying condition with unspecified diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.321","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3211","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3212","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3213","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3219","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.329","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3291","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3292","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3293","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3299","Description":"Diabetes mellitus due to underlying condition with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.331","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3311","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3312","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3313","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3319","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.339","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3391","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3392","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3393","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3399","Description":"Diabetes mellitus due to underlying condition with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.341","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3411","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3412","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3413","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3419","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.349","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3491","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3492","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3493","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3499","Description":"Diabetes mellitus due to underlying condition with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.351","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3511","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3512","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3513","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3519","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.352","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3521","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3522","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3523","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3529","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.353","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3531","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3532","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3533","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3539","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.354","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3541","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3542","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3543","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3549","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.355","Description":"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3551","Description":"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3552","Description":"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3553","Description":"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3559","Description":"Diabetes mellitus due to underlying condition with stable proliferative diabetic retinopathy, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.359","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3591","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3592","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3593","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.3599","Description":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.36","Description":"Diabetes mellitus due to underlying condition with diabetic cataract","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.37","Description":"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.37X1","Description":"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.37X2","Description":"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.37X3","Description":"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.37X9","Description":"Diabetes mellitus due to underlying condition with diabetic macular edema, resolved following treatment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.39","Description":"Diabetes mellitus due to underlying condition with other diabetic ophthalmic complication","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.40","Description":"Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.41","Description":"Diabetes mellitus due to underlying condition with diabetic mononeuropathy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.42","Description":"Diabetes mellitus due to underlying condition with diabetic polyneuropathy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.43","Description":"Diabetes mellitus due to underlying condition with diabetic autonomic (poly)neuropathy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.44","Description":"Diabetes mellitus due to underlying condition with diabetic amyotrophy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.49","Description":"Diabetes mellitus due to underlying condition with other diabetic neurological complication","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.51","Description":"Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy without gangrene","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.52","Description":"Diabetes mellitus due to underlying condition with diabetic peripheral angiopathy with gangrene","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.59","Description":"Diabetes mellitus due to underlying condition with other circulatory complications","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.610","Description":"Diabetes mellitus due to underlying condition with diabetic neuropathic arthropathy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.618","Description":"Diabetes mellitus due to underlying condition with other diabetic arthropathy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.620","Description":"Diabetes mellitus due to underlying condition with diabetic dermatitis","SearchInclusion":"Diabetes mellitus due to underlying condition with diabetic necrobiosis lipoidica","ClinicalNotes":""},
    {"ICD10Code":"E08.621","Description":"Diabetes mellitus due to underlying condition with foot ulcer","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.622","Description":"Diabetes mellitus due to underlying condition with other skin ulcer","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.628","Description":"Diabetes mellitus due to underlying condition with other skin complications","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.630","Description":"Diabetes mellitus due to underlying condition with periodontal disease","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.638","Description":"Diabetes mellitus due to underlying condition with other oral complications","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.641","Description":"Diabetes mellitus due to underlying condition with hypoglycemia with coma","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.649","Description":"Diabetes mellitus due to underlying condition with hypoglycemia without coma","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.65","Description":"Diabetes mellitus due to underlying condition with hyperglycemia","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.69","Description":"Diabetes mellitus due to underlying condition with other specified complication","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.8","Description":"Diabetes mellitus due to underlying condition with unspecified complications","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E08.9","Description":"Diabetes mellitus due to underlying condition without complications","SearchInclusion":"Cystic fibrosis related to diabetes\nDiabetes mellitus due to cystic fibrosis","ClinicalNotes":""},
    {"ICD10Code":"E09.00","Description":"Drug or chemical induced diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)","SearchInclusion":"Drug induced diabetes with hyperosmolarity\nHyperosmolarity co-occurrent and due to drug induced diabetes mellitus\nHyperosmolarity without nonketotic hyperglycemic hyperosmolar coma due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.01","Description":"Drug or chemical induced diabetes mellitus with hyperosmolarity with coma","SearchInclusion":"Drug induced diabetes with hyperosmolar coma\nHyperosmolar coma due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.10","Description":"Drug or chemical induced diabetes mellitus with ketoacidosis without coma","SearchInclusion":"Drug induced diabetes with ketoacidosis\nHyperosmolarity without coma due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.11","Description":"Drug or chemical induced diabetes mellitus with ketoacidosis with coma","SearchInclusion":"Drug induced diabetes with ketoacidotic coma\nKetoacidotic coma due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.21","Description":"Drug or chemical induced diabetes mellitus with diabetic nephropathy","SearchInclusion":"Drug or chemical induced diabetes mellitus with intercapillary glomerulosclerosis\nDrug or chemical induced diabetes mellitus with intracapillary glomerulonephrosis\nDrug or chemical induced diabetes mellitus with Kimmelstiel-Wilson disease                                                                                                                                                       Drug induced diabetes with diabetic nephropathy\nNephropathy due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.22","Description":"Drug or chemical induced diabetes mellitus with diabetic chronic kidney disease","SearchInclusion":"Chronic kidney disease due to drug induced diabetes mellitus\nChronic kidney disease stage 1 due to drug induced diabetes\nChronic kidney disease stage 2 due to drug induced diabetes\nChronic kidney disease stage 3 due to drug induced diabetes\nChronic kidney disease stage 4 due to drug induced diabetes\nChronic kidney disease stage 5 due to drug induced diabetes\nChronic kidney disease with end stage renal disease on dialysis due to drug induced diabetes mellitus\nDrug induced diabetes chronic kidney disease, dialysis\nDrug induced diabetes with diabetic kidney disease\nDrug induced diabetes with mild chronic kidney disease\nDrug induced diabetes, moderate chronic kidney disease\nDrug induced diabetes, severe chronic kidney disease","ClinicalNotes":""},
    {"ICD10Code":"E09.29","Description":"Drug or chemical induced diabetes mellitus with other diabetic kidney complication","SearchInclusion":"Drug or chemical induced diabetes mellitus with renal tubular degeneration","ClinicalNotes":""},
    {"ICD10Code":"E09.311","Description":"Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy with macular edema","SearchInclusion":"Diabetic retinopathy with macular edema due to drug induced diabetes mellitus\nDrug induced diabetes with macular edema","ClinicalNotes":""},
    {"ICD10Code":"E09.319","Description":"Drug or chemical induced diabetes mellitus with unspecified diabetic retinopathy without macular edema","SearchInclusion":"Diabetic retinopathy without macular edema due to drug induced diabetes mellitus\nDrug induced diabetes with diabetic retinopathy","ClinicalNotes":""},
    {"ICD10Code":"E09.321","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3211","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3212","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3213","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3219","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.329","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3291","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3292","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3293","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3299","Description":"Drug or chemical induced diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.331","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3311","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3312","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3313","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3319","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.339","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3391","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3392","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3393","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3399","Description":"Drug or chemical induced diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.341","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3411","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3412","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3413","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3419","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.349","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3491","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3492","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3493","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3499","Description":"Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.351","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3511","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3512","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3513","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3519","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.359","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3591","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3592","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3593","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.3599","Description":"Drug or chemical induced diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.36","Description":"Drug or chemical induced diabetes mellitus with diabetic cataract","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.37X1","Description":"Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.37X2","Description":"Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.37X3","Description":"Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.37X9","Description":"Drug or chemical induced diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.39","Description":"Drug or chemical induced diabetes mellitus with other diabetic ophthalmic complication","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.40","Description":"Drug or chemical induced diabetes mellitus with neurological complications with diabetic neuropathy, unspecified","SearchInclusion":"Drug induced diabetes with diabetic neuropathy\nNeuropathy due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.41","Description":"Drug or chemical induced diabetes mellitus with neurological complications with diabetic mononeuropathy","SearchInclusion":"Drug induced diabetes with diabetic mononeuropathy\nMononeuropathy due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.42","Description":"Drug or chemical induced diabetes mellitus with neurological complications with diabetic polyneuropathy","SearchInclusion":"Drug induced diabetes with diabetic polyneuropathy\nPolyneuropathy due to drug induced diabetes mellitus                                                   Drug or chemical induced diabetes mellitus with diabetic neuralgia","ClinicalNotes":""},
    {"ICD10Code":"E09.43","Description":"Drug or chemical induced diabetes mellitus with neurological complications with diabetic autonomic (poly)neuropathy","SearchInclusion":"Autonomic neuropathy due to drug induced diabetes mellitus\nDrug induced diabetes with autonomic neuropathy                                                                                      Drug or chemical induced diabetes mellitus with diabetic gastroparesis","ClinicalNotes":""},
    {"ICD10Code":"E09.44","Description":"Drug or chemical induced diabetes mellitus with neurological complications with diabetic amyotrophy","SearchInclusion":"Amyotrophy due to drug induced diabetes mellitus\nDrug induced diabetes with diabetic amyotrophy","ClinicalNotes":""},
    {"ICD10Code":"E09.49","Description":"Drug or chemical induced diabetes mellitus with neurological complications with other diabetic neurological complication","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.51","Description":"Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy without gangrene","SearchInclusion":"Drug induced diabetes with peripheral vascular disease\nPeripheral vascular disease without gangrene due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.52","Description":"Drug or chemical induced diabetes mellitus with diabetic peripheral angiopathy with gangrene","SearchInclusion":"Drug induced diabetes with gangrene\nPeripheral vascular disease with gangrene due to drug induced diabetes","ClinicalNotes":""},
    {"ICD10Code":"E09.59","Description":"Drug or chemical induced diabetes mellitus with other circulatory complications","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.610","Description":"Drug or chemical induced diabetes mellitus with diabetic neuropathic arthropathy","SearchInclusion":"Drug or chemical induced diabetes mellitus with Charct's joints                         Drug induced diabetes with charcot arthropathy\nNeuropathic arthropathy due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.618","Description":"Drug or chemical induced diabetes mellitus with other diabetic arthropathy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.620","Description":"Drug or chemical induced diabetes mellitus with diabetic dermatitis","SearchInclusion":"Drug or chemical induced diabetes mellitus with diabetic necrobiosis lipoidica                                                                                                                                           Dermatitis due to drug induced diabetes mellitus\nDrug induced diabetes with diabetic dermatitis","ClinicalNotes":""},
    {"ICD10Code":"E09.621","Description":"Drug or chemical induced diabetes mellitus with foot ulcer","SearchInclusion":"Drug induced diabetes with diabetic foot ulcer\nFoot ulcer due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.622","Description":"Drug or chemical induced diabetes mellitus with other skin ulcer","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.628","Description":"Drug or chemical induced diabetes mellitus with other skin complications","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.630","Description":"Drug or chemical induced diabetes mellitus with periodontal disease","SearchInclusion":"Periodontal disease due to drug induced dm\nPeriodontal disease due to drug-induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.638","Description":"Drug or chemical induced diabetes mellitus with other oral complications","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.641","Description":"Drug or chemical induced diabetes mellitus with hypoglycemia with coma","SearchInclusion":"Drug induced dm w hypoglycemic coma\nHypoglycemic coma due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.649","Description":"Drug or chemical induced diabetes mellitus with hypoglycemia without coma","SearchInclusion":"Drug induced dm w hypoglycemia\nHypoglycemia without coma due to drug induced diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E09.65","Description":"Drug or chemical induced diabetes mellitus with hyperglycemia","SearchInclusion":"Drug induced dm w hyperglycemia\nHyperglycemia due to drug induced diabetes mellitus\nHyperglycemia due to steroid induced diabetes mellitus\nSteroid induced diabetes with hyperglycemia","ClinicalNotes":""},
    {"ICD10Code":"E09.69","Description":"Drug or chemical induced diabetes mellitus with other specified complication","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E09.8","Description":"Drug or chemical induced diabetes mellitus with unspecified complications","SearchInclusion":"Drug induced diabetes mellitus with complications\nDrug induced diabetes with unspecified complication","ClinicalNotes":""},
    {"ICD10Code":"E09.9","Description":"Drug or chemical induced diabetes mellitus without complications","SearchInclusion":"Diabetes, steroid induced\nDrug induced diabetes\nDrug-induced diabetes mellitus\nDrug-induced diabetes mellitus without complications\nSteroid-induced diabetes","ClinicalNotes":""},
    {"ICD10Code":"E10.10","Description":"Type 1 diabetes mellitus with ketoacidosis without coma                                                                                                                                                                                                         Y","SearchInclusion":"Diabetes type 1 with ketoacidosis\nKetoacidosis in type 1 diabetes mellitus\nKetoacidosis in type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.11","Description":"Type 1 diabetes mellitus with ketoacidosis with coma                                                                                                                                                                                                            Y","SearchInclusion":"Diabetes mellitus, type 1 with ketoacidotic coma\nKetoacidotic coma in type 1 diabetes mellitus\nKetoacidotic coma in type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.21","Description":"Type 1 diabetes mellitus with diabetic nephropathy                                                                                                                                                                                                              Y","SearchInclusion":"Type 1 diabetes mellitus with intercapillary glomerulosclerosis\nType 1 diabetes mellitus with intracapillary glomerulonephrosis\nType 1 diabetes mellitus with Kimmelstiel-Wilson disease                                                                                Diabetes type 1 with diabetic nephropathy\nRenal disorder associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.22","Description":"Type 1 diabetes mellitus with diabetic chronic kidney disease                                                                                                                                                                                                   Y","SearchInclusion":"Chronic kidney disease due to type 1 diabetes mellitus\nChronic kidney disease stage 1 due to type 1 diabetes mellitus\nChronic kidney disease stage 2 due to type 1 diabetes mellitus\nChronic kidney disease stage 3 due to type 1 diabetes mellitus\nChronic kidney disease stage 4 due to type 1 diabetes mellitus\nChronic kidney disease stage 5 due to type 1 diabetes mellitus\nChronic kidney disease with end stage renal disease on dialysis due to type 1 diabetes mellitus\nDiabetes 1 with end stage renal disease on dialysis\nDiabetes type 1 on dialysis\nDiabetes type 1 with chronic kidney disease\nDiabetes type 1 with mild chronic kidney disease\nDiabetes type 1, moderate chronic kidney disease\nDiabetes type 1, severe chronic kidney disease\nHypertension in chronic kidney disease due to type 1 diabetes mellitus\nHypertension in chronic kidney disease with end stage renal disease on dialysis due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.29","Description":"Type 1 diabetes mellitus with other diabetic kidney complication                                                                                                                                                                                                Y","SearchInclusion":"Diabetes type 1 with kidney complications\nDiabetes type 1 with microalbuminemia\nDiabetes type 1 with nephrotic syndrome\nDiabetes, type 1 with proteinuria\nMicroalbuminuria due to type 1 diabetes mellitus\nNephrotic syndrome due to type 1 diabetes mellitus\nProteinuria due to type 1 diabetes mellitus\nRenal disorder associated with type 1 diabetes mellitus\nRenal disorder associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.311","Description":"Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema                                                                                                                                                                               Y","SearchInclusion":"Diabetes type 1 retinal edema\nDiabetes type 1 with macular edema and retinopathy\nMacular edema and retinopathy due to type 1 diabetes mellitus\nRetinal edema due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.319","Description":"Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema                                                                                                                                                                            Y","SearchInclusion":"Diabetes type 1 with retinopathy\nDiabetic retinopathy associated with type 1 diabetes mellitus\nDiabetic retinopathy associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"","Description":"","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3211","Description":"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3212","Description":"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3213","Description":"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3219","Description":"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"","Description":"","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3291","Description":"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3292","Description":"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3293","Description":"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3299","Description":"Type 1 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3311","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3312","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3313","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3319","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.339","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema                                                                                                                                                              Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3391","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3392","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3393","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3399","Description":"Type 1 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3411","Description":"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3412","Description":"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3413","Description":"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3419","Description":"Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3511","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3512","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3513","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3519","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3511","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3512","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3513","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3519","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3521","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3522","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3523","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3529","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.353","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3531","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3532","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3533","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3539","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3541","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3542","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3543","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3549","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3551","Description":"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3552","Description":"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3553","Description":"Type 1 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.359","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema                                                                                                                                                                          Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3591","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3592","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3593","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.3599","Description":"Type 1 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.36","Description":"Type 1 diabetes mellitus with diabetic cataract                                                                                                                                                                                                                 Y","SearchInclusion":"Diabetes, type 1 with cataract\nDiabetic cataract associated with type 1 diabetes mellitus\nDiabetic cataract associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.37X1","Description":"Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.37X2","Description":"Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.37X3","Description":"Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.37X9","Description":"Type 1 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.39","Description":"Type 1 diabetes mellitus with other diabetic ophthalmic complication                                                                                                                                                                                            Y","SearchInclusion":"Blindness due to type 1 diabetes mellitus\nDiabetes mellitus type 1 w complications\nDiabetes type 1 with blindness one eye\nDiabetes type 1 with eye complications\nDiabetes type 1 with retinal detachment\nDiabetes type 1 with retinal ischemia\nDiabetes type 1 with rubeosis iridis\nDiabetes type 1 with vitreous hemorrhage\nDiabetic oculopathy associated with type 1 diabetes mellitus\nDiabetic oculopathy associated with type i diabetes mellitus\nGlaucoma due to type 1 diabetes mellitus\nRetinal ischemia due to type 1 diabetes mellitus\nRubeosis iridis due to type 1 diabetes mellitus\nTraction retinal detachment due to type 1 diabetes mellitus\nUnilateral blindness due to type 1 diabetes mellitus\nVitreous hemorrhage due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.40","Description":"Type 1 diabetes mellitus with diabetic neuropathy, unspecified                                                                                                                                                                                                  Y","SearchInclusion":"Diabetes type 1 with neuropathy\nDiabetes type 1 with peripheral neuropathy\nDiabetes type 1 with peripheral sensory neuropathy\nNeuropathy due to type 1 diabetes mellitus\nPeripheral neuropathy due to type 1 diabetes mellitus\nSensory neuropathy due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.41","Description":"Type 1 diabetes mellitus with diabetic mononeuropathy                                                                                                                                                                                                           Y","SearchInclusion":"Diabetes, type 1 with neuropathy\nMononeuropathy associated with type 1 diabetes mellitus\nMononeuropathy associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.42","Description":"Type 1 diabetes mellitus with diabetic polyneuropathy                                                                                                                                                                                                           Y","SearchInclusion":"Diabetes type 1 with peripheral neuropathy\nDiabetes, type 1 with neuropathy\nPeripheral neuropathy due to type 1 diabetes mellitus\nPolyneuropathy associated with type 1 diabetes mellitus\nPolyneuropathy associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.43","Description":"Type 1 diabetes mellitus with diabetic autonomic (poly)neuropathy                                                                                                                                                                                               Y","SearchInclusion":"Autonomic neuropathy due to type 1 diabetes mellitus\nDiabetes type 1 with autonomic neuropathy\nDiabetes type 1 with gastroparesis\nDiabetic gastroparesis associated with type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.44","Description":"Type 1 diabetes mellitus with diabetic amyotrophy                                                                                                                                                                                                               Y","SearchInclusion":"Amyotrophy due to type 1 diabetes mellitus\nAmyotrophy, in diabetes type 1\nDiabetes, type 1 with amyotrophy","ClinicalNotes":""},
    {"ICD10Code":"E10.49","Description":"Type 1 diabetes mellitus with other diabetic neurological complication                                                                                                                                                                                          Y","SearchInclusion":"Cranial nerve palsy due to type 1 diabetes mellitus\nDiabetes type 1 with cranial nerve palsy\nDiabetes type 1 with neurologic disorder\nNeurological disorder associated with type 1 diabetes mellitus\nNeurological disorder associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.51","Description":"Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene                                                                                                                                                                                   Y","SearchInclusion":"Diabetes type 1 with peripheral vascular disease\nDiabetes type 1 with small vessel disease\nPeripheral angiopathy due to type 1 diabetes mellitus\nSmall vessel disease due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.52","Description":"Type 1 diabetes mellitus with diabetic peripheral angiopathy with gangrene                                                                                                                                                                                      Y","SearchInclusion":"Diabetes, type 1 with gangrene\nGangrene associated with type 1 diabetes mellitus\nGangrene associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.59","Description":"Type 1 diabetes mellitus with other circulatory complications                                                                                                                                                                                                   Y","SearchInclusion":"Diabetes mellitus type 1 w/ complications\nPeripheral circulatory disorder associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.610","Description":"Type 1 diabetes mellitus with diabetic neuropathic arthropathy                                                                                                                                                                                                  Y","SearchInclusion":"Diabetes type 1 with charcots arthropathy\nNeuropathic arthropathy due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.618","Description":"Type 1 diabetes mellitus with other diabetic arthropathy                                                                                                                                                                                                        Y","SearchInclusion":"Diabetes type 1 with arthropathy\nType 1 diabetes mellitus with arthropathy","ClinicalNotes":""},
    {"ICD10Code":"E10.620","Description":"Type 1 diabetes mellitus with diabetic dermatitis                                                                                                                                                                                                               Y","SearchInclusion":"Dermatitis due to type 1 diabetes mellitus\nDiabetes type 1 with diabetic dermatitis ","ClinicalNotes":""},
    {"ICD10Code":"E10.621","Description":"Type 1 diabetes mellitus with foot ulcer                                                                                                                                                                                                                        Y","SearchInclusion":"Diabetes type 1 with diabetic foot ulcer\nDiabetes type 1 with diabetic ulcer of foot\nDiabetes type 1 with diabetic ulcer of foot, bone necrosis\nDiabetes type 1 with diabetic ulcer of foot, muscle necrosis\nDiabetes type 1 with diabetic ulcer of foot, skin breakdown\nDiabetes type 1 with diabetic ulcer of heel\nDiabetes type 1 with diabetic ulcer of heel, bone necrosis\nDiabetes type 1 with diabetic ulcer of heel, muscle necrosis\nDiabetes type 1 with diabetic ulcer of heel, skin breakdown\nDiabetes type 1 with diabetic ulcer of left foot\nDiabetes type 1 with diabetic ulcer of left foot, bone necrosis\nDiabetes type 1 with diabetic ulcer of left foot, muscle necrosis\nDiabetes type 1 with diabetic ulcer of left foot, skin breakdown\nDiabetes type 1 with diabetic ulcer of left heel\nDiabetes type 1 with diabetic ulcer of left heel, bone necrosis\nDiabetes type 1 with diabetic ulcer of left heel, muscle necrosis\nDiabetes type 1 with diabetic ulcer of left heel, skin breakdown\nDiabetes type 1 with diabetic ulcer of left midfoot\nDiabetes type 1 with diabetic ulcer of left midfoot, bone necrosis\nDiabetes type 1 with diabetic ulcer of left midfoot, muscle necrosis\nDiabetes type 1 with diabetic ulcer of left midfoot, skin breakdown\nDiabetes type 1 with diabetic ulcer of midfoot\nDiabetes type 1 with diabetic ulcer of midfoot, bone necrosis\nDiabetes type 1 with diabetic ulcer of midfoot, muscle necrosis\nDiabetes type 1 with diabetic ulcer of midfoot, skin breakdown\nDiabetes type 1 with diabetic ulcer of right foot\nDiabetes type 1 with diabetic ulcer of right foot, bone necrosis\nDiabetes type 1 with diabetic ulcer of right foot, muscle necrosis\nDiabetes type 1 with diabetic ulcer of right foot, skin breakdown\nDiabetes type 1 with diabetic ulcer of right heel\nDiabetes type 1 with diabetic ulcer of right heel, bone necrosis\nDiabetes type 1 with diabetic ulcer of right heel, muscle necrosis\nDiabetes type 1 with diabetic ulcer of right heel, skin breakdown\nDiabetes type 1 with diabetic ulcer of right midfoot\nDiabetes type 1 with diabetic ulcer of right midfoot, bone necrosis\nDiabetes type 1 with diabetic ulcer of right midfoot, muscle necrosis\nDiabetes type 1 with diabetic ulcer of right midfoot, skin breakdown\nDiabetes type 1 with foot ulcer\nDiabetic ulcer of foot limited to skin layer due to dm 1\nDiabetic ulcer of foot with bone necrosis due to dm 1\nDiabetic ulcer of foot with fat layer exposure due to dm 1\nDiabetic ulcer of foot with muscle necrosis due to dm 1\nDiabetic ulcer of heel due to dm 1\nDiabetic ulcer of heel limited to skin layer due to dm 1\nDiabetic ulcer of heel with bone necrosis due to dm 1\nDiabetic ulcer of heel with fat layer exposure due to dm 1\nDiabetic ulcer of heel with muscle necrosis due to dm 1\nDiabetic ulcer of left foot due to diabetes mellitus type 1\nDiabetic ulcer of left foot due to dm 1\nDiabetic ulcer of left foot limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of left foot limited to skin layer due to dm 1\nDiabetic ulcer of left foot with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left foot with bone necrosis due to dm 1\nDiabetic ulcer of left foot with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of left foot with fat layer exposure due to dm 1\nDiabetic ulcer of left foot with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left foot with muscle necrosis due to dm 1\nDiabetic ulcer of left heel due to diabetes mellitus type 1\nDiabetic ulcer of left heel due to dm 1\nDiabetic ulcer of left heel limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of left heel limited to skin layer due to dm 1\nDiabetic ulcer of left heel with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left heel with bone necrosis due to dm 1\nDiabetic ulcer of left heel with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of left heel with fat layer exposure due to dm 1\nDiabetic ulcer of left heel with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left heel with muscle necrosis due to dm 1\nDiabetic ulcer of left midfoot due to diabetes mellitus type 1\nDiabetic ulcer of left midfoot due to dm 1\nDiabetic ulcer of left midfoot limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of left midfoot limited to skin layer due to dm 1\nDiabetic ulcer of left midfoot with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left midfoot with bone necrosis due to dm 1\nDiabetic ulcer of left midfoot with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of left midfoot with fat layer exposure due to dm 1\nDiabetic ulcer of left midfoot with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left midfoot with muscle necrosis due to dm 1\nDiabetic ulcer of midfoot due to dm 1\nDiabetic ulcer of midfoot limited to skin layer due to dm 1\nDiabetic ulcer of midfoot with bone necrosis due to dm 1\nDiabetic ulcer of midfoot with fat layer exposure due to dm 1\nDiabetic ulcer of midfoot with muscle necrosis due to dm 1\nDiabetic ulcer of right foot due to diabetes mellitus type 1\nDiabetic ulcer of right foot due to dm 1\nDiabetic ulcer of right foot limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of right foot limited to skin layer due to dm 1\nDiabetic ulcer of right foot with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right foot with bone necrosis due to dm 1\nDiabetic ulcer of right foot with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of right foot with fat layer exposure due to dm 1\nDiabetic ulcer of right foot with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right foot with muscle necrosis due to dm 1\nDiabetic ulcer of right heel due to diabetes mellitus type 1\nDiabetic ulcer of right heel due to dm 1\nDiabetic ulcer of right heel limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of right heel limited to skin layer due to dm 1\nDiabetic ulcer of right heel with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right heel with bone necrosis due to dm 1\nDiabetic ulcer of right heel with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of right heel with fat layer exposure due to dm 1\nDiabetic ulcer of right heel with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right heel with muscle necrosis due to dm 1\nDiabetic ulcer of right midfoot due to diabetes mellitus type 1\nDiabetic ulcer of right midfoot due to dm 1\nDiabetic ulcer of right midfoot limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of right midfoot limited to skin layer due to dm 1\nDiabetic ulcer of right midfoot with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right midfoot with bone necrosis due to dm 1\nDiabetic ulcer of right midfoot with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of right midfoot with fat layer exposure due to dm 1\nDiabetic ulcer of right midfoot with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right midfoot with muscle necrosis due to dm 1\nFoot ulcer due to type 1 diabetes mellitus\nForefoot ulcer due to type 1 diabetes mellitus\nHeel and/or midfoot ulcer due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.622","Description":"Type 1 diabetes mellitus with other skin ulcer                                                                                                                                                                                                                  Y","SearchInclusion":"Ankle ulcer due to type 1 diabetes mellitus\nChronic ulcer of skin due to type 1 diabetes mellitus\nDiabetes type 1 with chronic skin ulcer\nDiabetes type 1 with diabetic skin ulcer\nDiabetes type 1 with diabetic ulcer of ankle\nDiabetes type 1 with diabetic ulcer of ankle, bone necrosis\nDiabetes type 1 with diabetic ulcer of ankle, muscle necrosis\nDiabetes type 1 with diabetic ulcer of ankle, skin breakdown\nDiabetes type 1 with diabetic ulcer of calf\nDiabetes type 1 with diabetic ulcer of calf, bone necrosis\nDiabetes type 1 with diabetic ulcer of calf, muscle necrosis\nDiabetes type 1 with diabetic ulcer of calf, skin breakdown\nDiabetes type 1 with diabetic ulcer of left ankle\nDiabetes type 1 with diabetic ulcer of left ankle, bone necrosis\nDiabetes type 1 with diabetic ulcer of left ankle, muscle necrosis\nDiabetes type 1 with diabetic ulcer of left ankle, skin breakdown\nDiabetes type 1 with diabetic ulcer of left calf\nDiabetes type 1 with diabetic ulcer of left calf, bone necrosis\nDiabetes type 1 with diabetic ulcer of left calf, muscle necrosis\nDiabetes type 1 with diabetic ulcer of left calf, skin breakdown\nDiabetes type 1 with diabetic ulcer of left lower leg\nDiabetes type 1 with diabetic ulcer of left lower leg, bone necrosis\nDiabetes type 1 with diabetic ulcer of left lower leg, muscle necrosis\nDiabetes type 1 with diabetic ulcer of left lower leg, skin breakdown\nDiabetes type 1 with diabetic ulcer of left thigh\nDiabetes type 1 with diabetic ulcer of left thigh, bone necrosis\nDiabetes type 1 with diabetic ulcer of left thigh, muscle necrosis\nDiabetes type 1 with diabetic ulcer of left thigh, skin breakdown\nDiabetes type 1 with diabetic ulcer of left toe\nDiabetes type 1 with diabetic ulcer of left toe, bone necrosis\nDiabetes type 1 with diabetic ulcer of left toe, muscle necrosis\nDiabetes type 1 with diabetic ulcer of left toe, skin breakdown\nDiabetes type 1 with diabetic ulcer of lower leg\nDiabetes type 1 with diabetic ulcer of lower leg, bone necrosis\nDiabetes type 1 with diabetic ulcer of lower leg, muscle necrosis\nDiabetes type 1 with diabetic ulcer of lower leg, skin breakdown\nDiabetes type 1 with diabetic ulcer of right ankle\nDiabetes type 1 with diabetic ulcer of right ankle, bone necrosis\nDiabetes type 1 with diabetic ulcer of right ankle, muscle necrosis\nDiabetes type 1 with diabetic ulcer of right ankle, skin breakdown\nDiabetes type 1 with diabetic ulcer of right calf\nDiabetes type 1 with diabetic ulcer of right calf, bone necrosis\nDiabetes type 1 with diabetic ulcer of right calf, muscle necrosis\nDiabetes type 1 with diabetic ulcer of right calf, skin breakdown\nDiabetes type 1 with diabetic ulcer of right lower leg\nDiabetes type 1 with diabetic ulcer of right lower leg, bone necrosis\nDiabetes type 1 with diabetic ulcer of right lower leg, muscle necrosis\nDiabetes type 1 with diabetic ulcer of right lower leg, skin breakdown\nDiabetes type 1 with diabetic ulcer of right thigh\nDiabetes type 1 with diabetic ulcer of right thigh, bone necrosis\nDiabetes type 1 with diabetic ulcer of right thigh, muscle necrosis\nDiabetes type 1 with diabetic ulcer of right thigh, skin breakdown\nDiabetes type 1 with diabetic ulcer of right toe\nDiabetes type 1 with diabetic ulcer of right toe, bone necrosis\nDiabetes type 1 with diabetic ulcer of right toe, muscle necrosis\nDiabetes type 1 with diabetic ulcer of right toe, skin breakdown\nDiabetes type 1 with diabetic ulcer of thigh\nDiabetes type 1 with diabetic ulcer of thigh, bone necrosis\nDiabetes type 1 with diabetic ulcer of thigh, muscle necrosis\nDiabetes type 1 with diabetic ulcer of thigh, skin breakdown\nDiabetes type 1 with diabetic ulcer of toe\nDiabetes type 1 with diabetic ulcer of toe, bone necrosis\nDiabetes type 1 with diabetic ulcer of toe, muscle necrosis\nDiabetes type 1 with diabetic ulcer of toe, skin breakdown\nDiabetes type 1 with leg ulcer\nDiabetes, type 1 with ankle ulcer\nDiabetic ulcer of ankle limited to skin layer due to dm 1\nDiabetic ulcer of ankle with bone necrosis due to dm 1\nDiabetic ulcer of ankle with fat layer exposure due to dm 1\nDiabetic ulcer of ankle with muscle necrosis due to dm 1\nDiabetic ulcer of calf due to dm 1\nDiabetic ulcer of calf limited to skin layer due to dm 1\nDiabetic ulcer of calf with bone necrosis due to dm 1\nDiabetic ulcer of calf with fat layer exposure due to dm 1\nDiabetic ulcer of calf with muscle necrosis due to dm 1\nDiabetic ulcer of left ankle due to diabetes mellitus type 1\nDiabetic ulcer of left ankle due to dm 1\nDiabetic ulcer of left ankle limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of left ankle limited to skin layer due to dm 1\nDiabetic ulcer of left ankle with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left ankle with bone necrosis due to dm 1\nDiabetic ulcer of left ankle with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of left ankle with fat layer exposure due to dm 1\nDiabetic ulcer of left ankle with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left ankle with muscle necrosis due to dm 1\nDiabetic ulcer of left calf due to diabetes mellitus type 1\nDiabetic ulcer of left calf due to dm 1\nDiabetic ulcer of left calf limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of left calf limited to skin layer due to dm 1\nDiabetic ulcer of left calf with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left calf with bone necrosis due to dm 1\nDiabetic ulcer of left calf with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of left calf with fat layer exposure due to dm 1\nDiabetic ulcer of left calf with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left calf with muscle necrosis due to dm 1\nDiabetic ulcer of left lower leg due to diabetes mellitus type 1\nDiabetic ulcer of left lower leg limited to breakdown of skin layer due to dm 1\nDiabetic ulcer of left lower leg limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of left lower leg with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left lower leg with bone necrosis due to dm 1\nDiabetic ulcer of left lower leg with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of left lower leg with fat layer exposure due to dm 1\nDiabetic ulcer of left lower leg with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left lower leg with muscle necrosis due to dm 1\nDiabetic ulcer of left ower leg due to dm 1\nDiabetic ulcer of left thigh due to diabetes mellitus type 1\nDiabetic ulcer of left thigh due to dm 1\nDiabetic ulcer of left thigh limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of left thigh limited to skin layer due to dm 1\nDiabetic ulcer of left thigh with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left thigh with bone necrosis due to dm 1\nDiabetic ulcer of left thigh with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of left thigh with fat layer exposure due to dm 1\nDiabetic ulcer of left thigh with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left thigh with muscle necrosis due to dm 1\nDiabetic ulcer of left toe due to diabetes mellitus type 1\nDiabetic ulcer of left toe due to dm 1\nDiabetic ulcer of left toe limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of left toe limited to skin layer due to dm 1\nDiabetic ulcer of left toe with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left toe with bone necrosis due to dm 1\nDiabetic ulcer of left toe with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of left toe with fat layer exposure due to dm 1\nDiabetic ulcer of left toe with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of left toe with muscle necrosis due to dm 1\nDiabetic ulcer of lower leg due to dm 1\nDiabetic ulcer of lower leg limited to skin layer due to dm 1\nDiabetic ulcer of lower leg with bone necrosis due to dm 1\nDiabetic ulcer of lower leg with fat layer exposure due to dm 1\nDiabetic ulcer of lower leg with muscle necrosis due to dm 1\nDiabetic ulcer of right ankle due to diabetes mellitus type 1\nDiabetic ulcer of right ankle due to dm 1\nDiabetic ulcer of right ankle limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of right ankle limited to skin layer due to dm 1\nDiabetic ulcer of right ankle with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right ankle with bone necrosis due to dm 1\nDiabetic ulcer of right ankle with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of right ankle with fat layer exposure due to dm 1\nDiabetic ulcer of right ankle with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right ankle with muscle necrosis due to dm 1\nDiabetic ulcer of right calf due to diabetes mellitus type 1\nDiabetic ulcer of right calf due to dm 1\nDiabetic ulcer of right calf limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of right calf limited to skin layer due to dm 1\nDiabetic ulcer of right calf with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right calf with bone necrosis due to dm 1\nDiabetic ulcer of right calf with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of right calf with fat layer exposure due to dm 1\nDiabetic ulcer of right calf with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right calf with muscle necrosis due to dm 1\nDiabetic ulcer of right lower leg due to diabetes mellitus type 1\nDiabetic ulcer of right lower leg due to dm 1\nDiabetic ulcer of right lower leg limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of right lower leg limited to skin layer due to dm 1\nDiabetic ulcer of right lower leg with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right lower leg with bone necrosis due to dm 1\nDiabetic ulcer of right lower leg with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of right lower leg with fat layer exposure due to dm 1\nDiabetic ulcer of right lower leg with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right lower leg with muscle necrosis due to dm 1\nDiabetic ulcer of right thigh due to diabetes mellitus type 1\nDiabetic ulcer of right thigh due to dm 1\nDiabetic ulcer of right thigh limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of right thigh limited to skin layer due to dm 1\nDiabetic ulcer of right thigh with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right thigh with bone necrosis due to dm 1\nDiabetic ulcer of right thigh with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of right thigh with fat layer exposure due to dm 1\nDiabetic ulcer of right thigh with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right thigh with muscle necrosis due to dm 1\nDiabetic ulcer of right toe due to diabetes mellitus type 1\nDiabetic ulcer of right toe due to dm 1\nDiabetic ulcer of right toe limited to skin layer due to diabetes mellitus type 1\nDiabetic ulcer of right toe limited to skin layer due to dm 1\nDiabetic ulcer of right toe with bone necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right toe with bone necrosis due to dm 1\nDiabetic ulcer of right toe with fat layer exposure due to diabetes mellitus type 1\nDiabetic ulcer of right toe with fat layer exposure due to dm 1\nDiabetic ulcer of right toe with muscle necrosis due to diabetes mellitus type 1\nDiabetic ulcer of right toe with muscle necrosis due to dm 1\nDiabetic ulcer of thigh due to dm 1\nDiabetic ulcer of thigh limited to skin layer due to dm 1\nDiabetic ulcer of thigh with bone necrosis due to dm 1\nDiabetic ulcer of thigh with fat layer exposure due to dm 1\nDiabetic ulcer of thigh with muscle necrosis due to dm 1\nDiabetic ulcer of toe due to dm 1\nDiabetic ulcer of toe limited to skin layer due to dm 1\nDiabetic ulcer of toe with bone necrosis due to dm 1\nDiabetic ulcer of toe with fat layer exposure due to dm 1\nDiabetic ulcer of toe with muscle necrosis due to dm 1\nSkin ulcer due to type 1 diabetes mellitus\nUlcer of lower limb due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.628","Description":"Type 1 diabetes mellitus with other skin complications                                                                                                                                                                                                          Y","SearchInclusion":"Cheiropathy due to type 1 diabetes mellitus\nDiabetes type 1 with cheiropathy\nDiabetes, type 1 with dermopathy\nDiabetic dermopathy due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.630","Description":"Type 1 diabetes mellitus with periodontal disease                                                                                                                                                                                                               Y","SearchInclusion":"Periodontal disease due to diabetes type 1\nPeriodontal disease due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.638","Description":"Type 1 diabetes mellitus with other oral complications                                                                                                                                                                                                          Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E10.641","Description":"Type 1 diabetes mellitus with hypoglycemia with coma                                                                                                                                                                                                            Y","SearchInclusion":"Diabetes type 1 with hypoglycemic coma\nHypoglycemic coma in type 1 diabetes mellitus\nHypoglycemic coma in type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.649","Description":"Type 1 diabetes mellitus with hypoglycemia without coma                                                                                                                                                                                                         Y","SearchInclusion":"Diabetes 1 with hypoglycemia unawareness\nDiabetes type 1 with hypoglycemia\nHypoglycemia due to type 1 diabetes mellitus\nUnawareness of hypoglycemia in type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.65","Description":"Type 1 diabetes mellitus with hyperglycemia                                                                                                                                                                                                                     Y","SearchInclusion":"Diabetes type 1 with hyperglycemia\nHyperglycemia due to type 1 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.69","Description":"Type 1 diabetes mellitus with other specified complication                                                                                                                                                                                                      Y","SearchInclusion":"Diabetes mellitus, juvenile type, with hyperosmolar coma\nDiabetes mellitus, type 1 with hyperosmolar coma\nDiabetes type 1 with dyslipidemia\nDiabetes type 1 with erectile dysfunction\nDiabetes type 1 with hyperliidemia\nDiabetes type 1 with hyperlipidemia\nDiabetes type 1 with hyperosmolarity\nDiabetes type 1 with severe malnutrition\nDiabetes, type 1 with osteomyelitis\nDiabetic erectile dysfunction associated with type 1 diabetes mellitus\nDyslipidemia due to type 1 diabetes mellitus\nHyperlipidemia due to type 1 diabetes mellitus\nHyperosmolarity due to type 1 diabetes mellitus\nMale erectile dysfunction due to type 1 diabetes mellitus\nMixed hyperlipidemia associated with type 1 diabetes mellitus\nMixed hyperlipidemia due to type 1 diabetes mellitus\nOsteomyelitis due to type 1 diabetes mellitus\nSevere malnutrition due to type 1 diabetes mellitus\nType 1 diabetes mellitus with hyperosmolar coma","ClinicalNotes":""},
    {"ICD10Code":"E10.8","Description":"Type 1 diabetes mellitus with unspecified complications                                                                                                                                                                                                         Y","SearchInclusion":"Diabetes mellitus, type 1 with complication\nDisorder associated with type i diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E10.9","Description":"Type 1 diabetes mellitus without complications                                                                                                                                                                                                                  Y","SearchInclusion":"Diabetes mellitus type 1\nDiabetes mellitus type 1 without retinopathy\nDiabetes type 1\nDiabetes type 1, without complication\nNutrition therapy for diabetes type 1 done\nNutritional therapy for diabetes mellitus type 1\nType 1 diabetes mellitus\nType 1 diabetes mellitus without complication","ClinicalNotes":""},
    {"ICD10Code":"E11.00","Description":"Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)                                                                                                                                                        Y","SearchInclusion":"Diabetes type 2 with hyperosmolarity\nHyperosmolarity without nonketotic hyperglycemic hyperosmolar coma due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.01","Description":"Type 2 diabetes mellitus with hyperosmolarity with coma                                                                                                                                                                                                         Y","SearchInclusion":"Diabetes mellitus, adult onset, with hyperosmolar coma\nDiabetes mellitus, type 2 with hyperosmolar coma\nType 2 diabetes mellitus with hyperosmolar coma","ClinicalNotes":""},
    {"ICD10Code":"E11.10","Description":"Type 2 diabetes mellitus with ketoacidosis without coma","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.11","Description":"Type 2 diabetes mellitus with ketoacidosis with coma","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.21","Description":"Type 2 diabetes mellitus with diabetic nephropathy                                                                                                                                                                                                              Y","SearchInclusion":"Type 2 diabetes mellitus with intercapillary glomerulosclerosis\nType 2 diabetes mellitus with intracapillary glomerulonephrosis\nType 2 diabetes mellitus with Kimmelstiel-Wilson disease                                                                   Diabetes type 2 with nephrotic syndrome\nDiabetes, type 2 with nephropathy\nNephrotic syndrome due to type 2 diabetes mellitus\nPersistent proteinuria associated with type ii diabetes mellitus\nRenal disorder associated with type ii diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.22","Description":"Type 2 diabetes mellitus with diabetic chronic kidney disease                                                                                                                                                                                                   Y","SearchInclusion":"Chronic kidney disease due to type 2 diabetes mellitus\nChronic kidney disease due to type 2 diabetes mellitus with hyperparathyroidism due to end stage renal disease on dialysis\nChronic kidney disease stage 1 associated with type 2 diabetes mellitus\nChronic kidney disease stage 1 due to type 2 diabetes mellitus\nChronic kidney disease stage 2 associated with type 2 diabetes mellitus\nChronic kidney disease stage 2 due to type 2 diabetes mellitus\nChronic kidney disease stage 3 associated with type 2 diabetes mellitus\nChronic kidney disease stage 3 due to type 2 diabetes mellitus\nChronic kidney disease stage 4 associated with type 2 diabetes mellitus\nChronic kidney disease stage 4 due to type 2 diabetes mellitus\nChronic kidney disease stage 5 associated with type 2 diabetes mellitus\nChronic kidney disease stage 5 due to type 2 diabetes mellitus\nChronic kidney disease with end stage renal disease on dialysis due to type 2 diabetes mellitus\nChronic renal impairment associated with type 2 diabetes mellitus\nDiabetes 2 with end stage renal disease on dialysis\nDiabetes type 2 on dialysis\nDiabetes type 2 with chronic kidney disease\nDiabetes type 2 with kidney disease\nDiabetes type 2 with mild chronic kidney disease\nDiabetes type 2 with mild kidney disease\nDiabetes type 2 with moderate kidney disease\nDiabetes type 2 with severe kidney disease\nDiabetes type 2, mild chronic kidney disease\nDiabetes type 2, moderate chronic kidney disease\nDiabetes type 2, severe chronic kidney disease\nDm 2 w diabetic ckd, secondary hyperparathyroidism due to esrd, on dialysis\nEnd stage renal disease on dialysis due to type 2 diabetes mellitus\nHypertension concurrent and due to end stage renal disease on dialysis due to type 2 diabetes mellitus\nHypertension in chronic kidney disease due to type 2 diabetes mellitus\nHypertension in chronic kidney disease stage 1 due to type 2 diabetes mellitus\nHypertension in chronic kidney disease stage 2 due to type 2 diabetes mellitus\nHypertension in chronic kidney disease stage 3 due to type 2 diabetes mellitus\nHypertension in chronic kidney disease stage 4 due to type 2 diabetes mellitus\nHypertension in chronic kidney disease stage 5 due to type 2 diabetes mellitus\nHypertension in chronic kidney disease with end stage renal disease on dialysis due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.29","Description":"Type 2 diabetes mellitus with other diabetic kidney complication                                                                                                                                                                                                Y","SearchInclusion":"Type 2 diabetes mellitus with renal tubular degeneration                                  Diabetes type 2 with diabetic proteinuria\nDiabetes type 2 with kidney complications\nDiabetes type 2 with microalbuminemia\nMicroalbuminuria due to type 2 diabetes mellitus\nProteinuria due to type 2 diabetes mellitus\nProteinuria due to type 2 diabetes mellitus (disorder)\nRenal disorder associated with type 2 diabetes mellitus\nRenal disorder associated with type ii diabetes mellitus\nRenal disorder due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.311","Description":"Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema                                                                                                                                                                               Y","SearchInclusion":"Diabetes type 2 with macular edema and retinopathy\nDiabetes type 2 with retinal edema\nMacular edema and retinopathy due to type 2 diabetes mellitus\nRetinal edema due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.319","Description":"Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema                                                                                                                                                                            Y","SearchInclusion":"Diabetes type 2 with retinopathy\nDiabetic retinopathy associated with type 2 diabetes mellitus\nDiabetic retinopathy associated with type ii diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"","Description":"","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3211","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3212","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3213","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3219","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.329","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema                                                                                                                                                                  Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3291","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3292","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3293","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3299","Description":"Type 2 diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.331","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3311","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3312","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3313","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3319","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.339","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3391","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3392","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3393","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3399","Description":"Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.341","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3411","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3412","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3413","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3419","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.349","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3491","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3492","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3493","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3499","Description":"Type 2 diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.351","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema                                                                                                                                                                             Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3511","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3512","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3513","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3519","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3521","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3522","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3523","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3529","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3531","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3532","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3533","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3539","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3541","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3542","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3543","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3549","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3551","Description":"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3552","Description":"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3553","Description":"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3559","Description":"Type 2 diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.359","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema                                                                                                                                                                          Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3591","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3592","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3593","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.3599","Description":"Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.36","Description":"Type 2 diabetes mellitus with diabetic cataract                                                                                                                                                                                                                 Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.37X1","Description":"Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.37X2","Description":"Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.37X3","Description":"Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.37X9","Description":"Type 2 diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.39","Description":"Type 2 diabetes mellitus with other diabetic ophthalmic complication                                                                                                                                                                                            Y","SearchInclusion":"Blindness due to type 2 diabetes mellitus\nDiabetes mellitus type 2 w/ complications\nDiabetes type 2 with blindness one eye\nDiabetes type 2 with eye complications\nDiabetes type 2 with retinal detachment\nDiabetes type 2 with retinal ischemia\nDiabetes type 2 with rubeosis iridis\nDiabetes type 2 with suspect glaucoma\nDiabetes type 2 with vitreous hemorrhage\nDiabetic oculopathy associated with type 2 diabetes mellitus\nDiabetic oculopathy associated with type ii diabetes mellitus\nDiabetic vitreous hemorrhage associated with type 2 diabetes mellitus\nGlaucoma due to type 2 diabetes mellitus\nGlaucoma suspect due to type 2 diabetes mellitus\nRetinal ischemia due to type 2 diabetes mellitus\nRubeosis iridis due to type 2 diabetes mellitus\nTraction retinal detachment due to type 2 diabetes mellitus\nUnilateral blindness due to type 2 diabetes mellitus\nVitreous hemorrhage due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.40","Description":"Type 2 diabetes mellitus with diabetic neuropathy, unspecified                                                                                                                                                                                                  Y","SearchInclusion":"Diabetes 2, with neurogenic erectile dysfunction\nDiabetes type 2 with peripheral neuropathy\nDiabetes type 2 with peripheral sensory neuropathy\nDiabetes type2 with neuropathy\nDiabetic peripheral neuropathy associated with type 2 diabetes mellitus\nDm 2 with neuropathic ulcer foot and heel\nNeurogenic erectile dysfunction due to type 2 diabetes mellitus\nNeuropathic midfoot and/or heel ulcer due to type 2 diabetes mellitus\nNeuropathy due to type 2 diabetes mellitus\nPeripheral neuropathy due to type 2 diabetes mellitus\nPeripheral sensory neuropathy due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.41","Description":"Type 2 diabetes mellitus with diabetic mononeuropathy                                                                                                                                                                                                           Y","SearchInclusion":"Diabetes, type 2 with neuropathy\nMononeuropathy associated with type 2 diabetes mellitus\nMononeuropathy associated with type ii diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.42","Description":"Type 2 diabetes mellitus with diabetic polyneuropathy                                                                                                                                                                                                           Y","SearchInclusion":"Diabetes type 2 with diabetic polyneuropathy\nDiabetes type 2 with peripheral neuropathy\nDiabetic peripheral neuropathy associated with type 2 diabetes mellitus\nDiabetic polyneuropathy\nPolyneuropathy (disorder of multiple nerves) diabetic\nPolyneuropathy (multiple nerve disorder), diabetic\nPolyneuropathy associated with type 2 diabetes mellitus\nPolyneuropathy associated with type ii diabetes mellitus\nPolyneuropathy due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.43","Description":"Type 2 diabetes mellitus with diabetic autonomic (poly)neuropathy                                                                                                                                                                                               Y","SearchInclusion":"Diabetes type 2 with gastroparesis\nDiabetes type 2 with neuropathy\nDiabetic autonomic neuropathy associated with type 2 diabetes mellitus\nDiabetic gastroparesis associated with type 2 diabetes mellitus\nGastroparesis due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.44","Description":"Type 2 diabetes mellitus with diabetic amyotrophy                                                                                                                                                                                                               Y","SearchInclusion":"Amyotrophy due to type 2 diabetes mellitus\nAmyotrophy, in diabetes type 2\nDiabetes, type 2 with amyotrophy","ClinicalNotes":""},
    {"ICD10Code":"E11.49","Description":"Type 2 diabetes mellitus with other diabetic neurological complication                                                                                                                                                                                          Y","SearchInclusion":"Cranial nerve palsy due to type 2 diabetes mellitus\nDiabetes type 2 with cranial nerve palsy\nDiabetes type 2 with neurologic disorder\nDiabetes type 2 with neuropathic ulcer of ankle\nDiabetes type 2 with neuropathic ulcer of foot\nDiabetes type 2 with neuropathic ulcer of toe\nNeurologic disorder associated with type 2 diabetes mellitus\nNeurologic disorder associated with type ii diabetes mellitus\nNeuropathic ankle ulcer due to type 2 diabetes mellitus\nNeuropathic foot ulcer due to type 2 diabetes mellitus\nNeuropathic toe ulcer due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.51","Description":"Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene                                                                                                                                                                                   Y","SearchInclusion":"Diabetes mellitus type 2 with complications\nDiabetes type 2 with circulation disorder\nDiabetes type 2 with small vessel disease\nPeripheral circulatory disorder associated with type 2 diabetes mellitus\nPeripheral circulatory disorder associated with type ii diabetes mellitus\nPeripheral circulatory disorder due to type 2 diabetes mellitus\nSmall vessel disease due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.52","Description":"Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene                                                                                                                                                                                      Y","SearchInclusion":"Diabetes, type 2 with gangrene\nGangrene associated with type 2 diabetes mellitus\nGangrene associated with type ii diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.59","Description":"Type 2 diabetes mellitus with other circulatory complications                                                                                                                                                                                                   Y","SearchInclusion":"Diabetes type 2 w ischemic ulcer of midfoot and heel\nDiabetes type 2 with ischemic ulcer of ankle\nDiabetes type 2 with ischemic ulcer of foot\nDiabetes type 2 with ischemic ulcer of toe\nDiabetes type 2 with statis ulcer\nIschemic ankle ulcer due to type 2 diabetes mellitus\nIschemic foot ulcer due to type 2 diabetes mellitus\nIschemic heel and/or midfoot ulcer due to type 2 diabetes mellitus\nStasis ulcer due to type 2 diabetes mellitus\nUlcer of toe due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.610","Description":"Type 2 diabetes mellitus with diabetic neuropathic arthropathy                                                                                                                                                                                                  Y","SearchInclusion":"Diabetes type 2 with charcot's arthropathy\nDiabetic neuropathic arthropathy associated with type 2 diabetes mellitus\nNeuropathic arthropathy due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.618","Description":"Type 2 diabetes mellitus with other diabetic arthropathy                                                                                                                                                                                                        Y","SearchInclusion":"Diabetes type 2 with arthropathy\nType 2 diabetes mellitus with arthropathy","ClinicalNotes":""},
    {"ICD10Code":"E11.620","Description":"Type 2 diabetes mellitus with diabetic dermatitis                                                                                                                                                                                                               Y","SearchInclusion":"Dermatitis due to type 2 diabetes mellitus\nDiabetes type 2 with diabetic dermatitis","ClinicalNotes":""},
    {"ICD10Code":"E11.621","Description":"Type 2 diabetes mellitus with foot ulcer                                                                                                                                                                                                                        Y","SearchInclusion":"Diabetes type 2 w ischemic ulcer of midfoot and heel\nDiabetes type 2 with diabetic foot ulcer\nDiabetes type 2 with diabetic ulcer of foot\nDiabetes type 2 with diabetic ulcer of foot, bone necrosis\nDiabetes type 2 with diabetic ulcer of foot, muscle necrosis\nDiabetes type 2 with diabetic ulcer of foot, skin breakdown\nDiabetes type 2 with diabetic ulcer of heel\nDiabetes type 2 with diabetic ulcer of heel, bone necrosis\nDiabetes type 2 with diabetic ulcer of heel, muscle necrosis\nDiabetes type 2 with diabetic ulcer of heel, skin breakdown\nDiabetes type 2 with diabetic ulcer of left foot\nDiabetes type 2 with diabetic ulcer of left foot, bone necrosis\nDiabetes type 2 with diabetic ulcer of left foot, muscle necrosis\nDiabetes type 2 with diabetic ulcer of left foot, skin breakdown\nDiabetes type 2 with diabetic ulcer of left heel\nDiabetes type 2 with diabetic ulcer of left heel, bone necrosis\nDiabetes type 2 with diabetic ulcer of left heel, muscle necrosis\nDiabetes type 2 with diabetic ulcer of left heel, skin breakdown\nDiabetes type 2 with diabetic ulcer of left midfoot\nDiabetes type 2 with diabetic ulcer of left midfoot, bone necrosis\nDiabetes type 2 with diabetic ulcer of left midfoot, muscle necrosis\nDiabetes type 2 with diabetic ulcer of left midfoot, skin breakdown\nDiabetes type 2 with diabetic ulcer of midfoot\nDiabetes type 2 with diabetic ulcer of midfoot, bone necrosis\nDiabetes type 2 with diabetic ulcer of midfoot, muscle necrosis\nDiabetes type 2 with diabetic ulcer of midfoot, skin breakdown\nDiabetes type 2 with diabetic ulcer of right foot\nDiabetes type 2 with diabetic ulcer of right foot, bone necrosis\nDiabetes type 2 with diabetic ulcer of right foot, muscle necrosis\nDiabetes type 2 with diabetic ulcer of right foot, skin breakdown\nDiabetes type 2 with diabetic ulcer of right heel\nDiabetes type 2 with diabetic ulcer of right heel, bone necrosis\nDiabetes type 2 with diabetic ulcer of right heel, muscle necrosis\nDiabetes type 2 with diabetic ulcer of right heel, skin breakdown\nDiabetes type 2 with diabetic ulcer of right midfoot\nDiabetes type 2 with diabetic ulcer of right midfoot, bone necrosis\nDiabetes type 2 with diabetic ulcer of right midfoot, muscle necrosis\nDiabetes type 2 with diabetic ulcer of right midfoot, skin breakdown\nDiabetes type 2 with ischemic ulcer of foot\nDiabetes type 2 with neuropathic ulcer of foot\nDiabetic ulcer of foot limited to skin layer due to dm 2\nDiabetic ulcer of foot with bone necrosis due to dm 2\nDiabetic ulcer of foot with fat layer exposure due to dm 2\nDiabetic ulcer of foot with muscle necrosis due to dm 2\nDiabetic ulcer of heel due to dm 2\nDiabetic ulcer of heel limited to skin layer due to dm 2\nDiabetic ulcer of heel with bone necrosis due to dm 2\nDiabetic ulcer of heel with fat layer exposure due to dm 2\nDiabetic ulcer of heel with muscle necrosis due to dm 2\nDiabetic ulcer of left foot due to diabetes mellitus type 2\nDiabetic ulcer of left foot due to dm 2\nDiabetic ulcer of left foot limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of left foot limited to skin layer due to dm 2\nDiabetic ulcer of left foot with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left foot with bone necrosis due to dm 2\nDiabetic ulcer of left foot with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of left foot with fat layer exposure due to dm 2\nDiabetic ulcer of left foot with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left foot with muscle necrosis due to dm 2\nDiabetic ulcer of left heel due to diabetes mellitus type 2\nDiabetic ulcer of left heel due to dm 2\nDiabetic ulcer of left heel limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of left heel limited to skin layer due to dm 2\nDiabetic ulcer of left heel with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left heel with bone necrosis due to dm 2\nDiabetic ulcer of left heel with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of left heel with fat layer exposure due to dm 2\nDiabetic ulcer of left heel with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left heel with muscle necrosis due to dm 2\nDiabetic ulcer of left midfoot due to diabetes mellitus type 2\nDiabetic ulcer of left midfoot due to dm 2\nDiabetic ulcer of left midfoot limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of left midfoot limited to skin layer due to dm 2\nDiabetic ulcer of left midfoot with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left midfoot with bone necrosis due to dm 2\nDiabetic ulcer of left midfoot with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of left midfoot with fat layer exposure due to dm 2\nDiabetic ulcer of left midfoot with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left midfoot with muscle necrosis due to dm 2\nDiabetic ulcer of midfoot due to dm 2\nDiabetic ulcer of midfoot limited to skin layer due to dm 2\nDiabetic ulcer of midfoot with bone necrosis due to dm 2\nDiabetic ulcer of midfoot with fat layer exposure due to dm 2\nDiabetic ulcer of midfoot with muscle necrosis due to dm 2\nDiabetic ulcer of right foot due to diabetes mellitus type 2\nDiabetic ulcer of right foot due to dm 2\nDiabetic ulcer of right foot limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of right foot limited to skin layer due to dm 2\nDiabetic ulcer of right foot with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right foot with bone necrosis due to dm 2\nDiabetic ulcer of right foot with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of right foot with fat layer exposure due to dm 2\nDiabetic ulcer of right foot with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right foot with muscle necrosis due to dm 2\nDiabetic ulcer of right heel due to dm 2\nDiabetic ulcer of right heel limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of right heel limited to skin layer due to dm 2\nDiabetic ulcer of right heel with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right heel with bone necrosis due to dm 2\nDiabetic ulcer of right heel with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of right heel with fat layer exposure due to dm 2\nDiabetic ulcer of right heel with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right heel with muscle necrosis due to dm 2\nDiabetic ulcer of right midfoot due to diabetes mellitus type 2\nDiabetic ulcer of right midfoot due to dm 2\nDiabetic ulcer of right midfoot limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of right midfoot limited to skin layer due to dm 2\nDiabetic ulcer of right midfoot with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right midfoot with bone necrosis due to dm 2\nDiabetic ulcer of right midfoot with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of right midfoot with fat layer exposure due to dm 2\nDiabetic ulcer of right midfoot with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right midfoot with muscle necrosis due to dm 2\nFoot ulcer due to type 2 diabetes mellitus\nIschemic foot ulcer due to type 2 diabetes mellitus\nIschemic heel and/or midfoot ulcer due to type 2 diabetes mellitus\nNeuropathic foot ulcer due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.622","Description":"Type 2 diabetes mellitus with other skin ulcer                                                                                                                                                                                                                  Y","SearchInclusion":"Ankle ulcer due to type 2 diabetes mellitus\nChronic skin ulcer due to type 2 diabetes mellitus\nDiabetes type 2 with chronic skin ulcer\nDiabetes type 2 with diabetic ulcer of ankle\nDiabetes type 2 with diabetic ulcer of ankle, bone necrosis\nDiabetes type 2 with diabetic ulcer of ankle, muscle necrosis\nDiabetes type 2 with diabetic ulcer of ankle, skin breakdown\nDiabetes type 2 with diabetic ulcer of calf\nDiabetes type 2 with diabetic ulcer of calf, bone necrosis\nDiabetes type 2 with diabetic ulcer of calf, muscle necrosis\nDiabetes type 2 with diabetic ulcer of calf, skin breakdown\nDiabetes type 2 with diabetic ulcer of left ankle\nDiabetes type 2 with diabetic ulcer of left ankle, bone necrosis\nDiabetes type 2 with diabetic ulcer of left ankle, muscle necrosis\nDiabetes type 2 with diabetic ulcer of left ankle, skin breakdown\nDiabetes type 2 with diabetic ulcer of left calf\nDiabetes type 2 with diabetic ulcer of left calf, bone necrosis\nDiabetes type 2 with diabetic ulcer of left calf, muscle necrosis\nDiabetes type 2 with diabetic ulcer of left calf, skin breakdown\nDiabetes type 2 with diabetic ulcer of left lower leg\nDiabetes type 2 with diabetic ulcer of left lower leg, bone necrosis\nDiabetes type 2 with diabetic ulcer of left lower leg, muscle necrosis\nDiabetes type 2 with diabetic ulcer of left lower leg, skin breakdown\nDiabetes type 2 with diabetic ulcer of left thigh\nDiabetes type 2 with diabetic ulcer of left thigh, bone necrosis\nDiabetes type 2 with diabetic ulcer of left thigh, muscle necrosis\nDiabetes type 2 with diabetic ulcer of left thigh, skin breakdown\nDiabetes type 2 with diabetic ulcer of left toe\nDiabetes type 2 with diabetic ulcer of left toe, bone necrosis\nDiabetes type 2 with diabetic ulcer of left toe, muscle necrosis\nDiabetes type 2 with diabetic ulcer of left toe, skin breakdown\nDiabetes type 2 with diabetic ulcer of lower leg\nDiabetes type 2 with diabetic ulcer of lower leg, bone necrosis\nDiabetes type 2 with diabetic ulcer of lower leg, muscle necrosis\nDiabetes type 2 with diabetic ulcer of lower leg, skin breakdown\nDiabetes type 2 with diabetic ulcer of right ankle\nDiabetes type 2 with diabetic ulcer of right ankle, bone necrosis\nDiabetes type 2 with diabetic ulcer of right ankle, muscle necrosis\nDiabetes type 2 with diabetic ulcer of right ankle, skin breakdown\nDiabetes type 2 with diabetic ulcer of right calf\nDiabetes type 2 with diabetic ulcer of right calf, bone necrosis\nDiabetes type 2 with diabetic ulcer of right calf, muscle necrosis\nDiabetes type 2 with diabetic ulcer of right calf, skin breakdown\nDiabetes type 2 with diabetic ulcer of right heel\nDiabetes type 2 with diabetic ulcer of right lower leg\nDiabetes type 2 with diabetic ulcer of right lower leg, bone necrosis\nDiabetes type 2 with diabetic ulcer of right lower leg, muscle necrosis\nDiabetes type 2 with diabetic ulcer of right lower leg, skin breakdown\nDiabetes type 2 with diabetic ulcer of right thigh\nDiabetes type 2 with diabetic ulcer of right thigh, bone necrosis\nDiabetes type 2 with diabetic ulcer of right thigh, muscle necrosis\nDiabetes type 2 with diabetic ulcer of right thigh, skin breakdown\nDiabetes type 2 with diabetic ulcer of right toe\nDiabetes type 2 with diabetic ulcer of right toe, bone necrosis\nDiabetes type 2 with diabetic ulcer of right toe, muscle necrosis\nDiabetes type 2 with diabetic ulcer of right toe, skin breakdown\nDiabetes type 2 with diabetic ulcer of thigh\nDiabetes type 2 with diabetic ulcer of thigh, bone necrosis\nDiabetes type 2 with diabetic ulcer of thigh, muscle necrosis\nDiabetes type 2 with diabetic ulcer of thigh, skin breakdown\nDiabetes type 2 with diabetic ulcer of toe\nDiabetes type 2 with diabetic ulcer of toe, bone necrosis\nDiabetes type 2 with diabetic ulcer of toe, muscle necrosis\nDiabetes type 2 with diabetic ulcer of toe, skin breakdown\nDiabetes type 2 with foot ulcers\nDiabetes type 2 with ischemic ulcer of ankle\nDiabetes type 2 with ischemic ulcer of toe\nDiabetes type 2 with leg ulcer\nDiabetes type 2 with neuropathic ulcer of ankle\nDiabetes type 2 with neuropathic ulcer of toe\nDiabetes type 2 with ulcer\nDiabetes, type 2 with ankle ulcer\nDiabetes, type 2 with foot ulcer\nDiabetic skin ulcer associated with type 2 diabetes mellitus\nDiabetic ulcer of ankle limited to skin layer due to dm 2\nDiabetic ulcer of ankle with bone necrosis due to dm 2\nDiabetic ulcer of ankle with fat layer exposure due to dm 2\nDiabetic ulcer of ankle with muscle necrosis due to dm 2\nDiabetic ulcer of calf due to dm 2\nDiabetic ulcer of calf limited to skin layer due to dm 2\nDiabetic ulcer of calf with bone necrosis due to dm 2\nDiabetic ulcer of calf with fat layer exposure due to dm 2\nDiabetic ulcer of calf with muscle necrosis due to dm 2\nDiabetic ulcer of left ankle due to diabetes mellitus type 2\nDiabetic ulcer of left ankle due to dm 2\nDiabetic ulcer of left ankle limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of left ankle limited to skin layer due to dm 2\nDiabetic ulcer of left ankle with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left ankle with bone necrosis due to dm 2\nDiabetic ulcer of left ankle with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of left ankle with fat layer exposure due to dm 2\nDiabetic ulcer of left ankle with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left ankle with muscle necrosis due to dm 2\nDiabetic ulcer of left calf due to diabetes mellitus type 2\nDiabetic ulcer of left calf due to dm 2\nDiabetic ulcer of left calf limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of left calf limited to skin layer due to dm 2\nDiabetic ulcer of left calf with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left calf with bone necrosis due to dm 2\nDiabetic ulcer of left calf with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of left calf with fat layer exposure due to dm 2\nDiabetic ulcer of left calf with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left calf with muscle necrosis due to dm 2\nDiabetic ulcer of left lower leg due to diabetes mellitus type 2\nDiabetic ulcer of left lower leg limited to breakdown of skin layer due to dm 2\nDiabetic ulcer of left lower leg limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of left lower leg with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left lower leg with bone necrosis due to dm 2\nDiabetic ulcer of left lower leg with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of left lower leg with fat layer exposure due to dm 2\nDiabetic ulcer of left lower leg with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left lower leg with muscle necrosis due to dm 2\nDiabetic ulcer of left ower leg due to dm 2\nDiabetic ulcer of left thigh due to diabetes mellitus type 2\nDiabetic ulcer of left thigh due to dm 2\nDiabetic ulcer of left thigh limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of left thigh limited to skin layer due to dm 2\nDiabetic ulcer of left thigh with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left thigh with bone necrosis due to dm 2\nDiabetic ulcer of left thigh with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of left thigh with fat layer exposure due to dm 2\nDiabetic ulcer of left thigh with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left thigh with muscle necrosis due to dm 2\nDiabetic ulcer of left toe due to diabetes mellitus type 2\nDiabetic ulcer of left toe due to dm 2\nDiabetic ulcer of left toe limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of left toe limited to skin layer due to dm 2\nDiabetic ulcer of left toe with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left toe with bone necrosis due to dm 2\nDiabetic ulcer of left toe with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of left toe with fat layer exposure due to dm 2\nDiabetic ulcer of left toe with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of left toe with muscle necrosis due to dm 2\nDiabetic ulcer of lower leg due to dm 2\nDiabetic ulcer of lower leg limited to skin layer due to dm 2\nDiabetic ulcer of lower leg with bone necrosis due to dm 2\nDiabetic ulcer of lower leg with fat layer exposure due to dm 2\nDiabetic ulcer of lower leg with muscle necrosis due to dm 2\nDiabetic ulcer of right ankle due to diabetes mellitus type 2\nDiabetic ulcer of right ankle due to dm 2\nDiabetic ulcer of right ankle limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of right ankle limited to skin layer due to dm 2\nDiabetic ulcer of right ankle with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right ankle with bone necrosis due to dm 2\nDiabetic ulcer of right ankle with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of right ankle with fat layer exposure due to dm 2\nDiabetic ulcer of right ankle with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right ankle with muscle necrosis due to dm 2\nDiabetic ulcer of right calf due to diabetes mellitus type 2\nDiabetic ulcer of right calf due to dm 2\nDiabetic ulcer of right calf limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of right calf limited to skin layer due to dm 2\nDiabetic ulcer of right calf with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right calf with bone necrosis due to dm 2\nDiabetic ulcer of right calf with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of right calf with fat layer exposure due to dm 2\nDiabetic ulcer of right calf with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right calf with muscle necrosis due to dm 2\nDiabetic ulcer of right heel due to diabetes mellitus type 2\nDiabetic ulcer of right lower leg due to diabetes mellitus type 2\nDiabetic ulcer of right lower leg due to dm 2\nDiabetic ulcer of right lower leg limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of right lower leg limited to skin layer due to dm 2\nDiabetic ulcer of right lower leg with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right lower leg with bone necrosis due to dm 2\nDiabetic ulcer of right lower leg with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of right lower leg with fat layer exposure due to dm 2\nDiabetic ulcer of right lower leg with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right lower leg with muscle necrosis due to dm 2\nDiabetic ulcer of right thigh due to diabetes mellitus type 2\nDiabetic ulcer of right thigh due to dm 2\nDiabetic ulcer of right thigh limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of right thigh limited to skin layer due to dm 2\nDiabetic ulcer of right thigh with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right thigh with bone necrosis due to dm 2\nDiabetic ulcer of right thigh with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of right thigh with fat layer exposure due to dm 2\nDiabetic ulcer of right thigh with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right thigh with muscle necrosis due to dm 2\nDiabetic ulcer of right toe due to diabetes mellitus type 2\nDiabetic ulcer of right toe due to dm 2\nDiabetic ulcer of right toe limited to skin layer due to diabetes mellitus type 2\nDiabetic ulcer of right toe limited to skin layer due to dm 2\nDiabetic ulcer of right toe with bone necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right toe with bone necrosis due to dm 2\nDiabetic ulcer of right toe with fat layer exposure due to diabetes mellitus type 2\nDiabetic ulcer of right toe with fat layer exposure due to dm 2\nDiabetic ulcer of right toe with muscle necrosis due to diabetes mellitus type 2\nDiabetic ulcer of right toe with muscle necrosis due to dm 2\nDiabetic ulcer of thigh due to dm 2\nDiabetic ulcer of thigh limited to skin layer due to dm 2\nDiabetic ulcer of thigh with bone necrosis due to dm 2\nDiabetic ulcer of thigh with fat layer exposure due to dm 2\nDiabetic ulcer of thigh with muscle necrosis due to dm 2\nDiabetic ulcer of toe due to dm 2\nDiabetic ulcer of toe limited to skin layer due to dm 2\nDiabetic ulcer of toe with bone necrosis due to dm 2\nDiabetic ulcer of toe with fat layer exposure due to dm 2\nDiabetic ulcer of toe with muscle necrosis due to dm 2\nDm 2 with neuropathic ulcer foot and heel\nForefoot ulcer due to type 2 diabetes\nHeel and/or midfoot ulcer due to type 2 diabetes mellitus\nIschemic ankle ulcer due to type 2 diabetes mellitus\nLeg ulcer due to type 2 diabetes mellitus\nNeuropathic ankle ulcer due to type 2 diabetes mellitus\nNeuropathic midfoot and/or heel ulcer due to type 2 diabetes mellitus\nNeuropathic toe ulcer due to type 2 diabetes mellitus\nSkin ulcer due to type 2 diabetes mellitus\nUlcer of toe due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.628","Description":"Type 2 diabetes mellitus with other skin complications                                                                                                                                                                                                          Y","SearchInclusion":"Cheiropathy due to type 2 diabetes mellitus\nDiabetes type 2 with cheiropathy\nDiabetes type 2 with diabetic dermopathy\nDiabetic dermopathy associated with diabetes mellitus type 2\nDiabetic dermopathy due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.630","Description":"Type 2 diabetes mellitus with periodontal disease                                                                                                                                                                                                               Y","SearchInclusion":"Periodontal disease due to diabetes type 2\nPeriodontal disease due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.638","Description":"Type 2 diabetes mellitus with other oral complications                                                                                                                                                                                                          Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E11.641","Description":"Type 2 diabetes mellitus with hypoglycemia with coma                                                                                                                                                                                                            Y","SearchInclusion":"Diabetes type 2 with hypoglycemic coma\nHypoglycemic coma in type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.649","Description":"Type 2 diabetes mellitus with hypoglycemia without coma                                                                                                                                                                                                         Y","SearchInclusion":"Diabetes mellitus type 2 w complications\nDiabetes type 2 with hypoglycemia\nDiabetes type 2 with hypoglycemia unawareness\nHypoglycemia due to type 2 diabetes mellitus\nInsulin reactive hypoglycemia in type 2 diabetes mellitus\nUnawareness of hypoglycemia in type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.65","Description":"Type 2 diabetes mellitus with hyperglycemia                                                                                                                                                                                                                     Y","SearchInclusion":"Diabetes type 2 with hyperglycemia\nHyperglycemia due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.69","Description":"Type 2 diabetes mellitus with other specified complication                                                                                                                                                                                                      Y","SearchInclusion":"Diabetes mellitus, type 2 with ketoacidotic coma\nDiabetes type 2 low hdl and high triglyceride\nDiabetes type 2 with erectile dysfunction\nDiabetes type 2 with hyperlipidemia\nDiabetes type 2 with severe malnutrition\nDiabetes, type 2 with ketoacidosis\nDiabetes, type 2 with osteomyelitis\nDyslipidemia with high density lipoprotein below reference range and triglyceride above reference range due to type 2 diabetes mellitus\nErectile dysfunction associated with type 2 diabetes mellitus\nHyperlipidemia due to type 2 diabetes mellitus\nKetoacidosis in type 2 diabetes mellitus\nKetoacidosis in type ii diabetes mellitus\nKetoacidotic coma in type 2 diabetes mellitus\nKetoacidotic coma in type ii diabetes mellitus\nMixed hyperlipidemia associated with type 2 diabetes mellitus\nMixed hyperlipidemia due to type 2 diabetes mellitus\nOsteomyelitis due to type 2 diabetes mellitus\nSevere malnutrition due to type 2 diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E11.8","Description":"Type 2 diabetes mellitus with unspecified complications                                                                                                                                                                                                         Y","SearchInclusion":"Complication due to diabetes mellitus type 2\nComplication due to type 2 diabetes mellitus\nDiabetes type 2 with complication","ClinicalNotes":""},
    {"ICD10Code":"E11.9","Description":"Type 2 diabetes mellitus without complications                                                                                                                                                                                                                  Y","SearchInclusion":"Diabetes in pregnancy\nDiabetes mellitus diet education done\nDiabetes mellitus in the puerperium - baby delivered during current episode of care\nDiabetes mellitus type 2\nDiabetes mellitus type 2 without retinopathy\nDiabetes type 2\nDiabetes type 2 controlled with diet\nDiabetes type 2 on insulin\nDiabetes type 2, uncomplicated\nDiabetes type 2, without retinopathy\nDiabetic foot exam\nDiabetic foot exam done\nDietary diabetic patient education\nGestational diabetes mellitus\nInsulin treated type 2 diabetes mellitus\nInsulin-treated non-insulin-dependent diabetes mellitus\nMaturity onset diabetes mellitus in young\nMaturity onset diabetes of youth\nMaturity-onset diabetes of the young\nNutrition therapy for diabetes type 2 done\nNutritional therapy for diabetes mellitus type 2\nPostpartum (after pregnancy) diabetes\nPreexisting diabetes mellitus during postpartum\nPreexisting diabetes postpartum (after childbirth)\nType 2 diabetes mellitus\nType 2 diabetes mellitus controlled by diet\nType 2 diabetes mellitus without complication\nType ii diabetes mellitus without complication","ClinicalNotes":""},
    {"ICD10Code":"E13.00","Description":"Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)                                                                                                                                               Y","SearchInclusion":"Hyperosmolarity due to secondary diabetes mellitus\nSecondary diabetes with hyperosmolarity","ClinicalNotes":""},
    {"ICD10Code":"E13.01","Description":"Other specified diabetes mellitus with hyperosmolarity with coma                                                                                                                                                                                                Y","SearchInclusion":"Hyperosmolar coma due to secondary diabetes mellitus\nSecondary diabetes with hyperosmolar coma","ClinicalNotes":""},
    {"ICD10Code":"E13.10","Description":"Other specified diabetes mellitus with ketoacidosis without coma                                                                                                                                                                                                Y","SearchInclusion":"Diabetes, type 2 with ketoacidosis\nKetoacidosis due to secondary diabetes mellitus\nKetoacidosis in type 2 diabetes mellitus\nSecondary diabetes with ketoacidosis","ClinicalNotes":""},
    {"ICD10Code":"E13.11","Description":"Other specified diabetes mellitus with ketoacidosis with coma                                                                                                                                                                                                   Y","SearchInclusion":"Ketoacidotic coma due to secondary diabetes mellitus\nSecondary diabetes w diabetic ketoacidotic coma","ClinicalNotes":""},
    {"ICD10Code":"E13.21","Description":"Other specified diabetes mellitus with diabetic nephropathy                                                                                                                                                                                                     Y","SearchInclusion":"Other specified diabetes mellitus with intercapillary glomerulosclerosis\nOther specified diabetes mellitus with intracapillary glomerulonephrosis\nOther specified diabetes mellitus with Kimmelstiel-Wilson disease                                                    Diabetic nephropathy due to secondary diabetes mellitus\nSecondary diabetes, with nephropathy","ClinicalNotes":""},
    {"ICD10Code":"E13.22","Description":"Other specified diabetes mellitus with diabetic chronic kidney disease                                                                                                                                                                                          Y","SearchInclusion":"Chronic kidney disease due to secondary diabetes mellitus\nChronic kidney disease stage 1 due to secondary diabetes\nChronic kidney disease stage 2 due to secondary diabetes\nChronic kidney disease stage 3 due to secondary diabetes\nChronic kidney disease stage 4 due to secondary diabetes\nChronic kidney disease stage 5 due to secondary diabetes\nChronic kidney disease with end stage renal disease on dialysis due to secondary diabetes mellitus\nSecondary diabetes with chronic kidney disease\nSecondary diabetes, chronic kidney disease on dialysis","ClinicalNotes":""},
    {"ICD10Code":"E13.29","Description":"Other specified diabetes mellitus with other diabetic kidney complication                                                                                                                                                                                       Y","SearchInclusion":"Other specified diabetes mellitus with renal tubular degeneration                                               Renal manifestation due to secondary diabetes mellitus\nSecondary diabetes with kidney problems","ClinicalNotes":""},
    {"ICD10Code":"E13.311","Description":"Other specified diabetes mellitus with unspecified diabetic retinopathy with macular edema                                                                                                                                                                      Y","SearchInclusion":"Retinopathy with macular edema due to secondary diabetes mellitus\nSecondary diabetes with retinopathy with macular edema","ClinicalNotes":""},
    {"ICD10Code":"E13.319","Description":"Other specified diabetes mellitus with unspecified diabetic retinopathy without macular edema                                                                                                                                                                   Y","SearchInclusion":"Diabetic retinopathy due to secondary diabetes mellitus\nSecondary diabetes with retinopathy","ClinicalNotes":""},
    {"ICD10Code":"","Description":"","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3211","Description":"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3212","Description":"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3213","Description":"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3219","Description":"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3291","Description":"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3292","Description":"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3293","Description":"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3299","Description":"Other specified diabetes mellitus with mild nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.331","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema                                                                                                                                                        Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3311","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3312","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3313","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3319","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3391","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3392","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3393","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3399","Description":"Other specified diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3411","Description":"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3412","Description":"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3413","Description":"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3419","Description":"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3491","Description":"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3492","Description":"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3493","Description":"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3499","Description":"Other specified diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3511","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3512","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3513","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3519","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3521","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3522","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3523","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3529","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment involving the macula, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3531","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3532","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3533","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3539","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with traction retinal detachment not involving the macula, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3541","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3542","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3543","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3549","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy with combined traction retinal detachment and rhegmatogenous retinal detachment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3551","Description":"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3552","Description":"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3553","Description":"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3559","Description":"Other specified diabetes mellitus with stable proliferative diabetic retinopathy, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.359","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema                                                                                                                                                                 Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3591","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3592","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3593","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.3599","Description":"Other specified diabetes mellitus with proliferative diabetic retinopathy without macular edema, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.36","Description":"Other specified diabetes mellitus with diabetic cataract                                                                                                                                                                                                        Y","SearchInclusion":"Cataract due to secondary diabetes mellitus\nSecondary diabetes w diabetic cataract","ClinicalNotes":""},
    {"ICD10Code":"E13.37X1","Description":"Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, right eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.37X2","Description":"Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, left eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.37X3","Description":"Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, bilateral","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.37X9","Description":"Other specified diabetes mellitus with diabetic macular edema, resolved following treatment, unspecified eye","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.39","Description":"Other specified diabetes mellitus with other diabetic ophthalmic complication                                                                                                                                                                                   Y","SearchInclusion":"Ophthalmic manifestation due to secondary diabetes mellitus\nSecondary diabetes with ophthalmic manifestation","ClinicalNotes":""},
    {"ICD10Code":"E13.40","Description":"Other specified diabetes mellitus with diabetic neuropathy, unspecified                                                                                                                                                                                         Y","SearchInclusion":"Neuropathy due to secondary diabetes mellitus\nSecondary diabetes with neuropathy","ClinicalNotes":""},
    {"ICD10Code":"E13.41","Description":"Other specified diabetes mellitus with diabetic mononeuropathy                                                                                                                                                                                                  Y","SearchInclusion":"Mononeuropathy due to secondary diabetes mellitus\nSecondary diabetes w diabetic mononeuropathy","ClinicalNotes":""},
    {"ICD10Code":"E13.42","Description":"Other specified diabetes mellitus with diabetic polyneuropathy                                                                                                                                                                                                  Y","SearchInclusion":"Other specified diabetes mellitus with diabetic neuralgia","ClinicalNotes":""},
    {"ICD10Code":"E13.43","Description":"Other specified diabetes mellitus with diabetic autonomic (poly)neuropathy                                                                                                                                                                                      Y","SearchInclusion":"Other specified diabetes mellitus with diabetic gastroparesis","ClinicalNotes":""},
    {"ICD10Code":"E13.44","Description":"Other specified diabetes mellitus with diabetic amyotrophy                                                                                                                                                                                                      Y","SearchInclusion":"Amyotrophy due to secondary diabetes mellitus\nSecondary diabetes with amyotrophy","ClinicalNotes":""},
    {"ICD10Code":"E13.49","Description":"Other specified diabetes mellitus with other diabetic neurological complication                                                                                                                                                                                 Y","SearchInclusion":"Neurological manifestation due to secondary diabetes mellitus\nSecondary diabetes with neurological manifestation","ClinicalNotes":""},
    {"ICD10Code":"E13.51","Description":"Other specified diabetes mellitus with diabetic peripheral angiopathy without gangrene                                                                                                                                                                          Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.52","Description":"Other specified diabetes mellitus with diabetic peripheral angiopathy with gangrene                                                                                                                                                                             Y","SearchInclusion":"Other specified diabetes mellitus with diabetic gangrene","ClinicalNotes":""},
    {"ICD10Code":"E13.59","Description":"Other specified diabetes mellitus with other circulatory complications                                                                                                                                                                                          Y","SearchInclusion":"Diabetic peripheral vascular disorder due to secondary diabetes mellitus\nPeripheral circulatory disorder due to secondary diabetes mellitus\nSecondary diabetes with peripheral circulatory problem\nSecondary diabetes, with vascular disorder","ClinicalNotes":""},
    {"ICD10Code":"E13.610","Description":"Other specified diabetes mellitus with diabetic neuropathic arthropathy                                                                                                                                                                                         Y","SearchInclusion":"Other specified diabetes mellitus with Charct's joints","ClinicalNotes":""},
    {"ICD10Code":"E13.618","Description":"Other specified diabetes mellitus with other diabetic arthropathy                                                                                                                                                                                               Y","SearchInclusion":"Arthropathy due to secondary diabetes mellitus\nSecondary diabetes w diabetic arthropathy","ClinicalNotes":""},
    {"ICD10Code":"E13.620","Description":"Other specified diabetes mellitus with diabetic dermatitis                                                                                                                                                                                                      Y","SearchInclusion":"Dermatitis due to secondary diabetes mellitus\nSecondary diabetes w diabetic dermatitis                                                                                                  Other specified diabetes mellitus with diabetic necrobiosis lipoidica","ClinicalNotes":""},
    {"ICD10Code":"E13.621","Description":"Other specified diabetes mellitus with foot ulcer                                                                                                                                                                                                               Y","SearchInclusion":"Secondary diabetes w diabetic ulcer of left foot\nSecondary diabetes w diabetic ulcer of right foot\nUlcer of left foot due to secondary diabetes mellitus\nUlcer of right foot due to secondary diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E13.622","Description":"Other specified diabetes mellitus with other skin ulcer                                                                                                                                                                                                         Y","SearchInclusion":"Secondary diabetes with ulcer\nSkin ulcer due to secondary diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E13.628","Description":"Other specified diabetes mellitus with other skin complications                                                                                                                                                                                                 Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.630","Description":"Other specified diabetes mellitus with periodontal disease                                                                                                                                                                                                      Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.638","Description":"Other specified diabetes mellitus with other oral complications                                                                                                                                                                                                 Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.641","Description":"Other specified diabetes mellitus with hypoglycemia with coma                                                                                                                                                                                                   Y","SearchInclusion":"Hypoglycemic coma due to secondary diabetes mellitus\nSecondary diabetes w hypoglycemic coma","ClinicalNotes":""},
    {"ICD10Code":"E13.649","Description":"Other specified diabetes mellitus with hypoglycemia without coma                                                                                                                                                                                                Y","SearchInclusion":"Hypoglycemia due to secondary diabetes mellitus\nSecondary diabetes w hypoglycemia","ClinicalNotes":""},
    {"ICD10Code":"E13.65","Description":"Other specified diabetes mellitus with hyperglycemia                                                                                                                                                                                                            Y","SearchInclusion":"Hyperglycemia due to secondary diabetes mellitus\nSecondary diabetes with hyperglycemia","ClinicalNotes":""},
    {"ICD10Code":"E13.69","Description":"Other specified diabetes mellitus with other specified complication                                                                                                                                                                                             Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E13.8","Description":"Other specified diabetes mellitus with unspecified complications                                                                                                                                                                                                Y","SearchInclusion":"Complication due to secondary diabetes mellitus\nSecondary diabetes","ClinicalNotes":""},
    {"ICD10Code":"E13.9","Description":"Other specified diabetes mellitus without complications                                                                                                                                                                                                         Y","SearchInclusion":"Diabetes due to pancreatic injury\nDiabetes mellitus due to pancreatic injury\nSecondary diabetes\nSecondary diabetes mellitus","ClinicalNotes":""},
    {"ICD10Code":"E15.","Description":"Nondiabetic hypoglycemic coma","SearchInclusion":"Coma, hypoglycemic\nComa, hypoglycemic, nondiabetic\nHypoglycemic coma\nNon-diabetic hypoglycemic coma                                                                                                                    drug-induced insulin coma in nondiabetic\nhyperinsulinism with hypoglycemic coma\nhypoglycemic coma NOS","ClinicalNotes":""},
    {"ICD10Code":"E16.0","Description":"Drug-induced hypoglycemia without coma","SearchInclusion":"Drug induced hypoglycemia","ClinicalNotes":""},
    {"ICD10Code":"E16.1","Description":"Other hypoglycemia","SearchInclusion":"Functional hyperinsulinism\nFunctional nonhyperinsulinemic hypoglycemia\nHyperinsulinism NOS\nHyperplasia of pancreatic islet beta cells NOS                                                                            Hyperinsulinism\nHyperinsulinism, iatrogenic\nHyperplasia of pancreatic islet beta cell\nHypoglycemia (low blood sugar), reactive\nIatrogenic hyperinsulinism\nReactive hypoglycemia","ClinicalNotes":"A syndrome with excessively high insulin levels in the blood. It may cause hypoglycemia. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (insulinoma); autoantibodies against insulin (insulin antibodies); defective insulin receptor (insulin resistance); or overuse of exogenous insulin or hypoglycemic agents.\nSyndrome with excessively high insulin levels in the blood; it may cause hypoglycemia; etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor, autoantibodies against insulin, defective insulin receptor, or overuse of exogeneous insulin or hypoglycemic agents."},
    {"ICD10Code":"E16.2","Description":"Hypoglycemia, unspecified","SearchInclusion":"Hypoglycemia\nHypoglycemia (low blood sugar)\nHypoglycemia post gi surgery\nHypoglycemia unawareness\nHypoglycemic encephalopathy\nLoss of hypoglycemic warning\nPost gastrointestinal tract surgery hypoglycemia","ClinicalNotes":"A disorder characterized by laboratory test results that indicate a low concentration of glucose in the blood.\nA syndrome of abnormally low blood glucose level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the central nervous system resulting in hunger; sweating; paresthesia; impaired mental function; seizures; coma; and even death.\nAbnormally low blood sugar.\nAbnormally low level of glucose in the blood.\nHypoglycemia means low blood glucose. Your body needs glucose, a form of sugar, to have enough energy. After you eat, your blood absorbs glucose. If you eat more sugar than your body needs, your muscles, and liver store the extra. When your blood sugar begins to fall, a hormone tells your liver to release glucose.in most people, this raises blood sugar. If it doesn't, you have hypoglycemia, and your blood sugar can be dangerously low. Signs include\nhunger\nshakiness\ndizziness\nconfusion\ndifficulty speaking\nfeeling anxious or weak\nin people with diabetes, hypoglycemia is often a side effect of diabetes medicines. Eating or drinking something with carbohydrates can help. If it happens often, your health care provider may need to change your treatment plan.you can also have low blood sugar without having diabetes. Causes include certain medicines or diseases, hormone or enzyme deficiencies, and tumors. Laboratory tests can help find the cause. The kind of treatment depends on why you have low blood sugar.\nSyndrome of abnormally low blood glucose level; clinical hypoglycemia has diverse etiologies; severe hypoglycemia eventually lead to glucose deprivation of the central nervous system resulting in hunger, sweating, paresthesia, impaired mental function, seizures, coma, and even death."},
    {"ICD10Code":"E16.3","Description":"Increased secretion of glucagon","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E16.4","Description":"Increased secretion of gastrin","SearchInclusion":"Hypergastrinemia\nHyperplasia of pancreatic endocrine cells with gastrin excess\nZollinger-Ellison syndrome                                                                               Hypergastrinemia\nIncreased gastrin secretion","ClinicalNotes":"A disorder in which tumors of the pancreatic islet cells produce large amounts of gastrin (a hormone), leading to excess acid in the stomach and, possibly, a peptic ulcer (ulcer of the stomach or the upper part of the small intestine).\nA syndrome characterized by the presence of a gastrin-secreting tumor, usually in the pancreas or duodenum, resulting in increased gastric acidity and formation of gastric ulcers. Signs and symptoms include abdominal pain and diarrhea. It may be sporadic or a manifestation of multiple endocrine neoplasia type 1.\nA syndrome that is characterized by the triad of severe peptic ulcer, hypersecretion of gastric acid, and gastrin-producing tumors of the pancreas or other tissue (gastrinoma). This syndrome may be sporadic or be associated with multiple endocrine neoplasia type 1.\nTriad comprising intractable, sometimes fulminating atypical ulcers, extremely elevated gastic acidity, and gastrin secreting non beta islet cell tumors."},
    {"ICD10Code":"E16.8","Description":"Other specified disorders of pancreatic internal secretion","SearchInclusion":"Increased secretion from endocrine pancreas of growth hormone-releasing hormone\nIncreased secretion from endocrine pancreas of pancreatic polypeptide\nIncreased secretion from endocrine pancreas of somatostatin\nIncreased secretion from endocrine pancreas of vasoactive-intestinal polypeptide","ClinicalNotes":""},
    {"ICD10Code":"E16.9","Description":"Disorder of pancreatic internal secretion, unspecified","SearchInclusion":"Disorder of pancreatic internal secretion\nIslet cell hyperplasia\nPancreatic secretion disorder                                                                                                                      Islet-cell hyperplasia NOS\nPancreatic endocrine cell hyperplasia NOS","ClinicalNotes":"A sporadic or inherited disorder characterized by the focal or diffuse proliferation of the cells of the islets of langerhans in the pancreas. It results in hyperinsulinemia and hypoglycemia.\nAn inherited autosomal recessive syndrome characterized by the disorganized formation of new islets in the pancreas and congenital hyperinsulinism. It is due to focal hyperplasia of pancreatic islet cells budding off from the ductal structures and forming new islets of langerhans. Mutations in the islet cells involve the potassium channel gene kcnj11 or the atp-binding cassette transporter gene abcc8, both on chromosome 11."},
    {"ICD10Code":"E20.0","Description":"Idiopathic hypoparathyroidism","SearchInclusion":"","ClinicalNotes":"A condition of low or absent pth level and hypocalcemia. It usually occurs as part of an autoimmune syndrome."},
    {"ICD10Code":"E20.1","Description":"Pseudohypoparathyroidism","SearchInclusion":"Pseudopseudohypoparathyroidism","ClinicalNotes":"A condition characterized by the insensitivity of the tissues to respond to the activity of the parathyroid hormone. It results in increased levels of parathyroid hormone in the serum, hypocalcemia, and hyperphosphatemia.\nA hereditary syndrome clinically similar to hypoparathyroidism. It is characterized by hypocalcemia; hyperphosphatemia; and associated skeletal development impairment and caused by failure of response to parathyroid hormone rather than deficiencies. A severe form with resistance to multiple hormones is referred to as type 1a and is associated with maternal mutant allele of the alpha chain of stimulatory g protein.\nHereditary condition clinically resembling hypoparathyroidism, but caused by failure of response to rather than deficiency of parathyroid hormones; characterized by hypocalcemia and hyperphosphatemia, and commonly associated with short stature, obesity, short metacarpals, and ectopic calcification.\nOriginally reported as a hypocalcemic syndrome similar to hypoparathyroidism, but with renal and skeletal resistance to parathyroid hormone (pth) and designated as \"pseudohypoparathyroidism.\" albright later defined a normocalcemic variant which he termed \"pseudopseudohypoparathyroidism.\" two separate forms of pseudohypoparathyroidism are recognized. Type i in which there is no increase in the urinary excretion of cyclic adenosine monophosphate (camp) and phosphate in response to parathyroid hormone (pth). Type ii in which there is a response to pth, but without phosphate diuresis. The erythrocytes of some patients with type i contain a defective receptor-cyclase coupling protein (stimulatory guanine nucleoside-binding protein, or gs) which is responsible for coupling the cellular receptor that binds parathyroid hormone (pth) and is involved with the formation and release of cyclic adenosine monophosphate (camp). This variant has been designated as \"pseudohypoparathyroidism type ia.\" the syndrome is associated with mental deficiency, dystrophic bone lesions, short stature, and other defects."},
    {"ICD10Code":"E20.8","Description":"Other hypoparathyroidism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E20.9","Description":"Hypoparathyroidism, unspecified","SearchInclusion":"Bilateral tetanic cataract\nBilateral tetanic cataract (eye condition)\nHypoparathyroidism\nLeft tetanic cataract\nLeft tetanic cataract (eye condition)\nRight tetanic cataract\nRight tetanic cataract (eye condition)\nTetanic cataract","ClinicalNotes":"A condition caused by a deficiency of parathyroid hormone (or pth). It is characterized by hypocalcemia and hyperphosphatemia. Hypocalcemia leads to tetany. The acquired form is due to removal or injuries to the parathyroid glands. The congenital form is due to mutations of genes, such as tbx1; (see digeorge syndrome); casr encoding calcium-sensing receptor; or pth encoding parathyroid hormone.\nA disorder characterized by a decrease in production of parathyroid hormone by the parathyroid glands.\nAn endocrine disorder characterized by decreased production of parathyroid hormone by the parathyroid glands. It is usually caused by damage of the parathyroid glands during head and neck surgery. Signs and symptoms include muscle cramps, abdominal pain, dry skin, brittle nails, cataracts, tetany, and convulsions.\nCondition produced by greatly reduced function of the parathyroids possibly due to autoimmune disease or genetic factors, or by the removal of those bodies; lack of parathyroid hormone leads to a fall in plasma calcium level, which may result in increase neuromuscular excitability and ultimately tetany followed by a rise in plasma phosphate level."},
    {"ICD10Code":"E21.0","Description":"Primary hyperparathyroidism","SearchInclusion":"Hyperplasia of parathyroid\nOsteitis fibrosa cystica generalisata [von Recklinghausen's disease of bone]  Hyperparathyroidism, primary\nParathyroid hyperplasia","ClinicalNotes":"A condition of abnormally elevated output of parathyroid hormone due to parathyroid hyperplasia or parathyroid neoplasms. It is characterized by the combination of hypercalcemia, phosphaturia, elevated renal 1,25-dihydroxyvitamin d3 synthesis, and increased bone resorption.\nAbnormal increase in the number of otherwise normal cells in the parathyroid gland without tumor formation that leading to enlargement of the gland; it differs from hypertrophy, which is an increase in bulk without an increase in the number of cells.\nHyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones."},
    {"ICD10Code":"E21.1","Description":"Secondary hyperparathyroidism, not elsewhere classified","SearchInclusion":"Hyperparathyroidism, secondary (non renal)\nSecondary hyperparathyroidism of nonrenal origin","ClinicalNotes":""},
    {"ICD10Code":"E21.2","Description":"Other hyperparathyroidism","SearchInclusion":"Tertiary hyperparathyroidism                                                                                                                    Hyperparathyroidism","ClinicalNotes":""},
    {"ICD10Code":"E21.3","Description":"Hyperparathyroidism, unspecified","SearchInclusion":"Hyperparathyroidism\nHyperparathyroidism (high parathyroid hormone level)","ClinicalNotes":"A condition in which the parathyroid gland (one of four pea-sized organs found on the thyroid) makes too much parathyroid hormone. This causes a loss of calcium from the bones and an increased level of calcium in the blood. Symptoms include bone pain and kidney problems.\nA condition of abnormally elevated output of parathyroid hormone (or pth) triggering responses that increase blood calcium. It is characterized by hypercalcemia and bone resorption, eventually leading to bone diseases. Primary hyperparathyroidism is caused by parathyroid hyperplasia or parathyroid neoplasms. Secondary hyperparathyroidism is increased pth secretion in response to hypocalcemia, usually caused by chronic kidney diseases.\nA disorder characterized by an increase in production of parathyroid hormone by the parathyroid glands. This results in hypercalcemia (abnormally high levels of calcium in the blood).\nAbnormally increased activity of the parathyroid glands, which may be primary or secondary; primary hyperparathyroidism is associated with neoplasia or hyperplasia; excess of parathyroid hormone leads to alteration in function of bone, renal tubules, and gastrointestinal mucosa.\nHyperfunction of the parathyroid glands resulting in the overproduction of parathyroid hormone. It may be primary or secondary; primary hyperparathyroidism is caused by parathyroid adenoma, parathyroid hyperplasia, parathyroid carcinoma, and multiple endocrine neoplasia. It is associated with hypercalcemia and hypophosphatemia. Signs and symptoms include weakness, fatigue, nausea, vomiting, constipation, depression, bone pain, osteoporosis, cystic bone lesions, and kidney stones. Secondary hyperparathyroidism is caused by the chronic stimulation of the parathyroid glands in patients with chronic renal failure, rickets, and malabsorption syndromes.\nWhat: hyperparathyroidism. Hyperparathyroidism: a condition due to an increase in the secretion of the parathyroids, causing generalized osteitis fibrosa cystica, elevated serum calcium, decreased serum phosphorus, and increased excretion of both calcium and phosphorus. Why: several rheumatological disorders are associated with hyperpara- thyroidism. First, hyperuricemia and gouty arthritis (which may mimic hyperparathyroidism with renal stone formation and colic) have an increased incidence in patients with hyperparathyroidism. Second, patients with primary hyperparathyroidism show an increased incidence of chondrocalcinosis with episodes of calcium pyrophosphate crystal induced synovitis. Approximately 25% of patients with hyperparathyroidism will show radiographic evidence of calcification of articular cartilage and joint capsules. Finally, there can be a synovial and cartilaginous lesion (\"osteogenic synovitis\") in patients with hyperparathyroidism which may mimic other primary rheumatic diseases such as rheumatoid arthritis. In osteogenic synovitis there is softening and collapse of subchondral bone. Eventually the cartilage overlying this area erodes and is replaced by an irregular fibrocartilage. Eventually the articular surface of the joint is destroyed and secondary degenerative arthritis may develop."},
    {"ICD10Code":"E21.4","Description":"Other specified disorders of parathyroid gland","SearchInclusion":"Cyst of parathyroid\nParathyroid cyst","ClinicalNotes":""},
    {"ICD10Code":"E21.5","Description":"Disorder of parathyroid gland, unspecified","SearchInclusion":"Disorder of parathyroid gland\nParathyroid disorder","ClinicalNotes":"Deviation from or interruption of the normal structure or function of the parathyroid gland.\nMost people have four pea-sized glands, called parathyroid glands, on the thyroid gland in the neck. Though their names are similar, the thyroid and parathyroid glands are completely different. The parathyroid glands make parathyroid hormone (pth), which helps your body keep the right balance of calcium and phosphorous. If your parathyroid glands make too much or too little hormone, it disrupts this balance. If they secrete extra pth, you have hyperparathyroidism, and your blood calcium rises. In many cases, a benign tumor on a parathyroid gland makes it overactive. Or, the extra hormones can come from enlarged parathyroid glands. Very rarely, the cause is cancer.if you do not have enough pth, you have hypoparathyroidism. Your blood will have too little calcium and too much phosphorous. Causes include injury to the glands, endocrine disorders, or genetic conditions. Treatment is aimed at restoring the balance of calcium and phosphorous.\nPathological processes of the parathyroid glands. They usually manifest as hypersecretion or hyposecretion of parathyroid hormone that regulates the balance of calcium; phosphorus; and magnesium in the body."},
    {"ICD10Code":"E22.0","Description":"Acromegaly and pituitary gigantism","SearchInclusion":"Overproduction of growth hormone                                                                            Acromegaly\nGrowth hormone overproduction\nHypersomatotropic gigantism\nOverproduction of growth hormone\nPituitary gigantism\nSotos syndrome\nSotos' syndrome","ClinicalNotes":""},
    {"ICD10Code":"E22.1","Description":"Hyperprolactinemia","SearchInclusion":"Hyperprolactinemia (high prolactin hormone level)","ClinicalNotes":"Increased levels of prolactin in the blood, which may be associated with amenorrhea and galactorrhea. Relatively common etiologies include prolactinoma, medication effect, kidney failure, granulomatous diseases of the pituitary gland, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (from Joynt, Clinical Neurology, 1992, ch36, pp77-8)\nIncreased levels of prolactin in the blood, which may be associated with amenorrhea and galactorrhea; relatively common etiologies include prolactinoma, medication effect, kidney failure, granulomatous diseases of the pituitary gland, and disorders which interfere with the hypothalamic inhibition of prolactin release; ectopic (non-pituitary) production of prolactin may also occur."},
    {"ICD10Code":"E22.2","Description":"Syndrome of inappropriate secretion of antidiuretic hormone","SearchInclusion":"Syndrome inappropriate antidiuretic hormone secretion\nSyndrome of inappropriate vasopressin secretion","ClinicalNotes":"A condition of hyponatremia and renal salt loss attributed to overexpansion of body fluids resulting from sustained release of antidiuretic hormones which stimulates renal resorption of water. It is characterized by normal kidney function, high urine osmolality, low serum osmolality, and neurological dysfunction. Etiologies include adh-producing neoplasms, injuries or diseases involving the hypothalamus, the pituitary gland, and the lung. This syndrome can also be drug-induced.\nA syndrome characterized by abnormal secretion of antidiuretic hormone in conjunction with neoplastic growth occurring anywhere in the body."},
    {"ICD10Code":"E22.8","Description":"Other hyperfunction of pituitary gland","SearchInclusion":"Central precocious puberty","ClinicalNotes":""},
    {"ICD10Code":"E22.9","Description":"Hyperfunction of pituitary gland, unspecified","SearchInclusion":"Hyperpituitarism","ClinicalNotes":""},
    {"ICD10Code":"E23.0","Description":"Hypopituitarism","SearchInclusion":"Fertile eunuch syndrome\nHypogonadotropic hypogonadism\nIdiopathic growth hormone deficiency\nIsolated deficiency of gonadotropin\nIsolated deficiency of growth hormone\nIsolated deficiency of pituitary hormone\nKallmann's syndrome\nLorain-Levi short stature\nNecrosis of pituitary gland (postpartum)\nPanhypopituitarism\nPituitary cachexia\nPituitary insufficiency NOS\nPituitary short stature\nSheehan's syndrome\nSimmonds' disease                                                                                                                                                Anterior pituitary hormone deficiency\nFemale infertility due to pituitary disorder\nFemale infertility of pituitary origin\nFollicle stimulating hormone deficiency\nFsh - follicle stimulating hormone deficiency\nGonadotropin deficiency, isolated\nGrowth hormone deficiency\nGrowth hormone deficiency after bone marrow transplant\nGrowth hormone deficiency, bone marrow transplant\nGrowth hormone deficiency, isolated\nHypogonadism with anosmia\nHypogonadism, anosmia\nHypogonadotropic hypogonadism\nIsolated gonadotropin deficiency\nIsolated somatotropin deficiency\nLh - luteinizing hormone deficiency\nLuteinizing hormone deficiency\nPanhypopituitarism\nPartial growth hormone deficiency\nPartial hypopituitarism\nPituitary dwarfism\nSomatotropin deficiency, partial","ClinicalNotes":"A condition of diminution or cessation of secretion of one or more hormones from the anterior pituitary gland. This may result from surgical or radiation ablation, non-secretory pituitary neoplasms, metastatic tumors, infarction, pituitary apoplexy, infiltrative or granulomatous processes, and other conditions.\nA form of dwarfism caused by complete or partial growth hormone deficiency, resulting from either the lack of growth hormone-releasing factor from the hypothalamus or from the mutations in the growth hormone gene (gh1) in the pituitary gland. It is also known as type i pituitary dwarfism. Human hypophysial dwarf is caused by a deficiency of human growth hormone during development.\nA genetically heterogeneous disorder caused by hypothalamic gnrh deficiency and olfactory nerve defects. It is characterized by congenital hypogonadotropic hypogonadism and anosmia, possibly with additional midline defects. It can be transmitted as an x-linked (genetic diseases, x-linked), an autosomal dominant, or an autosomal recessive trait.\nA syndrome, sometimes considered as three separate entities (kalmann syndromes 1, 2, and 3), characterized mainly by reduced hypothalamic function and reduced pituitary gonadotropic activity and deficiency of gonadotropin-releasing hormone with resulting hypogonadism and absent or reduced sense of smell due to agenesis of the olfactory bulbs. Associated anomalies include cleft palate, neurosensory hearing loss, congenital heart defect, intestinal malrotation, renal agenesis, hypertension, mental retardation, color blindness, and other defects. Most abnormalities occur in types 1 and 2; type 3 is marked mainly by hypogonadotropic hypogonadism, anosmia, and craniofacial abnormalities.\nAn x-linked or autosomal dominant genetic syndrome characterized by hypogonadotropic hypogonadism and anosmia.\nAnosmia due to failure of the olfactory lobes to develop, with secondary hypogonadism due to gonadotropic hormone deficiency.\nDiminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including lh; follicle stimulating hormone; somatotropin; and corticotropin). This may result from surgical or radiation ablation, non-secretory pituitary neoplasms, metastatic tumors, infarction, pituitary apoplexy, infiltrative or granulomatous processes, and other conditions.\nDiminution or cessation of secretion of one or more hormones from the anterior pituitary gland (including luteinizing hormone, follicle stimulating hormone, somatotropin; and corticotropin); may result from surgical or radiation ablation, non-secretory pituitary neoplasms, metastatic tumors, infarction, pituitary apoplexy, infiltrative or granulomatous processes, and other conditions.\nForm of dwarfism due to deficient release of growth hormone which may result from dysfunction of the hypothalamus or anterior pituitary gland."},
    {"ICD10Code":"E23.1","Description":"Drug-induced hypopituitarism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E23.2","Description":"Diabetes insipidus","SearchInclusion":"Diabetes insipidus, central\nDiabetes insipidus, partial\nNeurohypophyseal diabetes insipidus\nPartial diabetes insipidus","ClinicalNotes":"A disease that is characterized by frequent urination, excretion of large amounts of dilute urine, and excessive thirst.\nA disease that is characterized by frequent urination, excretion of large amounts of dilute urine, and excessive thirst. Etiologies of diabetes insipidus include deficiency of antidiuretic hormone (also known as adh or vasopressin) secreted by the neurohypophysis, impaired kidney response to adh, and impaired hypothalamic regulation of thirst.\nA disorder characterized by excretion of large amounts of urine, accompanied by excessive thirst. Causes include deficiency of antidiuretic hormone or failure of the kidneys to respond to antidiuretic hormone. It may also be drug-related.\nDiabetes insipidus (di) causes frequent urination. You become extremely thirsty, so you drink. Then you urinate. This cycle can keep you from sleeping or even make you wet the bed. Your body produces big volumes of urine that are almost all water.di is different from diabetes mellitus (dm), which involves insulin problems and high blood sugar. The symptoms can be similar; however, di is related to how your kidneys handle fluids. It's much less common than dm. Urine and blood tests can show which one you have.usually, di is caused by a problem with your pituitary gland or your kidneys. Treatment depends on the cause of the problem. Medicines can often help.\nMetabolic disorder due to injury of the neurohypophyseal system; results in deficient quanity of antidiuretic hormone being released or produced, failure of tubular reabsorption of water in the kidney."},
    {"ICD10Code":"E23.3","Description":"Hypothalamic dysfunction, not elsewhere classified","SearchInclusion":"Exercise induced hypothalamic insufficiency\nHypothalamic insufficiency, exercise induced\nHypothalamic insufficiency, primary\nHypothalamic syndrome\nPrimary hypothalamic insufficiency","ClinicalNotes":""},
    {"ICD10Code":"E23.6","Description":"Other disorders of pituitary gland","SearchInclusion":"Abscess of pituitary\nAdiposogenital dystrophy                                                                                                                Abscess of pituitary\nCyst, pituitary\nDisorder of posterior pituitary\nEmpty sella syndrome\nHypophysitis, lymphocytic granulomatous\nHypothalamic insufficiency, secondary\nLymphocytic granulomatous hypophysitis\nPituitary cyst\nPituitary disorder, posterior\nRathke's pouch cyst\nRathkes pouch cyst\nSecondary hypothalamic insufficiency","ClinicalNotes":""},
    {"ICD10Code":"E23.7","Description":"Disorder of pituitary gland, unspecified","SearchInclusion":"Disease of pituitary gland\nDisorder of anterior pituitary\nDisorder of optic chiasm due to pituitary disorder\nDisorder of pituitary gland\nOptic chiasm disorder assoc with pituitary disorder\nPituitary disorder, anterior","ClinicalNotes":"Disorders involving either the adenohypophysis or the neurohypophysis. These diseases usually manifest as hypersecretion or hyposecretion of pituitary hormones. Neoplastic pituitary masses can also cause compression of the optic chiasm and other adjacent structures.\nDisorders of the anterior or posterior pituitary gland which usually manifest as hypersecretion or hyposecretion of pituitary hormones.\nYour pituitary gland is a pea-sized gland at the base of your brain. The pituitary is the \"master control gland\" - it makes hormones that affect growth and the functions of other glands in the body. With pituitary disorders, you often have too much or too little of one of your hormones. Injuries can cause pituitary disorders, but the most common cause is a pituitary tumor."},
    {"ICD10Code":"E24.0","Description":"Pituitary-dependent Cushing's disease","SearchInclusion":"Cushing disease\nPituitary dependent hypercortisolism                                                                                                         Overproduction of pituitary ACTH\nPituitary-dependent hypercorticalism","ClinicalNotes":"A disease of the pituitary gland characterized by the excess amount of adrenocorticotropic hormone secreted. This leads to hypersecretion of cortisol (hydrocortisone) by the adrenal glands resulting in cushing syndrome."},
    {"ICD10Code":"E24.1","Description":"Nelson's syndrome","SearchInclusion":"Nelson syndrome","ClinicalNotes":"A syndrome characterized by hyperpigmentation, enlarging pituitary mass, visual defects secondary to compression of the optic chiasm, and elevated serum acth. It is caused by the expansion of an underlying acth-secreting pituitary adenoma that grows in the absence of feedback inhibition by adrenal corticosteroids, usually after adrenalectomy.\nA syndrome that develops following bilateral adrenalectomy for cushing syndrome. The signs and symptoms result from the presence of an adenocorticotropin-secreting pituitary gland adenoma, and include enlargement of the sella turcica and pressure on the adjacent structures, and skin hyperpigmentation."},
    {"ICD10Code":"E24.2","Description":"Drug-induced Cushing's syndrome","SearchInclusion":"Cushings, iatrogenic\nIatrogenic cushing's disease\nSteroid induced cushing syndrome","ClinicalNotes":""},
    {"ICD10Code":"E24.3","Description":"Ectopic ACTH syndrome","SearchInclusion":"","ClinicalNotes":"A syndrome characterized by abnormal secretion of adrenocorticotrophic hormone in conjunction with neoplastic growth occurring anywhere in the body. The most common associations are tumors of the bronchus (oat cell or carcinoid), thymic tumors (epithelial or carcinoid), and pancreatic endocrine tumor. Symptom complex due to acth production by non-pituitary neoplasms."},
    {"ICD10Code":"E24.4","Description":"Alcohol-induced pseudo-Cushing's syndrome","SearchInclusion":"Pseudo-cushing syndrome due to alcohol","ClinicalNotes":""},
    {"ICD10Code":"E24.8","Description":"Other Cushing's syndrome","SearchInclusion":"Hypercortisolism due to nonpituitary tumor","ClinicalNotes":""},
    {"ICD10Code":"E24.9","Description":"Cushing's syndrome, unspecified","SearchInclusion":"Adrenal cushing's syndrome\nCushing disease\nCushing syndrome\nCushing's syndrome, myopathy\nHypercortisolism\nMyopathy due to cushing's syndrome\nPituitary dependent hypercortisolism","ClinicalNotes":"A condition caused by prolonged exposure to excess levels of cortisol (hydrocortisone) or other glucocorticoids from endogenous or exogenous sources. It is characterized by upper body obesity; osteoporosis; hypertension; diabetes mellitus; hirsutism; amenorrhea; and excess body fluid. Endogenous cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of adrenocorticotropin and those that are acth-independent.\nA condition in which there is too much cortisol (a hormone made by the outer layer of the adrenal gland) in the body. Cushing syndrome may be caused by taking too many steroid drugs or by certain types of tumors. Tumors that make adrenocorticotropic hormone (acth) cause the adrenal gland to make too much cortisol. Symptoms of cushing syndrome include a round face, thin arms and legs, severe fatigue and muscle weakness, high blood pressure, high blood sugar, purple or pink stretch marks on the skin, and weight gain, especially in the abdomen.\nA condition in which there is too much cortisol (a hormone made by the outer layer of the adrenal gland) in the body. In cushing disease, this happens when an adenoma (benign tumor) in the pituitary gland makes too much adrenocorticotropic hormone (acth). This causes the adrenal gland to make too much cortisol. Symptoms include a round face, thin arms and legs, severe fatigue and muscle weakness, high blood pressure and high blood sugar, purple or pink stretch marks on the skin, and weight gain, especially in the abdomen.\nA rare hormonal disease that occurs when the body produces too much of the hormone cortisol\nA syndrome caused by high levels of cortisol in the blood either due to excessive production and secretion of corticosteroids secondary to pituitary or adrenocortical neoplasms, or intake of glucocorticoid drugs. Signs and symptoms include a round face, upper body obesity, fragile and thin skin, purple stretch marks in the skin, fatigue, muscle weakness, hypertension, diabetes mellitus, hypertrichosis and amenorrhea in women, impotence in men, and osteoporosis.\nCondition, more commonly seen in females, due to hyperadrenocorticism resulting from neoplasms of the adrenal cortex or the anterior lobe of the pituitary, or to prolonged excessive intake of glucocorticoids for therapeutic purposes; symptoms and signs may include rapidly developing adiposity of the face, neck, and trunk, kyphosis caused by osteoporosis of the spine, hypertension, diabetes mellitus, amenorrhea, hypertrichosis in females, impotence in males, dusky complexion with purple markings, polycythemia, pain in the abdomen and back, and muscular wasting and weakness.\nCushing's syndrome is a hormonal disorder. The cause is long-term exposure to too much cortisol, a hormone that your adrenal gland makes. Sometimes, taking synthetic hormone medicine to treat an inflammatory disease leads to cushing's. Some kinds of tumors produce a hormone that can cause your body to make too much cortisol.cushing's syndrome is rare. Some symptoms are\nupper body obesity\nthin arms and legs\nsevere fatigue and muscle weakness\nhigh blood pressure\nhigh blood sugar\neasy bruising\nlab tests can show if you have it and find the cause. Your treatment will depend on why you have too much cortisol. If it is because you have been taking synthetic hormones, a lower dose may control your symptoms. If the cause is a tumor, surgery and other therapies may be needed."},
    {"ICD10Code":"E25.0","Description":"Congenital adrenogenital disorders associated with enzyme deficiency","SearchInclusion":"Congenital adrenal hyperplasia\n21-Hydroxylase deficiency\nSalt-losing congenital adrenal hyperplasia                                                                    3 beta-hydroxysteroid dehydrogenase deficiency\nAdrenal hyperplasia, congenital\nAdrenal hyperplasia, congenital, simple virilizing\nAdrenal hyperplasia, congenital, virilizing, non salt\nCongenital adrenal hyperplasia\nCongenital adrenal hyperplasia, undervirilized xy due to 17-alpha hydroxylase deficiency\nCongenital adrenal hyperplasia, virilizing, non-salt-losing\nCongenital adrenal hyperplasia, virilizing, salt-losing\nLate onset congenital adrenal hyperplasia\nSteroid 21-monooxygenase deficiency, simple virilizing type\nUndervirilized xy, 3-beta hydroxysteroid deficiency\nUndervirilized xy, congenital adrenal hyperplasis,","ClinicalNotes":"A genetic disorder characterized by defects in the synthesis of cortisol and/or aldosterone, resulting in hyperplasia of the adrenal cortical cells.\nA group of inherited disorders of the adrenal glands, caused by enzyme defects in the synthesis of cortisol (hydrocortisone) and/or aldosterone leading to accumulation of precursors for androgens. Depending on the hormone imbalance, congenital adrenal hyperplasia can be classified as salt-wasting, hypertensive, virilizing, or feminizing. Defects in steroid 21-hydroxylase; steroid 11-beta-hydroxylase; steroid 17-alpha-hydroxylase; 3-beta-hydroxysteroid dehydrogenase (3-hydroxysteroid dehydrogenases); testosterone 5-alpha-reductase; or steroidogenic acute regulatory protein; among others, underlie these disorders.\nGroup of syndromes caused by inherited defects in cortisol and/or aldosterone biosynthesis; acth elevation is caused by low levels of cortisol, whose production is impaired by absence or deficiency of one of the five enzymes necessary for its synthesis from cholesterol."},
    {"ICD10Code":"E25.8","Description":"Other adrenogenital disorders","SearchInclusion":"Idiopathic adrenogenital disorder                                                                                   Virilized female due to gestational hyperandrogenism\nVirilized xx, gestational hyperandrogenism","ClinicalNotes":""},
    {"ICD10Code":"E25.9","Description":"Adrenogenital disorder, unspecified","SearchInclusion":"Adrenogenital disorder\nVirilized female due to gestational hyperandrogenism\nVirilized xx, gestational hyperandrogenism                                                          Adrenogenital syndrome NOS","ClinicalNotes":"Abnormal sex differentiation or congenital disorders of sex development caused by abnormal levels of steroid hormones expressed by the gonads or the adrenal glands, such as in congenital adrenal hyperplasia and adrenal cortex neoplasms. Due to abnormal steroid biosynthesis, clinical features include virilism in females; feminization in males; or precocious sexual development in children."},
    {"ICD10Code":"E26.01","Description":"Conn's syndrome","SearchInclusion":"Conn syndrome\nConns syndrome    ","ClinicalNotes":"An endocrine disorder characterized by excessive production of aldosterone by the adrenal glands. Causes include adrenal gland adenoma and adrenal gland hyperplasia. The overproduction of aldosterone results in sodium and water retention and hypokalemia. Patients present with high blood pressure, muscle weakness, and headache.\nOverproduction of aldosterone by an adrenal cortical adenoma, characterized typically by low potassium levels, underacidity of the body, muscular weakness, excess urination, excess thirst, and high blood pressure.\nPrimary hyperaldosteronism caused by the excess production of aldosterone by an adenoma of the zona glomerulosa or conn adenoma."},
    {"ICD10Code":"E26.02","Description":"Glucocorticoid-remediable aldosteronism","SearchInclusion":"Familial aldosteronism type I                                                                                                             Glucocorticoid-suppressible hyperaldosteronism\nHyperaldosteronism, glucocorticoid remediable","ClinicalNotes":""},
    {"ICD10Code":"E26.09","Description":"Other primary hyperaldosteronism","SearchInclusion":"Aldosteronism, primary\nPrimary aldosteronism                                                                                                             Primary aldosteronism due to adrenal hyperplasia (bilateral)","ClinicalNotes":""},
    {"ICD10Code":"E26.1","Description":"Secondary hyperaldosteronism","SearchInclusion":"Aldosteronism, secondary","ClinicalNotes":""},
    {"ICD10Code":"E26.81","Description":"Bartter's syndrome","SearchInclusion":"Bartter syndrome\nPseudoprimary hyperaldosteronism","ClinicalNotes":"A group of disorders caused by defective salt reabsorption in the ascending loop of henle. It is characterized by severe salt-wasting, hypokalemia; hypercalciuria; metabolic alkalosis, and hyper-reninemic hyperaldosteronism without hypertension. There are several subtypes including ones due to mutations in the renal specific sodium-potassium-chloride symporters.\nA rare inherited syndrome characterized by juxtaglomerular cell hyperplasia, hyperaldosteronism, hypokalemia, and alkalosis. Patients have high levels of plasma renin concentration which is not associated with hypertension.\nHypertrophy and hyperplasia of the juxtaglomerular apparatus with secondary hyperaldosteronism with normal blood pressure and hyperkalemic alkalosis in the absence of edema. Most patients show growth and mental retardation. Nephrocalcinosis and hypercalcinuria occur in some cases. Diuretic abuse may produce a syndrome with similar characteristics (pseudo-bartter or factitious bartter syndrome).\nTransmitted as an autosomal recessive trait; characterized by hypertrophy and hyperplasia of the juxtaglomerular cells, and increased concentrations of renin, angiotensin ii, and aldosterone in the absence of edema and hypertension."},
    {"ICD10Code":"E26.89","Description":"Other hyperaldosteronism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E26.9","Description":"Hyperaldosteronism, unspecified","SearchInclusion":"Aldosteronism NOS\nHyperaldosteronism NOS                                                                                                                                Aldosteronism and nodular hyperplasia, adrenal cortex\nHyperaldosteronism\nHyperaldosteronism with nodular hyperplasia of adrenal cortex","ClinicalNotes":"A condition caused by the overproduction of aldosterone. It is characterized by sodium retention and potassium excretion with resultant hypertension and hypokalemia.\nAbnormality of electrolyte function caused by excessive secretion of aldosterone by the adrenal cortex."},
    {"ICD10Code":"E27.0","Description":"Other adrenocortical overactivity","SearchInclusion":"Overproduction of ACTH, not associated with Cushing's disease\nPremature adrenarche                                                                                                                                           Acquired benign adrenal androgenic overactivity\nAdrenal androgenic overactivity, acquired benign\nPremature adrenarche\nPremature adrenarche (puberty disorder)","ClinicalNotes":""},
    {"ICD10Code":"E27.1","Description":"Primary adrenocortical insufficiency","SearchInclusion":"Addison's disease\nAutoimmune adrenalitis                                                                                                       Addison's disease\nAddison's disease, myopathy\nAdrenal calcification\nAdrenal insufficiency, primary\nMyopathy in addison's disease","ClinicalNotes":"A hormonal disorder that occurs when the adrenal glands fail to release adequate amounts of glucocorticoids (cortisol), mineralocorticoids (aldosterone, 11-deoxycorticosterone), and androgens (dehydroepiandrosterone) to meet physiologic needs, despite release of acth from the pituitary.\nA rare endocrine or hormonal disorder that occurs when the adrenal glands do not produce enough of the hormone cortisol and in some cases, the hormone aldosterone. It may be due to a disorder of the adrenal glands themselves (primary adrenal insufficiency) or to inadequate secretion of acth by the pituitary gland (secondary adrenal insufficiency).\nAn adrenal disease characterized by the progressive destruction of the adrenal cortex, resulting in insufficient production of aldosterone and hydrocortisone. Clinical symptoms include anorexia; nausea; weight loss; muscle weakness; and hyperpigmentation of the skin due to increase in circulating levels of acth precursor hormone which stimulates melanocytes.\nDisease characterized by hypotension, weight loss, anorexia, weakness, and sometimes a bronze-like melanotic hyperpigmentation of the skin; due to tuberculosis or autoimmune induced disease (hypofunction) of the adrenal glands that results in deficiency of aldosterone and cortisol.\nYour adrenal glands are just above your kidneys. The outside layer of these glands makes hormones that help your body respond to stress and regulate your blood pressure and water and salt balance. Addison's disease happens if the adrenal glands don't make enough of these hormones. A problem with your immune system usually causes addison's disease. The immune system mistakenly attacks your own tissues, damaging your adrenal glands. Other causes include infections and cancer. Symptoms include\nweight loss\nmuscle weakness\nfatigue that gets worse over time\nlow blood pressure\npatchy or dark skin\nlab tests can confirm that you have addison's disease. If you don't treat it, it can be fatal. You will need to take hormone pills for the rest of your life. If you have addison's disease, you should carry an emergency id. It should say that you have the disease, list your medicines and say how much you need in an emergency."},
    {"ICD10Code":"E27.2","Description":"Addisonian crisis","SearchInclusion":"Adrenal crisis\nAdrenocortical crisis","ClinicalNotes":""},
    {"ICD10Code":"E27.3","Description":"Drug-induced adrenocortical insufficiency","SearchInclusion":"Drug induced adrenocortical insufficiency","ClinicalNotes":""},
    {"ICD10Code":"E27.40","Description":"Unspecified adrenocortical insufficiency","SearchInclusion":"Adrenocortical insufficiency NOS\nHypoaldosteronism                                                                                                                                          Acth deficiency\nAdrenal cortical hypofunction\nAdrenal insufficiency, medullary\nAdrenal insufficiency, secondary\nAdrenal insufficiency, severe\nAdrenal medullary insufficiency\nAdrenocortical insufficiency\nSecondary adrenal insufficiency\nSevere adrenal insufficiency","ClinicalNotes":"A congenital or acquired condition of insufficient production of aldosterone by the adrenal cortex leading to diminished aldosterone-mediated synthesis of na(+)-k(+)-exchanging atpase in renal tubular cells. Clinical symptoms include hyperkalemia, sodium-wasting, hypotension, and sometimes metabolic acidosis.\nAldosterone deficiency, usually associated with hypoadrenalism and characterized by hypotension, dehydration, and a tendency to excrete excessive amounts of sodium."},
    {"ICD10Code":"E27.49","Description":"Other adrenocortical insufficiency","SearchInclusion":"Adrenal hemorrhage\nAdrenal infarction                                                                                                                                                   Adrenal atrophy\nAdrenal hemorrhage\nAdrenal infarction\nGlucocorticoid deficiency\nMineralocorticoid deficiency","ClinicalNotes":"Hemorrhage and necrosis of the adrenal gland tissue. Bilateral and extensive hemorrhage may lead to acute adrenal insufficiency, shock, and death."},
    {"ICD10Code":"E27.5","Description":"Adrenomedullary hyperfunction","SearchInclusion":"Adrenomedullary hyperplasia\nCatecholamine hypersecretion                                                                                Medulloadrenal hyperfunction","ClinicalNotes":""},
    {"ICD10Code":"E27.8","Description":"Other specified disorders of adrenal gland","SearchInclusion":"Abnormality of cortisol-binding globulin                                                                                                 Abnormality of cortisol-binding globulin\nAldosteronism and nodular hyperplasia, adrenal cortex\nCortisol binding globulin abnormality\nHyperaldosteronism with nodular hyperplasia of adrenal cortex","ClinicalNotes":""},
    {"ICD10Code":"E27.9","Description":"Disorder of adrenal gland, unspecified","SearchInclusion":"Adrenal disorder\nAdrenal hypertension (htn)\nAdrenal incidentaloma\nAdrenal mass\nBilateral adrenal mass\nDisorder of adrenal gland\nEndocrine hypertension\nIncidental finding of mass in the adrenal gland\nLeft adrenal mass\nMass of left adrenal gland\nMass of right adrenal gland\nRight adrenal mass","ClinicalNotes":"Pathologic condition or abnormal functioning of either or both of the paired glands situated in the retroperitoneal tissues at the superior pole of the kidneys or adrenal glands.\nPathological processes of the adrenal glands.\nYour adrenal, or suprarenal, glands are located on the top of each kidney. These glands produce hormones that you can't live without, including sex hormones and cortisol, which helps you respond to stress and has many other functions.adrenal disorders can cause your adrenal glands to make too much or not enough hormones. With cushing's syndrome, there's too much cortisol, while with addison's disease, there is too little. Some people are born unable to make enough cortisol. tumors can also cause disorders in your adrenal glands. Bleeding and infection can cause an adrenal gland problem that can be fatal without quick treatment.treatment depends on which problem you have. Surgery or medicines can treat many adrenal gland disorders."},
    {"ICD10Code":"E28.0","Description":"Estrogen excess","SearchInclusion":"Hyperestrogenism","ClinicalNotes":""},
    {"ICD10Code":"E28.1","Description":"Androgen excess","SearchInclusion":"Hypersecretion of ovarian androgens                                                                                              Hyperandrogenemia\nHyperandrogenemia (excess androgen hormone)\nHypersecretion of ovarian androgens\nHypersecretion, ovarian androgens\nIncreased androgen level","ClinicalNotes":""},
    {"ICD10Code":"E28.2","Description":"Polycystic ovarian syndrome","SearchInclusion":"Sclerocystic ovary syndrome\nStein-Leventhal syndrome                                                                                                                                              Isosexual virilization\nPolycystic ovaries\nVirilization, isosexual","ClinicalNotes":"A complex disorder characterized by infertility, hirsutism; obesity; and various menstrual disturbances such as oligomenorrhea; amenorrhea; anovulation. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.\nA condition marked by infertility, enlarged ovaries, menstrual problems, high levels of male hormones, excess hair on the face and body, acne, and obesity. Women with pcos have an increased risk of diabetes, high blood pressure, heart disease, and endometrial cancer.\nA disorder that manifests as multiple cysts on the ovaries. It results in hormonal imbalances and leads to irregular and abnormal menstrual periods, excess growth of hair, acne eruptions and obesity.\nA health problem that can affect a woman's menstrual cycle, fertility, hormones, insulin production, heart, blood vessels, and appearance\nA non-neoplastic disorder characterized by bilateral polycystic and enlarged ovaries. Clinical signs include amenorrhea, oligomenorrhea, infertility, obesity, hirsutism, and virilism.\nClinical symptom complex characterized by presence of multiple cysts on the ovaries, oligomenorrhea or amenorrhea, anovulation and regularly associated with excessive amounts of body hair (hirsuitism), excessive body weight, infertility and insulin resistance.\nPolycystic ovary syndrome (pcos) happens when a woman's ovaries or adrenal glands produce more male hormones than normal. One result is that cysts (fluid-filled sacs) develop on the ovaries. Women who are obese are more likely to have polycystic ovary syndrome.symptoms of pcos include:\ninfertility\npelvic pain\nexcess hair growth on the face, chest, stomach, thumbs, or toes\nbaldness or thinning hair\nacne, oily skin, or dandruff\npatches of thickened dark brown or black skin\nwomen with pcos are at higher risk of diabetes, metabolic syndrome, heart disease, and high blood pressure.medicines can help control the symptoms. Birth control pills help women have normal periods, reduce male hormone levels, and clear acne. Other medicines can reduce hair growth and control blood pressure and cholesterol. There is no cure."},
    {"ICD10Code":"E28.310","Description":"Symptomatic premature menopause","SearchInclusion":"Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with premature menopause","ClinicalNotes":"A condition in which the ovaries stop working and menstrual periods stop before age 40. Natural menopause usually occurs around age 50. A woman is said to be in menopause when she hasn't had a period for 12 months in a row. Symptoms of menopause include hot flashes, mood swings, night sweats, vaginal dryness, trouble concentrating, and infertility. Premature menopause can be caused by some cancer treatments, surgery to remove the ovaries, and certain diseases or genetic conditions.\nA disorder characterized by ovarian failure before the age of 40. Symptoms include hot flashes, night sweats, mood swings and a decrease in sex drive.\nOvarian failure before the age of 40. Symptoms include hot flashes, night sweats, mood swings, and decreased sex drive.\nThe premature cessation of menses (menstruation) when the last menstrual period occurs in a woman under the age of 40. It is due to the depletion of ovarian follicles. Premature menopause can be caused by diseases; ovariectomy; radiation; chemicals; and chromosomal abnormalities."},
    {"ICD10Code":"E28.319","Description":"Asymptomatic premature menopause","SearchInclusion":"Premature menopause","ClinicalNotes":""},
    {"ICD10Code":"E28.39","Description":"Other primary ovarian failure","SearchInclusion":"Decreased estrogen\nResistant ovary syndrome                                                                                                               Female infertility due to diminished ovarian reserve\nOvarian failure (loss of ovary function) before age 40\nOvarian failure, primary\nPremature ovarian failure\nPrimary ovarian failure\nSecondary ovarian failure","ClinicalNotes":"A form of ovarian failure, caused by resistance to gonadotropins stimulation. It may be caused by defects in the receptors for follicle stimulating hormone or luteinizing hormone. It may be due to factors interfering with the actions of gonadotropins, such as antibodies blocking the ligand-receptor interaction."},
    {"ICD10Code":"E28.8","Description":"Other ovarian dysfunction","SearchInclusion":"Ovarian hyperfunction NOS                                                                                                                                  Diminished ovarian reserve\nDiminished ovarian reserve due to advanced matenal age\nDiminished ovarian reserve due to advanced maternal age\nDiminished ovarian reserve due to increased fsh and estradiol\nDiminished ovarian reserve due to low antral follicle\nDiminished ovarian reserve due to poor fsh response\nDiminished ovarian reserve evidenced by low antral follicle count\nDiminished ovarian reserve, increased follicle stimulating hormone (fsh) and estrogen\nDiminished ovarian reserve, poor follicle stimulating hormone (fsh) response","ClinicalNotes":""},
    {"ICD10Code":"E28.9","Description":"Ovarian dysfunction, unspecified","SearchInclusion":"Disorder of endocrine ovary\nOvarian dysfunction","ClinicalNotes":""},
    {"ICD10Code":"E29.0","Description":"Testicular hyperfunction","SearchInclusion":"Hypersecretion of testicular hormones","ClinicalNotes":"Gonadotropin-independent familial sexual precocity\nTestotoxicosis"},
    {"ICD10Code":"E29.1","Description":"Testicular hypofunction","SearchInclusion":"Defective biosynthesis of testicular androgen NOS\n5-delta-Reductase deficiency (with male pseudohermaphroditism)\nTesticular hypogonadism NOS                                                                                Hypogonadism, male\nHypotestosteronism\nMale hypogonadism\nTesticular failure with hypogonadism","ClinicalNotes":""},
    {"ICD10Code":"E29.8","Description":"Other testicular dysfunction","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E29.9","Description":"Testicular dysfunction, unspecified","SearchInclusion":"Disorder of endocrine testis\nTesticular dysfunction","ClinicalNotes":""},
    {"ICD10Code":"E30.0","Description":"Delayed puberty","SearchInclusion":"Constitutional delay of puberty\nDelayed sexual development                                                                                                                          Delay in sexual development and/or puberty\nDelayed menarche (late occurance of first menstrual cycle)\nDelayed menarche (late occurrence of first menstrual cycle)\nLate menarche\nSexual development, delayed","ClinicalNotes":"A disorder characterized by unusually late sexual maturity.\nThe lack of development of sexual maturation in boys and girls at a chronological age that is 2.5 standard deviations above the mean age at onset of puberty in a population. Delayed puberty can be classified by defects in the hypothalamic lhrh pulse generator, the pituitary gland, or the gonads. These patients will undergo spontaneous but delayed puberty whereas patients with sexual infantilism will not.\nUnusually late sexual maturity."},
    {"ICD10Code":"E30.1","Description":"Precocious puberty","SearchInclusion":"Constitutional sexual precocity\nCryptogenic sexual precocity\nEarly menarche\nPrecocious pubarche\nPrecocious sexual development\nPremature menarche\nSexual precocity, constitutional\nSexual precocity, cryptogenic                                                                                                                  Precocious menstruation","ClinicalNotes":"A disorder characterized by unusually early development of secondary sexual features; the onset of sexual maturation begins usually before age 8 for girls and before age 9 for boys.\nDevelopment of sexual maturation in boys and girls at a chronological age that is 2.5 standard deviations below the mean age at onset of puberty in the population. This early maturation of the hypothalamic-pituitary-gonadal axis results in sexual precocity, elevated serum levels of gonadotropins and gonadal steroid hormones such as estradiol and testosterone.\nUnusually early sexual development or maturity; premature puberty.\nUnusually early sexual maturity."},
    {"ICD10Code":"E30.8","Description":"Other disorders of puberty","SearchInclusion":"Premature thelarche                                                                                                                 Premature breast development\nPremature development of the breasts","ClinicalNotes":""},
    {"ICD10Code":"E30.9","Description":"Disorder of puberty, unspecified","SearchInclusion":"Disorder of puberty","ClinicalNotes":""},
    {"ICD10Code":"E31.0","Description":"Autoimmune polyglandular failure","SearchInclusion":"Schmidt's syndrome                                                                                                                                                                           Autoimmune polyendocrinopathy\nLloyd syndrome\nPolyglandular autoimmune syndrome, type 2\nSchmidts syndrome","ClinicalNotes":"A rare genetic syndrome characterized by autoantibodies production against more than one endocrine organ. The range of endocrinopathies includes hypoparathyroidism, adrenal insufficiency, hypogonadism, type 1 diabetes mellitus and hypothyroidism.\nAn autoimmune diseases affecting multiple endocrine organs\nAutoimmune diseases affecting multiple endocrine organs. Type i is characterized by childhood onset and chronic mucocutaneous candidiasis (candidiasis, chronic mucocutaneous), while type ii exhibits any combination of adrenal insufficiency (addison's disease), lymphocytic thyroiditis (thyroiditis, autoimmune;), hypoparathyroidism; and gonadal failure. In both types organ-specific antibodies against a variety of endocrine glands have been detected. The type ii syndrome differs from type i in that it is associated with hla-a1 and b8 haplotypes, onset is usually in adulthood, and candidiasis is not present."},
    {"ICD10Code":"E31.1","Description":"Polyglandular hyperfunction","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E31.20","Description":"Multiple endocrine neoplasia [MEN] syndrome, unspecified","SearchInclusion":"Multiple endocrine adenomatosis NOS\nMultiple endocrine neoplasia [MEN] syndrome NOS                                                                            Multiple endocrine neoplasia syndrome\nPolyglandular activity in multiple endocrine adenomatosis","ClinicalNotes":"A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more endocrine glands that secrete peptide hormones or amines. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are men1 and men2 with gene mutations on chromosome 11 and chromosome 10, respectively.\nAn autosomal dominant inherited neoplastic syndrome characterized by the development of various endocrine neoplasms and abnormalities in various anatomic sites. There are three types recognized: type 1 (men 1), caused by inactivation of the tumor suppressor gene men-1, type 2a (men 2a), caused by mutation of the ret gene, and type 2b (men 2b) also caused by mutation of the ret gene. Patients with men 1 may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors. Patients with men 2a develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia. Patients with men 2b develop medullary thyroid carcinomas and numerous neural defects including neuromas.\nAn inherited condition that may result in the development of cancers of the endocrine system. There are several types of multiple endocrine neoplasia syndrome, and patients with each type may develop different types of cancer. The altered genes that cause each type can be detected with a blood test.\nGroup of specific, familial syndromes characterized by simultaneous neoplastic transformation of multiple endocrine tissues, typically the parathyroid glands, pancreatic islets, and anterior pituitary."},
    {"ICD10Code":"E31.21","Description":"Multiple endocrine neoplasia [MEN] type I","SearchInclusion":"Wermer's syndrome                                                                    Multiple endocrine neoplasia, type 1\nMultiple endocrine neoplasm type 1","ClinicalNotes":"A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the parathyroid glands, the pituitary gland, and the pancreatic islets. The resulting clinical signs include hyperparathyroidism; hypercalcemia; hyperprolactinemia; cushing disease; gastrinoma; and zollinger-ellison syndrome. This disease is due to loss-of-function of the men1 gene, a tumor suppressor gene (genes, tumor suppressor) on chromosome 11 (locus: 11q13).\nA rare, inherited disorder that affects the endocrine glands and can cause tumors in the parathyroid and pituitary glands and the pancreas. These tumors are usually benign (not cancer). They cause the glands to secrete high levels of hormones, which can lead to other medical problems, such as kidney stones, fertility problems, and severe ulcers. In some cases, tumors inside the pancreas can become malignant (cancer).\nMultiple endocrine neoplasia caused by inactivation of the tumor suppressor gene men-1. Patients may develop hyperparathyroidism and parathyroid gland adenomas, pituitary gland adenomas, pancreatic islet cell neoplasms, and carcinoid tumors."},
    {"ICD10Code":"E31.22","Description":"Multiple endocrine neoplasia [MEN] type IIA","SearchInclusion":"Sipple's syndrome                                                                                                                                                           Multiple endocrine neoplasia type 2a\nMultiple endocrine neoplasia type 2a cancerous\nMultiple endocrine neoplasia type 2a noncancerous\nMultiple endocrine neoplasia type 2a, benign\nMultiple endocrine neoplasia type 2a, malignant\nMultiple endocrine neoplasia, type 2","ClinicalNotes":"A form of multiple endocrine neoplasia characterized by the presence of medullary carcinoma (carcinoma, medullary) of the thyroid gland, and usually with the co-occurrence of pheochromocytoma, producing calcitonin and adrenaline, respectively. Less frequently, it can occur with hyperplasia or adenoma of the parathyroid glands. This disease is due to gain-of-function mutations of the men2 gene on chromosome 10 (locus: 10q11.2), also known as the ret proto-oncogene that encodes a receptor protein-tyrosine kinase. It is an autosomal dominant inherited disease.\nMultiple endocrine neoplasia caused by mutation of the ret gene. Patients develop medullary thyroid carcinomas, and may also develop pheochromocytomas and parathyroid gland hyperplasia."},
    {"ICD10Code":"E31.23","Description":"Multiple endocrine neoplasia [MEN] type IIB","SearchInclusion":"Multiple endocrine neoplasia type iib\nMultiple endocrine neoplasia, type 3","ClinicalNotes":""},
    {"ICD10Code":"E31.8","Description":"Other polyglandular dysfunction","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E31.9","Description":"Polyglandular dysfunction, unspecified","SearchInclusion":"Polyglandular dysfunction","ClinicalNotes":""},
    {"ICD10Code":"E32.0","Description":"Persistent hyperplasia of thymus","SearchInclusion":"Hypertrophy of thymus                                                                                                                                      Persistent hyperplasia thymus","ClinicalNotes":"Enlargement of the thymus. A condition described in the late 1940's and 1950's as pathological thymic hypertrophy was status thymolymphaticus and was treated with radiotherapy. Unnecessary removal of the thymus was also practiced. It later became apparent that the thymus undergoes normal physiological hypertrophy, reaching a maximum at puberty and involuting thereafter. The concept of status thymolymphaticus has been abandoned. Thymus hyperplasia is present in two thirds of all patients with myasthenia gravis."},
    {"ICD10Code":"E32.1","Description":"Abscess of thymus","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E32.8","Description":"Other diseases of thymus","SearchInclusion":"Atrophy of thymus\nAtrophy of thymus gland\nCyst of thymus\nCyst of thymus gland","ClinicalNotes":""},
    {"ICD10Code":"E32.9","Description":"Disease of thymus, unspecified","SearchInclusion":"Disorder of thymus gland\nHypothalamic mass\nThymus disorder","ClinicalNotes":"Condition in which there is a deviation from or interruption of the normal structure or function of the thymus."},
    {"ICD10Code":"E34.0","Description":"Carcinoid syndrome","SearchInclusion":"","ClinicalNotes":"A combination of symptoms caused by the release of serotonin and other substances from carcinoid tumors of the gastrointestinal tract. Symptoms may include flushing of the face, flat angiomas (small collections of dilated blood vessels) of the skin, diarrhea, bronchial spasms, rapid pulse, and sudden drops in blood pressure.\nA symptom complex associated with carcinoid tumor and characterized by attacks of severe flushing of the skin, diarrheal watery stools, bronchoconstriction, sudden drops in blood pressure, edema, and ascites. The carcinoid tumors are usually located in the gastrointestinal tract and metastasize to the liver. Symptoms are caused by tumor secretion of serotonin, prostaglandins, and other biologically active substances. Cardiac manifestations constitute carcinoid heart disease."},
    {"ICD10Code":"E34.1","Description":"Other hypersecretion of intestinal hormones","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E34.2","Description":"Ectopic hormone secretion, not elsewhere classified","SearchInclusion":"Ectopic hormone secretion disorder\nEctopic production of endocrine substance","ClinicalNotes":""},
    {"ICD10Code":"E34.3","Description":"Short stature due to endocrine disorder","SearchInclusion":"Constitutional short stature\nLaron-type short stature                                                                                                                 Constitutional short stature\nDwarfism\nHomozygous leri weill dyschondrosteosis syndrome\nLanger mesomelic dysplasia syndrome\nShort stature\nTrue dwarfism","ClinicalNotes":"A dwarf is a person of short stature - under 4' 10\" as an adult. More than 200 different conditions can cause dwarfism. A single type, called achondroplasia, causes about 70 percent of all dwarfism. Achondroplasia is a genetic condition that affects about 1 in 15,000 to 1 in 40,000 people. It makes your arms and legs short in comparison to your head and trunk. Other genetic conditions, kidney disease and problems with metabolism or hormones can also cause short stature.dwarfism itself is not a disease. However, there is a greater risk of some health problems. With proper medical care, most people with dwarfism have active lives and live as long as other people.\nA genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.\nAn autosomal recessive disorder characterized by short stature, defective growth hormone receptor, and failure to generate insulin-like growth factor i by growth hormone. Laron syndrome is not a form of primary pituitary dwarfism (growth hormone deficiency dwarfism) but the result of mutation of the human ghr gene on chromosome 5.\nCondition of being undersized as a result of premature arrest of skeletal growth.\nShort stature that usually results from genetic mutations. Other causes include hormonal deficiencies and poor nutrition."},
    {"ICD10Code":"E34.4","Description":"Constitutional tall stature","SearchInclusion":"Constitutional gigantism","ClinicalNotes":""},
    {"ICD10Code":"E34.50","Description":"Androgen insensitivity syndrome, unspecified","SearchInclusion":"Androgen insensitivity NOS                                                                                                                             Androgen resistance syndrome\nInsensitivity, androgen","ClinicalNotes":"A disorder also known as complete androgen insensitivity syndrome (cais). The 46,xy genetic male totally lacks androgen responsiveness in the target organs thus exhibits a female phenotype.\nA disorder of sexual development in persons with 46xy karyotype, characterized by an abnormality of the genes encoding androgen receptors. It results in a female sex appearance or the development of both male and female characteristics.\nAspects of female morphology in a xy genotype caused by defects in cellular receptors for testosterone and dihydrotestosterone, transmitted as an x-linked trait.\nSexual ambiguity in males due to a sexual differentiation disorder caused by testicular failure to respond to androgens. The affected males have abdominal and inguinal testes, female external genitalia and breasts, blind vaginas, and absent uteri. Some patients have absent pubic and axillary hair, hence the synonym \"hairless pseudofemale.\" mental retardation occurs in some cases."},
    {"ICD10Code":"E34.51","Description":"Complete androgen insensitivity syndrome","SearchInclusion":"Complete androgen insensitivity\nde Quervain syndrome\nGoldberg-Maxwell syndrome                                                                                                                       Testicular feminization","ClinicalNotes":"A disorder also known as complete androgen insensitivity syndrome (cais). The 46,xy genetic male totally lacks androgen responsiveness in the target organs thus exhibits a female phenotype.\nA disorder of sexual development in persons with 46xy karyotype, characterized by an abnormality of the genes encoding androgen receptors. It results in a female sex appearance or the development of both male and female characteristics.\nAspects of female morphology in a xy genotype caused by defects in cellular receptors for testosterone and dihydrotestosterone, transmitted as an x-linked trait.\nSexual ambiguity in males due to a sexual differentiation disorder caused by testicular failure to respond to androgens. The affected males have abdominal and inguinal testes, female external genitalia and breasts, blind vaginas, and absent uteri. Some patients have absent pubic and axillary hair, hence the synonym \"hairless pseudofemale.\" mental retardation occurs in some cases."},
    {"ICD10Code":"E34.52","Description":"Partial androgen insensitivity syndrome","SearchInclusion":"Partial androgen insensitivity\nReifenstein syndrome                                                                                                            Partial androgen insensitivity","ClinicalNotes":"A disorder also known as partial androgen insensitivity syndrome (pais). These patients exhibit partial resistance to androgenic and metabolic effects of testosterone."},
    {"ICD10Code":"E34.8","Description":"Other specified endocrine disorders","SearchInclusion":"Pineal gland dysfunction\nProgeria                                                                                                                                                   Cyst of pineal gland\nHutchinson-gilford syndrome\nPineal cyst\nProgeria syndrome","ClinicalNotes":"A disease that produces rapid aging, beginning in childhood\nA very rare genetic disorder caused by mutations in the lmna gene. It is characterized by premature aging. Signs and symptoms include failure to thrive, limited growth, alopecia, wrinkled skin, small face, development of atherosclerosis, and heart disease. There is no cure for this condition. Individuals do not usually survive beyond their early twenties. Death usually occurs as a result of complications from atherosclerosis.\nAn abnormal congenital condition, associated with defects in the lamin type a gene, which is characterized by premature aging in children, where all the changes of cell senescence occur. It is manifested by premature greying; hair loss; hearing loss (deafness); cataracts (cataract); arthritis; osteoporosis; diabetes mellitus; atrophy of subcutaneous fat; skeletal hypoplasia; elevated urinary hyaluronic acid; and accelerated atherosclerosis. Many affected individuals develop malignant tumors, especially sarcoma."},
    {"ICD10Code":"E34.9","Description":"Endocrine disorder, unspecified","SearchInclusion":"Endocrine disturbance NOS\nHormone disturbance NOS                                                                                                  Arthropathy assoc w endocrine disorder\nArthropathy due to endocrine disorder\nArthropathy with endocrine disorder\nDecreased testosterone level\nDisorder of endocrine system\nEndocrine disorder\nEndocrine myopathy\nHypertension secondary to endocrine disorder\nLow testosterone\nMyopathy, endocrine\nSecondary hypertension (htn) due to endocrine disorders","ClinicalNotes":"Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs.\nImpairment of health or a condition of abnormal functioning of the system of glands that release their secretions (hormones) directly into the circulatory system.\nPathological processes of the endocrine glands, and diseases resulting from abnormal level of available hormones.\nYour endocrine system includes eight major glands throughout your body. These glands make hormones. Hormones are chemical messengers. They travel through your bloodstream to tissues or organs. Hormones work slowly and affect body processes from head to toe. These include\ngrowth and development\nmetabolism - digestion, elimination, breathing, blood circulation and maintaining body temperature\nsexual function\nreproduction\nmood\nif your hormone levels are too high or too low, you may have a hormone disorder. Hormone diseases also occur if your body does not respond to hormones the way it is supposed to. Stress, infection and changes in your blood's fluid and electrolyte balance can also influence hormone levels.in the United States, the most common endocrine disease is diabetes. There are many others. They are usually treated by controlling how much hormone your body makes. Hormone supplements can help if the problem is too little of a hormone."},
    {"ICD10Code":"E35.","Description":"Disorders of endocrine glands in diseases classified elsewhere","SearchInclusion":"Echinococcus granulosus infection of thyroid\nEchinococcus granulosus thyroid gland infection","ClinicalNotes":""},
    {"ICD10Code":"E36.01","Description":"Intraoperative hemorrhage and hematoma of an endocrine system organ or structure complicating an endocrine system procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E36.02","Description":"Intraoperative hemorrhage and hematoma of an endocrine system organ or structure complicating other procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E36.11","Description":"Accidental puncture and laceration of an endocrine system organ or structure during an endocrine system procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E36.12","Description":"Accidental puncture and laceration of an endocrine system organ or structure during other procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E36.8","Description":"Other intraoperative complications of endocrine system","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E40.","Description":"Kwashiorkor","SearchInclusion":"Severe malnutrition with nutritional edema with dyspigmentation of skin and hair","ClinicalNotes":"A syndrome produced by severe protein deficiency, characterized by retarded growth, changes in skin and hair pigment, edema, and pathologic changes in the liver, including fatty infiltration, necrosis, and fibrosis. The word is a local name in gold coast, africa, meaning \"displaced child\". Although first reported from africa, kwashiorkor is now known throughout the world, but mainly in the tropics and subtropics. It is considered to be related to marasmus."},
    {"ICD10Code":"E41.","Description":"Nutritional marasmus","SearchInclusion":"Severe malnutrition with marasmus","ClinicalNotes":""},
    {"ICD10Code":"E42.","Description":"Marasmic kwashiorkor","SearchInclusion":"Intermediate form severe protein-calorie malnutrition\nSevere protein-calorie malnutrition with signs of both kwashiorkor and marasmus","ClinicalNotes":""},
    {"ICD10Code":"E43.","Description":"Unspecified severe protein-calorie malnutrition","SearchInclusion":"\nStarvation edema                                                                                                                    Diabetes type 1 with severe malnutrition\nDiabetes type 2 with severe malnutrition\nEdema due to nutritional deficiency\nNutritional edema\nProtein calorie malnutrition, severe\nSevere malnutrition due to type 1 diabetes mellitus\nSevere malnutrition due to type 2 diabetes mellitus\nSevere protein-calorie malnutrition (gomez: less than 60% of standard weight)","ClinicalNotes":""},
    {"ICD10Code":"E44.0","Description":"Moderate protein-calorie malnutrition","SearchInclusion":"Moderate protein-calorie malnutrition (weight for age 60-74% of standard)\nProtein calorie malnutrition, moderate","ClinicalNotes":""},
    {"ICD10Code":"E44.1","Description":"Mild protein-calorie malnutrition","SearchInclusion":"Mild protein-calorie malnutrition (weight for age 75-89% of standard)\nProtein calorie malnutrition, mild (gomez 75-90% s","ClinicalNotes":""},
    {"ICD10Code":"E45.","Description":"Retarded development following protein-calorie malnutrition","SearchInclusion":"Nutritional short stature\nNutritional stunting\nPhysical retardation due to malnutrition","ClinicalNotes":""},
    {"ICD10Code":"E46.","Description":"Unspecified protein-calorie malnutrition","SearchInclusion":"Deficiency of macronutrients\nHypoalbuminemia due to protein calorie malnutrition\nMalnutrition\nMalnutrition (calorie)\nMalnutrition, not enough calories in diet\nNutritional disorder\nProtein calorie malnutrition\nProtein-calorie malnutrition with hypoalbuminemia                                                                          Malnutrition NOS\nProtein-calorie imbalance NOS","ClinicalNotes":"A condition caused by not getting enough calories or the right amount of key nutrients, such as vitamins and minerals, that are needed for health. Malnutrition may occur when there is a lack of nutrients in the diet or when the body cannot absorb nutrients from food. Cancer and cancer treatment may cause malnutrition.\nAn imbalanced nutritional status resulted from insufficient intake of nutrients to meet normal physiological requirement.\nDisorder of nutrition due to unbalanced or insufficient diet or to defective assimilation or utilization of nutrients.\nFood provides the energy and nutrients you need to be healthy. If you don't get enough nutrients -- including proteins, carbohydrates, fats, vitamins, and minerals - you may suffer from malnutrition.causes of malnutrition include:\nlack of specific nutrients in your diet. Even the lack of one vitamin can lead to malnutrition.\nan unbalanced diet\ncertain medical problems, such as malabsorption syndromes and cancers\nsymptoms may include fatigue, dizziness and weight loss, or you may have no symptoms. Your doctor will do tests, depending on the cause of your problem. Treatment may include replacing the missing nutrients and treating the underlying cause.\nInadequate nutrition resulting from poor diet, malabsorption, or abnormal nutrient distribution.\nThe lack of sufficient energy or protein to meet the body's metabolic demands, as a result of either an inadequate dietary intake of protein, intake of poor quality dietary protein, increased demands due to disease, or increased nutrient losses."},
    {"ICD10Code":"E50.0","Description":"Vitamin A deficiency with conjunctival xerosis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E50.1","Description":"Vitamin A deficiency with Bitot's spot and conjunctival xerosis","SearchInclusion":"Bitot's spot in the young child                                                                                                                          Vitamin A deficiency, with conjunctival xerosis","ClinicalNotes":""},
    {"ICD10Code":"E50.2","Description":"Vitamin A deficiency with corneal xerosis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E50.3","Description":"Vitamin A deficiency with corneal ulceration and xerosis","SearchInclusion":"Vitamin a deficiency with corneal xerosis and ulcer\nVitamin a deficiency, corneal ulceration and xerosis","ClinicalNotes":""},
    {"ICD10Code":"E50.4","Description":"Vitamin A deficiency with keratomalacia","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E50.5","Description":"Vitamin A deficiency with night blindness","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E50.6","Description":"Vitamin A deficiency with xerophthalmic scars of cornea","SearchInclusion":"Vitamin a deficiency, xerophthalmic scars of cornea","ClinicalNotes":""},
    {"ICD10Code":"E50.7","Description":"Other ocular manifestations of vitamin A deficiency","SearchInclusion":"Xerophthalmia NOS","ClinicalNotes":"Dryness of the eye due to inadequate production of tears. Causes include vitamin a deficiency, sjogren syndrome, rheumatoid arthritis, systemic lupus erythematosus, and scleroderma.\nDryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin a deficiency, trauma, or any condition in which the eyelids do not close completely.\nDryness of the eye surfaces caused by deficiency of tears or conjunctival secretions; may be associated with vitamin a deficiency, trauma, or any condition in which the eyelids do not close completely."},
    {"ICD10Code":"E50.8","Description":"Other manifestations of vitamin A deficiency","SearchInclusion":"Follicular keratosis\nXeroderma","ClinicalNotes":"A non-neoplastic disorder characterized by abnormally dry skin. Causes include vitamin a deficiency, sunlight exposure, medications, metabolic disorders, autoimmune disorders, and hereditary genetic disorders.\nAn autosomal dominant inherited chronic skin disorder caused by mutations in the atp2a2 gene. It is characterized by the development of yellow-brown keratotic skin papules in the neck, ears, forehead, chest, back and groin. It is associated with fragility of the free margins of the nails.\nAn autosomal dominantly inherited skin disorder characterized by warty malodorous papules that coalesce into plaques. It is caused by mutations in the atp2a2 gene encoding serca2 protein, one of the sarcoplasmic reticulum calcium-transporting atpases. The condition is similar, clinically and histologically, to benign familial pemphigus, another autosomal dominant skin disorder. Both diseases have defective calcium pumps (calcium-transporting atpases) and unstable desmosomal adhesion junctions (desmosomes) between keratinocytes.\nSlowly progressive autosomal dominant disorder of keratinization with papules on the seborrheic areas of the body that coalesce to form plaques which may become crusted and secondarily infected; lesions may darken and fuse over time to form papillomatous and warty malodorous growths"},
    {"ICD10Code":"E50.9","Description":"Vitamin A deficiency, unspecified","SearchInclusion":"Hypovitaminosis A NOS                                                                                                                                                                       Vitamin A deficiency","ClinicalNotes":"A nutritional condition produced by a deficiency of vitamin a in the diet, characterized by night blindness and other ocular manifestations such as dryness of the conjunctiva and later of the cornea (xerophthalmia). Vitamin a deficiency is a very common problem worldwide, particularly in developing countries as a consequence of famine or shortages of vitamin a-rich foods. In the United States it is found among the urban poor, the elderly, alcoholics, and patients with malabsorption. (from cecil textbook of medicine, 19th ed, p1179)\nCondition due to a deficiency of vitamin a.\nDeficiency of vitamin a due to malnutrition, malabsorption, or dietary lack. It is manifested with reduced night vision, night blindness, and xerophthalmia."},
    {"ICD10Code":"E51.11","Description":"Dry beriberi","SearchInclusion":"Beriberi NOS\nBeriberi with polyneuropathy                                                                                                    Beriberi","ClinicalNotes":"A disease caused by a deficiency of thiamine (vitamin b1) and characterized by polyneuritis, cardiac pathology, and edema. The epidemic form is found primarily in areas in which white (polished) rice is the staple food, as in japan, china, the philippines, india, and other countries of southeast asia."},
    {"ICD10Code":"E51.12","Description":"Wet beriberi","SearchInclusion":"Beriberi with cardiovascular manifestations\nCardiovascular beriberi\nShoshin disease","ClinicalNotes":""},
    {"ICD10Code":"E51.2","Description":"Wernicke's encephalopathy","SearchInclusion":"Wernicke's disease\nWernickes disease","ClinicalNotes":"An acute neurological disorder characterized by the triad of ophthalmoplegia, ataxia, and disturbances of mental activity or consciousness. Eye movement abnormalities include nystagmus, external rectus palsies, and reduced conjugate gaze. Thiamine deficiency and chronic alcoholism are associated conditions. Pathologic features include periventricular petechial hemorrhages and neuropil breakdown in the diencephalon and brainstem. Chronic thiamine deficiency may lead to korsakoff syndrome. Use aphasia for wernicke's aphasia."},
    {"ICD10Code":"E51.8","Description":"Other manifestations of thiamine deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E51.9","Description":"Thiamine deficiency, unspecified","SearchInclusion":"Thiamin deficiency","ClinicalNotes":"A nutritional condition produced by a deficiency of thiamine in the diet, characterized by anorexia, irritability, and weight loss. Later, patients experience weakness, peripheral neuropathy, headache, and tachycardia. In addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption. In countries relying on polished rice as a dietary staple, beriberi prevalence is very high. \nNutritional condition produced by a deficiency of thiamine in the diet, characterized by anorexia, irritability, and weight loss; later, patients experience weakness, peripheral neuropathy, headache, and tachycardia; in addition to being caused by a poor diet, thiamine deficiency in the United States most commonly occurs as a result of alcoholism, since ethanol interferes with thiamine absorption."},
    {"ICD10Code":"E52.","Description":"Niacin deficiency [pellagra]","SearchInclusion":"Niacin (-tryptophan) deficiency\nNicotinamide deficiency\nPellagra (alcoholic)                                                                                                                               Niacin deficiency\nPellagra","ClinicalNotes":"A disease due to deficiency of niacin, a b-complex vitamin, or its precursor tryptophan. It is characterized by scaly dermatitis which is often associated with diarrhea and dementia (the three d's)."},
    {"ICD10Code":"E53.0","Description":"Riboflavin deficiency","SearchInclusion":"Ariboflavinosis\nVitamin B2 deficiency","ClinicalNotes":"A dietary deficiency of riboflavin causing a syndrome chiefly marked by cheilitis, angular stomatitis, glossitis associated with a purplish red or magenta-colored tongue that may show fissures, corneal vascularization, dyssebacia, and anemia."},
    {"ICD10Code":"E53.1","Description":"Pyridoxine deficiency","SearchInclusion":"","ClinicalNotes":"Condition due to a deficiency of riboflavin (vitamin b12) which is associated with inadequate consumption of riboflavin rich foods; produces lesions of skin, digestive tract and nervous system; usually part of a multiple nutrient deficiency."},
    {"ICD10Code":"E53.8","Description":"Deficiency of other specified B group vitamins","SearchInclusion":"Biotin deficiency\nCyanocobalamin deficiency\nFolate deficiency\nFolic acid deficiency\nPantothenic acid deficiency\nVitamin B12 deficiency                                                                                                                 Cerebral degeneration due to vitamin b12 deficiency\nCobalamin deficiency\nFolic acid deficiency\nNeuropathy due to vitamin b12 deficiency\nPeripheral nerve disorder due to vit b12 deficiency\nPolyneuropathy (multiple nerve disorder)\nPolyneuropathy due to vitamin b deficiency\nSubacute combined degeneration of spinal cord\nSubacute degeneration of spinal cord due to vitamin b12 deficiency\nVitamin b12 deficiency","ClinicalNotes":"A nutritional condition produced by a deficiency of folic acid in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. It is indistinguishable from vitamin b 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in b 12 deficiency do not occur. (merck manual, 16th ed)\nA nutritional condition produced by a deficiency of vitamin b 12 in the diet, characterized by megaloblastic anemia. Since vitamin b 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin b 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. (from cecil textbook of medicine, 19th ed, p848)\nCondition due to a deficiency of vitamin b12.\nState in which folate is absent or in diminished amount relative to the normal requirement of an organism or a biologic system."},
    {"ICD10Code":"E53.9","Description":"Vitamin B deficiency, unspecified","SearchInclusion":"Vitamin b deficiency","ClinicalNotes":"A condition due to deficiency in any member of the vitamin b complex. These b vitamins are water-soluble and must be obtained from the diet because they are easily lost in the urine. Unlike the lipid-soluble vitamins, they cannot be stored in the body fat.\nCondition due to a deficiency of one or more of the b vitamins."},
    {"ICD10Code":"E54.","Description":"Ascorbic acid deficiency","SearchInclusion":"Deficiency of vitamin C\nScurvy                                                                                                                                                       Vitamin c deficiency","ClinicalNotes":"A condition due to a dietary deficiency of ascorbic acid (vitamin c), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into scurvy in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic alcoholism.\nAn acquired blood vessel disorder caused by severe deficiency of vitamin c (ascorbic acid) in the diet leading to defective collagen formation in small blood vessels. Scurvy is characterized by bleeding in any tissue, weakness, anemia, spongy gums, and a brawny induration of the muscles of the calves and legs.\nCondition due to a deficiency of vitamin c."},
    {"ICD10Code":"E55.0","Description":"Rickets, active","SearchInclusion":"Infantile osteomalacia\nJuvenile osteomalacia                                                                                                                     Active rickets\nHereditary vitamin d dependent rickets type 1\nRickets\nVitamin d-dependent rickets","ClinicalNotes":"A condition caused by deficiency of vitamin d, especially in infancy and childhood, with disturbance of normal ossification.\nA condition caused by vitamin d deficiency\nBone softening and weakening usually caused by deficiency or impaired metabolism of vitamin d. Deficiency of calcium, magnesium, or phosphorus may also cause rickets. It predominantly affects children who suffer from severe malnutrition. It manifests with bone pain, fractures, muscle weakness, and skeletal deformities.\nDisorder of calcium and phosphorus metabolism affecting bony structures, due to a variety of defects in vitamin d, calcium, and phosphorous homeostasis, including dietary deficiencies or malabsorption.\nRickets causes soft, weak bones in children. It usually occurs when they do not get enough vitamin d, which helps growing bones absorb important nutrients. Vitamin d comes from sunlight and food. Your skin produces vitamin d in response to the sun's rays. Some foods also contain vitamin d, including fortified dairy products and cereals, and some kinds of fish. Your child might not get enough vitamin d if he or she\nhas dark skin\nspends too little time outside\nhas on sunscreen all the time when out of doors\ndoesn't eat foods containing vitamin d because of lactose intolerance or a strict vegetarian diet\nis breastfed without receiving vitamin d supplements\ncan't make or use vitamin d because of a medical disorder such as celiac disease\nin addition to dietary rickets, children can get an inherited form of the disease."},
    {"ICD10Code":"E55.9","Description":"Vitamin D deficiency, unspecified","SearchInclusion":"Avitaminosis D                                                                                                                                  Vitamin d deficiency","ClinicalNotes":"A nutritional condition produced by a deficiency of vitamin d in the diet, insufficient production of vitamin d in the skin, inadequate absorption of vitamin d from the diet, or abnormal conversion of vitamin d to its bioactive metabolites. It is manifested clinically as rickets in children and osteomalacia in adults. Condition due to a deficiency of vitamin d."},
    {"ICD10Code":"E56.0","Description":"Deficiency of vitamin E","SearchInclusion":"Vitamin e deficiency","ClinicalNotes":"A nutritional condition produced by a deficiency of vitamin e in the diet, characterized by posterior column and spinocerebellar tract abnormalities, areflexia, ophthalmoplegia, and disturbances of gait, proprioception, and vibration. In premature infants vitamin e deficiency is associated with hemolytic anemia, thrombocytosis, edema, intraventricular hemorrhage, and increasing risk of retrolental fibroplasia and bronchopulmonary dysplasia. An apparent inborn error of vitamin e metabolism, named familial isolated vitamin e deficiency, has recently been identified. Condition due to a deficiency of vitamin e."},
    {"ICD10Code":"E56.1","Description":"Deficiency of vitamin K","SearchInclusion":"Vitamin k deficiency","ClinicalNotes":"A nutritional condition produced by a deficiency of vitamin k in the diet, characterized by an increased tendency to hemorrhage (hemorrhagic disorders). Such bleeding episodes may be particularly severe in newborn infants. (from cecil textbook of medicine, 19th ed, p1182)\nCondition due to a deficiency of vitamin k.\nDeficiency of vitamin k. It may lead to bleeding, manifested with ecchymoses, petechiae, and hematomas. In infants it may cause hemorrhagic disease of newborn with intracranial and retroperitoneal bleeding."},
    {"ICD10Code":"E56.8","Description":"Deficiency of other vitamins","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E56.9","Description":"Vitamin deficiency, unspecified","SearchInclusion":"Vitamin deficiency","ClinicalNotes":"A disorder that is caused by the deficiency of a vitamin. The deficiency may result from either suboptimal vitamin intake or conditions that prevent the vitamin's use or absorption in the body. Representative examples include beriberi caused by thiamine deficiency, scurvy caused by vitamin c deficiency, and rickets caused by vitamin d deficiency.\nCondition due to a deficiency of one or more essential vitamins."},
    {"ICD10Code":"E58.","Description":"Dietary calcium deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E59.","Description":"Dietary selenium deficiency","SearchInclusion":"Keshan disease                                                                                                                       Selenium deficiency","ClinicalNotes":""},
    {"ICD10Code":"E60.","Description":"Dietary zinc deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E61.0","Description":"Copper deficiency","SearchInclusion":"Hypocupremia                                                                                                                                                          Abnormally diminished concentration of copper in the blood.","ClinicalNotes":""},
    {"ICD10Code":"E61.1","Description":"Iron deficiency","SearchInclusion":"Iron deficiency without anemia\nLow serum ferritin","ClinicalNotes":""},
    {"ICD10Code":"E61.2","Description":"Magnesium deficiency","SearchInclusion":"","ClinicalNotes":"A nutritional condition produced by a deficiency of magnesium in the diet, characterized by anorexia, nausea, vomiting, lethargy, and weakness. Symptoms are paresthesias, muscle cramps, irritability, decreased attention span, and mental confusion, possibly requiring months to appear. Deficiency of body magnesium can exist even when serum values are normal. In addition, magnesium deficiency may be organ-selective, since certain tissues become deficient before others. (harrison's principles of internal medicine, 12th ed, p1936)\nCondition due to decreased dietary intake of magnesium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss; deficiency causes irritability of the nervous system with tetany, vasodilation, convulsions, tremors, depression, and psychotic behavior."},
    {"ICD10Code":"E61.3","Description":"Manganese deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E61.4","Description":"Chromium deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E61.5","Description":"Molybdenum deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E61.6","Description":"Vanadium deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E61.7","Description":"Deficiency of multiple nutrient elements","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E61.8","Description":"Deficiency of other specified nutrient elements","SearchInclusion":"Mineral deficiency","ClinicalNotes":""},
    {"ICD10Code":"E61.9","Description":"Deficiency of nutrient element, unspecified","SearchInclusion":"Nutrient element deficiency","ClinicalNotes":""},
    {"ICD10Code":"E63.0","Description":"Essential fatty acid [EFA] deficiency","SearchInclusion":"Essential fatty acid deficiency","ClinicalNotes":""},
    {"ICD10Code":"E63.1","Description":"Imbalance of constituents of food intake","SearchInclusion":"Nutritional imbalance","ClinicalNotes":""},
    {"ICD10Code":"E63.8","Description":"Other specified nutritional deficiencies","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E63.9","Description":"Nutritional deficiency, unspecified","SearchInclusion":"Maternal nutritional deficiency during childbirth\nNutritional deficiency\nNutritional deficiency in childbirth\nNutritional deficiency in pregnancy\nNutritional deficiency postpartum\nPostpartum (after childbirth) nutritional deficiency","ClinicalNotes":"A condition caused by not getting enough calories or the right amount of key nutrients, such as vitamins and minerals, that are needed for health. Malnutrition may occur when there is a lack of nutrients in the diet or when the body cannot absorb nutrients from food. Cancer and cancer treatment may cause malnutrition.\nAn imbalanced nutritional status resulted from insufficient intake of nutrients to meet normal physiological requirement.\nDisorder of nutrition due to unbalanced or insufficient diet or to defective assimilation or utilization of nutrients.\nFood provides the energy and nutrients you need to be healthy. If you don't get enough nutrients -- including proteins, carbohydrates, fats, vitamins, and minerals - you may suffer from malnutrition.causes of malnutrition include:\nlack of specific nutrients in your diet. Even the lack of one vitamin can lead to malnutrition.\nan unbalanced diet\ncertain medical problems, such as malabsorption syndromes and cancers\nsymptoms may include fatigue, dizziness and weight loss, or you may have no symptoms. Your doctor will do tests, depending on the cause of your problem. Treatment may include replacing the missing nutrients and treating the underlying cause.\nInadequate nutrition resulting from poor diet, malabsorption, or abnormal nutrient distribution."},
    {"ICD10Code":"E64.0","Description":"Sequelae of protein-calorie malnutrition","SearchInclusion":"Sequelae of protein calorie malnutrition\nSequelae of protein-energy malnutrition","ClinicalNotes":""},
    {"ICD10Code":"E64.1","Description":"Sequelae of vitamin A deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E64.2","Description":"Sequelae of vitamin C deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E64.3","Description":"Sequelae of rickets","SearchInclusion":"Late effect of rickets","ClinicalNotes":""},
    {"ICD10Code":"E64.8","Description":"Sequelae of other nutritional deficiencies","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E64.9","Description":"Sequelae of unspecified nutritional deficiency","SearchInclusion":"Late effect of nutritional deficiency\nSequelae of nutritional deficiency","ClinicalNotes":""},
    {"ICD10Code":"E65.","Description":"Localized adiposity","SearchInclusion":"Fat pad                                                                                                                                                                        Adiposity, localized\nExcess panniculus of abdomen\nExcess subcutaneous fat of back\nExcess subcutaneous fat of breast\nExcess subcutaneous fat of lower limb\nExcess subcutaneous fat of upper limb\nPanniculus of abdomen\nPannus, abdominal\nTissue excess, arm panniculus\nTissue excess, back panniculus\nTissue excess, breast panniculus\nTissue excess, leg panniculus","ClinicalNotes":"Encapsulated adipose tissue."},
    {"ICD10Code":"E66.01","Description":"Morbid (severe) obesity due to excess calories","SearchInclusion":"Morbid obesity\nObesity (body mass index (bmi) more than 40\nObesity body mass index (bmi) >=40\nObesity, body mass index (bmi 40-44.9\nObesity, body mass index (bmi) >= 70\nObesity, body mass index (bmi) 45-49.9\nObesity, body mass index (bmi) 50-59.9\nObesity, body mass index (bmi) 60-69.9\nObesity, body mass index (bmi) more than 99 percentile\nSevere adult obesity with bmi between 40-44.9\nSevere adult obesity with bmi between 45-49.9\nSevere adult obesity with bmi between 50 to 59.9\nSevere childhood obesity with bmi >99 percentile\nSevere obesity\nSevere obesity in pregnancy\nSeverely obese adult with body mass index","ClinicalNotes":""},
    {"ICD10Code":"E66.09","Description":"Other obesity due to excess calories","SearchInclusion":"","ClinicalNotes":"Hypoventilation syndrome in very obese persons with excessive adipose tissue around the abdomen and diaphragm. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic hypoxia; hypercapnia; polycythemia; and long periods of sleep during day and night (hypersomnolence). It is a condition often related to obstructive sleep apnea but can occur separately."},
    {"ICD10Code":"E66.1","Description":"Drug-induced obesity","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E66.2","Description":"Morbid (severe) obesity with alveolar hypoventilation","SearchInclusion":"Extreme obesity with alveolar hypoventilation\nPickwickian syndrome","ClinicalNotes":"Hypoventilation syndrome in very obese persons with excessive adipose tissue around the abdomen and diaphragm. It is characterized by diminished to absent ventilatory chemoresponsiveness; chronic hypoxia; hypercapnia; polycythemia; and long periods of sleep during day and night (hypersomnolence). It is a condition often related to obstructive sleep apnea but can occur separately."},
    {"ICD10Code":"E66.3","Description":"Overweight","SearchInclusion":"Body mass index 25-29 - overweight\nChildhood overweight, bmi greater than 85 percentile\nOverweight (body mass index 85-95 percentile for age)\nOverweight adult with bmi 25-25.9\nOverweight adult with bmi 26-26.9\nOverweight adult with bmi 27-27.9\nOverweight adult with bmi 29-29.9\nOverweight body mass index (bmi) 25-29.9\nOverweight in childhood\nOverweight pediatric\nOverweight, body mass index (bmi) 25-25.9\nOverweight, body mass index (bmi) 26-26.9\nOverweight, body mass index (bmi) 27-27.9\nOverweight, body mass index (bmi) 29-29.9","ClinicalNotes":"A status with body weight that is above certain standard of acceptable or desirable weight. In the scale of body mass index, overweight is defined as having a bmi of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (adipose tissue), hence overweight does not equal \"over fat\".\nBeing too heavy for one's height. Excess body weight can come from fat, muscle, bone, and/or water retention. Being overweight does not always mean being obese.\nBmi 25"},
    {"ICD10Code":"E66.8","Description":"Other obesity","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E66.9","Description":"Obesity, unspecified","SearchInclusion":"","ClinicalNotes":"A change in skin color due to deposition of carotene."},
    {"ICD10Code":"E67.0","Description":"Hypervitaminosis A","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E67.1","Description":"Hypercarotinemia","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E67.2","Description":"Megavitamin-B6 syndrome","SearchInclusion":"Hypervitaminosis b6","ClinicalNotes":""},
    {"ICD10Code":"E67.3","Description":"Hypervitaminosis D","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E67.8","Description":"Other specified hyperalimentation","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E68.","Description":"Sequelae of hyperalimentation","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E70.0","Description":"Classical phenylketonuria","SearchInclusion":"Dihydropteridine reductase deficiency\nPhenylketonuria\nPhenylketonuria, classical","ClinicalNotes":""},
    {"ICD10Code":"E70.1","Description":"Other hyperphenylalaninemias","SearchInclusion":"Classical phenylketonuria\nHyperphenylalaninemia\nMaternal phenylketonuria\nPhenylketonuria\nPhenylketonuria, maternal","ClinicalNotes":""},
    {"ICD10Code":"E70.20","Description":"Disorder of tyrosine metabolism, unspecified","SearchInclusion":"Disorder of tyrosine metabolism\nTyrosine metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E70.21","Description":"Tyrosinemia","SearchInclusion":"Hypertyrosinemia                                                                                                        Hypertyrosinemia\nHypertyrosinemia, richner hanhart type\nTyrosinemia type i\nTyrosinemia type iii\nTyrosinemia, type 3","ClinicalNotes":"A group of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency. Type i tyrosinemia features episodic weakness, self-mutilation, hepatic necrosis, renal tubular injury, and seizures and is caused by a deficiency of the enzyme fumarylacetoacetase. Type ii tyrosinemia features intellectual disability, painful corneal ulcers, and keratoses of the palms and plantar surfaces and is caused by a deficiency of the enzyme tyrosine transaminase. Type iii tyrosinemia features intellectual disability and is caused by a deficiency of the enzyme 4-hydroxyphenylpyruvate dioxygenase. \nAn autosomal recessive inherited metabolic disorder caused by mutations in the fah, hpd, and tat genes. It is characterized by deficiency of one of the enzymes that are involved in the metabolism of tyrosine. It results in elevated blood tyrosine levels and accumulation of tyrosine and its byproducts in the liver, kidney, nervous system and other organs.\nGroup of disorders which have in common elevations of tyrosine in the blood and urine secondary to an enzyme deficiency."},
    {"ICD10Code":"E70.29","Description":"Other disorders of tyrosine metabolism","SearchInclusion":"Alkaptonuria\nOchronosis                                                                                                                                                                        Alcaptonuric ochronosis\nAlkaptonuria\nOchronosis","ClinicalNotes":"A disorder characterized by bluish-black discoloration of the cartilaginous tissues due to accumulation of homogentisic acid. It is associated with alkaptonuria. Signs and symptoms include dark urine, skin pigmentation, and arthritis.\nA rare autosomal recessive disorder characterized by abnormalities in the metabolism of phenylalanine and tyrosine. It results in the accumulation in the blood of homogentisic acid which is excreted in the urine. The presence of homogentisic acid in the urine causes its color to turn black. The excessive amount of homogentisic acid in the blood may cause damage to cartilage and heart valves, and may result in the formation of kidney stones.\nAn inborn error of amino acid metabolism resulting from a defect in the enzyme homogentisate 1,2-dioxygenase, an enzyme involved in the breakdown of phenylalanine and tyrosine. It is characterized by accumulation of homogentisic acid in the urine, ochronosis in various tissues, and arthritis.\nThe yellowish discoloration of connective tissue due to deposition of homogentisic acid (a brown-black pigment). This is due to defects in the metabolism of phenylalanine and tyrosine. Ochronosis occurs in alkaptonuria, but has also been associated with exposure to certain chemicals (e.g., phenol, trinitrophenol, benzene derivatives).\nWhat: ochronosis. Ochronosis: the pathologic accumulation of a blue-black pigment in the connective tissues of persons with alkaptonuria, a rare inborn error of metabolism. These persons lack the enzyme homogentisic acid oxidase, resulting in a buildup of homogentisic acid, a precursor of the pigment. Why: the great majority of patients with ochronosis eventually develop an arthropathy clinically resembling degenerative joint disease. How: ochronosis is diagnosed by the combination of pigmentation of the cartilage, the presence of homogentisic acid in the urine, and arthritis usually involving the knees, hips, lumbosacral spine, and shoulders. The slate blue-black pigmentation is most apparent in the sclera of the eyes, the external ears, and the tympanic membranes. The cerumen may also show a dark discoloration. The presence of homogentisic acid in the urine is determined by the dark color which occurs when the urine is alkalinized and by paper chromatography. Refs: schumacher hr and holdsworth de: ochronotic arthropathy"},
    {"ICD10Code":"E70.30","Description":"Albinism, unspecified","SearchInclusion":"Albinism","ClinicalNotes":"A congenital disorder characterized by partial or complete absence of melanin pigment in the eyes, hair and skin.\nA group of genetic conditions marked by little or none of the pigment melanin in the skin, hair, and/or eyes. People with albinism may have vision problems and white or yellow hair; reddish, violet, blue or brown eyes; and pale skin.\nGeneral term for a number of inherited defects of amino acid metabolism in which there is a deficiency or absence of pigment in the eyes, skin, or hair.\nInherited disease where in which there is a deficiency or absence of pigment in the eyes, skin, or hair."},
    {"ICD10Code":"E70.310","Description":"X-linked ocular albinism","SearchInclusion":"Ocular albinism, type i\nX linked ocular albinism","ClinicalNotes":""},
    {"ICD10Code":"E70.311","Description":"Autosomal recessive ocular albinism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E70.318","Description":"Other ocular albinism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E70.319","Description":"Ocular albinism, unspecified","SearchInclusion":"Ocular albinism","ClinicalNotes":"Albinism affecting the eye in which pigment of the hair and skin is normal or only slightly diluted. The classic type is x-linked (nettleship-falls), but an autosomal recessive form also exists. Ocular abnormalities may include reduced pigmentation of the iris, nystagmus, photophobia, strabismus, and decreased visual acuity."},
    {"ICD10Code":"E70.320","Description":"Tyrosinase negative oculocutaneous albinism","SearchInclusion":"Albinism I\nOculocutaneous albinism ty-neg","ClinicalNotes":""},
    {"ICD10Code":"E70.321","Description":"Tyrosinase positive oculocutaneous albinism","SearchInclusion":"Albinism II\nOculocutaneous albinism ty-pos","ClinicalNotes":""},
    {"ICD10Code":"E70.328","Description":"Other oculocutaneous albinism","SearchInclusion":"Cross syndrome","ClinicalNotes":"A syndrome of gingival fibromatosis, pigmentation disorders, microphthalmia, and delayed psychomotor development. It was first observed in the kramer family, hence the synonym kramer syndrome."},
    {"ICD10Code":"E70.329","Description":"Oculocutaneous albinism, unspecified","SearchInclusion":"Oculocutaneous albinism","ClinicalNotes":"An autosomal recessive inherited disorder caused by mutations of the oca2, slc45a2, tyr and tyrp1 genes. It is characterized by hypopigmentation of the skin, hair, and eyes, resulting in very fair skin, white colored hair, and reduced pigmentation in the iris and retina. Individuals may have vision disturbances and photophobia.\nHeterogeneous group of autosomal recessive disorders comprising at least four recognized types, all having in common varying degrees of hypopigmentation of the skin, hair"},
    {"ICD10Code":"E70.330","Description":"Chediak-Higashi syndrome","SearchInclusion":"Chediak higashi syndrome","ClinicalNotes":"A form of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections. In many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions. The disease is transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the aleutian mink, and albino hereford cattle.\nA rare autosomal recessive immunodeficiency disorder characterized by abnormal intracellular protein transport. Chediak-higashi syndrome (chs) is characterized by immune deficiency; partial oculocutaneous albinism; a bleeding disorder due to deficient platelet dense bodies; neutropenia; neutrophils with impaired chemotaxis and bactericidal activity; recurrent infection; and abnormal natural killer (nk) cell function. Chs may be associated with hepatosplenomegaly, lymphadenopathy, anemia, thrombocytopenia, roentgenologic changes in bones, lungs and heart, and skin and psychomotor abnormalities; it is often fatal in childhood as a result of infection or an accelerated lymphoma-like phase. Chs occurs in mink, cattle, and mice, as well as man.\nForm of phagocyte bactericidal dysfunction characterized by unusual oculocutaneous albinism, high incidence of lymphoreticular neoplasms, and recurrent pyogenic infections; in many cell types, abnormal lysosomes are present leading to defective pigment distribution and abnormal neutrophil functions; transmitted by autosomal recessive inheritance and a similar disorder occurs in the beige mouse, the aleutian mink, and albino hereford cattle."},
    {"ICD10Code":"E70.331","Description":"Hermansky-Pudlak syndrome","SearchInclusion":"Hermansky pudlak syndrome","ClinicalNotes":"A group of autosomal recessive inherited disorders characterized by albinism, bleeding tendency, and lung disorders such as pulmonary fibrosis.\nSyndrome characterized by the triad of oculocutaneous albinism (albinism, oculocutaneous); platelet storage pool deficiency; and lysosomal accumulation of ceroid lipofuscin."},
    {"ICD10Code":"E70.338","Description":"Other albinism with hematologic abnormality","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E70.339","Description":"Albinism with hematologic abnormality, unspecified","SearchInclusion":"Albinism w hematologic abnormality\nAlbinism with hematologic disorder","ClinicalNotes":""},
    {"ICD10Code":"E70.39","Description":"Other specified albinism","SearchInclusion":"Piebaldism","ClinicalNotes":"A rare, autosomal dominant disorder caused usually by mutations in the kit gene. It is characterized by abnormalities in the development of melanocytes. It presents with multiple symmetrical hypopigmented or depigmented patches of skin and a midline patch of white hair.\nAutosomal dominant, congenital disorder characterized by localized hypomelanosis of the skin and hair. The most familiar feature is a white forelock presenting in 80 to 90 percent of the patients. The underlying defect is possibly related to the differentiation and migration of melanoblasts, as well as to defective development of the neural crest (neurocristopathy). Piebaldism may be closely related to waardenburg syndrome."},
    {"ICD10Code":"E70.40","Description":"Disorders of histidine metabolism, unspecified","SearchInclusion":"Disorder of histidine metabolism\nHistidine metabolism disease","ClinicalNotes":""},
    {"ICD10Code":"E70.41","Description":"Histidinemia","SearchInclusion":"","ClinicalNotes":"Autosomal recessive aminoacidopathy due to deficiency of histidine ammonia-lyase; characterized by accumulation of histidine in serum and urinary excretion of histidine and metabolites, but is usually benign; may cause mild central nervous system dysfunction."},
    {"ICD10Code":"E70.49","Description":"Other disorders of histidine metabolism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E70.5","Description":"Disorders of tryptophan metabolism","SearchInclusion":"Disorder of tryptophan metabolism\nTryptophan metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E70.8","Description":"Other disorders of aromatic amino-acid metabolism","SearchInclusion":"Hydroxykynureninuria\nIndicanuria\nWaardenburg's syndrome\nWaardenburgs syndrome","ClinicalNotes":""},
    {"ICD10Code":"E70.9","Description":"Disorder of aromatic amino-acid metabolism, unspecified","SearchInclusion":"Aromatic amino acid, metabolism disturbances\nDisorder of aromatic amino acid metabolism","ClinicalNotes":""},
    {"ICD10Code":"E71.0","Description":"Maple-syrup-urine disease","SearchInclusion":"Maple syrup urine disease","ClinicalNotes":"An autosomal recessive inherited disorder caused by mutations in the bckdha, bckdhb, dbt, and dld genes. It is characterized by a deficiency of branched-chain alpha-keto acid dehydrogenase complex, leading to accumulation of metabolites in the body fluids. The name of the disease derives from the sweet odor of the urine in infants, reminiscent of maple syrup. Signs and symptoms usually appear in infancy and include lethargy and developmental delays. If untreated, it may lead to seizures, coma, and death.\nAn autosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids (amino acids, branched-chain). These metabolites accumulate in body fluids and render a \"maple syrup\" odor. The disease is divided into classic, intermediate, intermittent, and thiamine responsive subtypes. The classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia. The intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting. (from Adams et al., Principles of Neurology, 6th ed, p936)\nAutosomal recessive inherited disorder with multiple forms of phenotypic expression, caused by a defect in the oxidative decarboxylation of branched-chain amino acids; metabolites accumulate in body fluids and render a \"maple syrup\" odor; divided into classic, intermediate, intermittent, and thiamine responsive subtypes; classic form presents in the first week of life with ketoacidosis, hypoglycemia, emesis, neonatal seizures, and hypertonia; the intermediate and intermittent forms present in childhood or later with acute episodes of ataxia and vomiting."},
    {"ICD10Code":"E71.110","Description":"Isovaleric acidemia","SearchInclusion":"Acidemia, isovaleric\nIsovaleryl-coa dehydrogenase deficiency","ClinicalNotes":"A rare autosomal recessive inherited disorder caused by mutations in the ivd gene. It is characterized by abnormalities in the metabolism of leucine. Signs and symptoms vary from very mild to life threatening and include vomiting, seizures, lethargy, and coma.\nAutosomal recessive aminoacidopathy due to deficiency of isovaleryl-coa dehydrogenase, with elevated plasma isovaleric acid and urinary isovaleric acid and isovalerylglycine, causing a characteristic odor of sweaty feet; clinical signs include severe acidosis and ketosis, lethargy, convulsions, pernicious vomiting, thrombocytopenia, neutropenia, and pancytopenia."},
    {"ICD10Code":"E71.111","Description":"3-methylglutaconic aciduria","SearchInclusion":"Aciduria, 3 methylgluaconic","ClinicalNotes":"A group of five inherited disorders caused by mutations in the auh, dnajc19, opa3, and taz genes. The disorders are characterized by impairment in the function of mitochondria, resulting in the accumulation and excretion of 3-methylglutaconic acid, and the presence of 3-methylglutaric acid in the urine."},
    {"ICD10Code":"E71.118","Description":"Other branched-chain organic acidurias","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E71.120","Description":"Methylmalonic acidemia","SearchInclusion":"Cobalamin c disease\nMethylmalonic acidemia, cobalamin c type","ClinicalNotes":"A rare autosomal recessive inherited disorder caused by mutations of the mut, mmaa, mmab, mmadhc, and mcee genes. It is characterized by abnormalities in the metabolism of lipids and proteins. Signs and symptoms usually appear early in life and vary from mild to life threatening. They include vomiting, dehydration, hypotonia, developmental delays, hepatomegaly, lethargy, intellectual disabilities, and chronic kidney disease.\nAutosomal recessive aminoacidopathy characterized by an excess of methylmalonic acid in the blood and urine, with metabolic ketoacidosis, hyperglycinemia, hyperglycinuria and hyperammonemia; results from defects that cause deficiencies of methylmalonyl-coa mutase."},
    {"ICD10Code":"E71.121","Description":"Propionic acidemia","SearchInclusion":"A rare autosomal inherited organic acid disorder caused by mutations in the pcca and pccb genes. It results in the accumulation of harmful organic acids in the blood and urine. Signs and symptoms appear in infancy and include vomiting, poor feeding, loss of appetite, hypotonia, and lethargy.\nAutosomal recessive metabolic disorder caused by mutations in propionyl-coa carboxylase genes that result in dysfunction of branch chain amino acids and of the metabolism of certain fatty acids. Neonatal clinical onset is characterized by severe metabolic acidemia accompanied by hyperammonemia, hyperglycemia, lethargy, vomiting, hypotonia; and hepatomegaly. Survivors of the neonatal onset propionic acidemia often show developmental retardation, and intolerance to dietary proteins. Late-onset form of the disease shows mild mental and/or developmental retardation, sometimes without metabolic acidemia.\nElevated accumulation and excretion of glycine accompanied by ketosis that is secondary to methylmalonicacidemia, isovalericacidemia and other organic acidemias, as distinguished from nonketotic hyperglycinemia.","ClinicalNotes":""},
    {"ICD10Code":"E71.128","Description":"Other disorders of propionate metabolism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E71.19","Description":"Other disorders of branched-chain amino-acid metabolism","SearchInclusion":"Hyperleucine-isoleucinemia\nHypervalinemia","ClinicalNotes":""},
    {"ICD10Code":"E71.2","Description":"Disorder of branched-chain amino-acid metabolism, unspecified","SearchInclusion":"Branched chain amino acid metabolism disorder\nDisorder of branched-chain amino acid metabolism","ClinicalNotes":""},
    {"ICD10Code":"E71.30","Description":"Disorder of fatty-acid metabolism, unspecified                                                                                                                                                                                                                  Y","SearchInclusion":"Disorder of fatty acid metabolism\nFatty acid oxidation disorder","ClinicalNotes":""},
    {"ICD10Code":"E71.310","Description":"Long chain/very long chain acyl CoA dehydrogenase deficiency","SearchInclusion":"LCAD\nVLCAD                                                                                                                                                                                             Fatty acid oxidation disorder, lchadd\nFatty acid oxidation disorder, vlcadd\nLong chain acyl-coa dehydrogenase deficiency\nVery long chain acyl-coa dehydrogenase deficiency","ClinicalNotes":""},
    {"ICD10Code":"E71.311","Description":"Medium chain acyl CoA dehydrogenase deficiency","SearchInclusion":"Fatty acid oxidation disorder\nMedium-chain acyl-coenzyme a dehydrogenase deficiency                                         MCAD","ClinicalNotes":"A genetic disorder characterized by deficiency of the enzyme medium-chain acyl-coenzyme a dehydrogenase that metabolizes medium-chain fatty acids. Signs and symptoms appear in infancy or childhood and may be triggered during fasting or illness. They include vomiting, hypoglycemia and lethargy."},
    {"ICD10Code":"E71.312","Description":"Short chain acyl CoA dehydrogenase deficiency","SearchInclusion":"Deficiency of butyryl-coa dehydrogenase\nFatty acid oxidation disorder, scadd","ClinicalNotes":"A genetic disorder characterized by deficiency of the enzyme short-chain acyl-coenzyme a dehydrogenase that metabolizes short-chain fatty acids. Signs and symptoms appear in infancy or childhood and may be triggered during fasting or illness. They include vomiting, hypoglycemia, lethargy, hypotonia and failure to thrive."},
    {"ICD10Code":"E71.313","Description":"Glutaric aciduria type II","SearchInclusion":"Glutaric aciduria type II A\nGlutaric aciduria type II B\nGlutaric aciduria type II C                                                                                                                                               Fatty acid oxidation disorder, madd\nGlutaric aciduria, type 2","ClinicalNotes":"A rare autosomal recessive inherited metabolic disorder caused by mutations in the etfa, etfb, and etfdh genes. It is characterized by defects of the electron transfer flavoprotein or electron transfer flavoprotein dehydrogenase. Clinical presentations include congenital abnormalities, hepatomegaly, metabolic acidosis, and hypotonia.\nA rare autosomal recessive inherited metabolic disorder caused by mutations in the etfa, etfb, or etfdh genes. It is characterized by deficiency of the enzyme electron transfer flavoprotein or the enzyme electron transfer flavoprotein dehydrogenase. It results in metabolic acidosis, hypoglycemia, and behavioral changes. Additional abnormalities include brain malformations, facial malformations, dilated cardiomyopathy, and hepatomegaly.\nAn autosomal recessive disorder of fatty acid oxidation, and branched chain amino acids (amino acids, branched-chain); lysine; and choline catabolism, that is due to defects in either subunit of electron transfer flavoprotein or its dehydrogenase, electron transfer flavoprotein-ubiquinone oxidoreductase"},
    {"ICD10Code":"E71.314","Description":"Muscle carnitine palmitoyltransferase deficiency","SearchInclusion":"Carnitine palmitoyl transferase deficiency\nCarnitine palmitoyl transferase, type 1 deficiency\nCarnitine palmitoyl transferase, type 2 deficiency\nCarnitine palmitoyltransferase deficiency\nCarnitine palmitoyltransferase i deficiency\nCarnitine palmitoyltransferase ii deficiency","ClinicalNotes":""},
    {"ICD10Code":"E71.318","Description":"Other disorders of fatty-acid oxidation","SearchInclusion":"Deficiency, trifunctional protein\nMitochondrial trifunctional protein deficiency\nUndervirilization of male due to steroidogenic acute regulatory protein deficiency\nUndervirilized xy, star protein deficiency","ClinicalNotes":""},
    {"ICD10Code":"E71.32","Description":"Disorders of ketone metabolism","SearchInclusion":"Disorder of ketone metabolism\nKetone metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E71.39","Description":"Other disorders of fatty-acid metabolism","SearchInclusion":"Long chain fatty acid transport deficiency","ClinicalNotes":""},
    {"ICD10Code":"E71.40","Description":"Disorder of carnitine metabolism, unspecified","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E71.41","Description":"Primary carnitine deficiency","SearchInclusion":"Carnitine deficiency, primary\nRenal carnitine transport defect","ClinicalNotes":"An autosomal recessive inherited disorder caused by mutations in the slc22a5 gene. It is characterized by the presence of a defective protein called octn2 which is involved in the transportation of carnitine into the cells. This abnormality results in reduced energy production and accumulation of fatty acids in the tissues. Clinical manifestations of confusion, muscle weakness, hypoglycemia, encephalopathy and cardiomyopathy may be exacerbated during fasting."},
    {"ICD10Code":"E71.42","Description":"Carnitine deficiency due to inborn errors of metabolism","SearchInclusion":"Carnitine deficiency due to inborn error of metabolism\nCarnitine deficiency from inborn errors metabolism","ClinicalNotes":""},
    {"ICD10Code":"E71.43","Description":"Iatrogenic carnitine deficiency","SearchInclusion":"Carnitine deficiency due to hemodialysis\nCarnitine deficiency due to Valproic acid therapy","ClinicalNotes":"Management of extracorporeal passage of the patient's blood through a dialyzer\nRemoval of certain elements from the blood based on the difference in their rates of diffusion through a semipermeable membrane.\nTherapy for the insufficient cleansing of the blood by the kidneys based on dialysis."},
    {"ICD10Code":"E71.440","Description":"Ruvalcaba-Myhre-Smith syndrome","SearchInclusion":"Ruvalcaba myhre smith syndrome\nRuvalcaba-myhre syndrome","ClinicalNotes":"A genetic syndrome caused by mutations in the pten gene. It is characterized by macrocephaly and the presence of hamartomas.\nA syndrome originally reported (ruvalcaba) as an association of macrocephaly, intestinal polyposis, and pigmentation of the penis, bannayan later described it as a separate entity of macrocephaly, multiple lipomas, and hemangiomas, and riley and smith observed a concurrence of macrocephaly, pseudoepithelioma, and multiple hemangioma. The three conditions were recognized by dvir as different expressions of the same syndrome. The symptoms usually first become apparent in infancy but they may also appear later in life."},
    {"ICD10Code":"E71.448","Description":"Other secondary carnitine deficiency","SearchInclusion":"Carnitine deficiency, secondary\nSecondary carnitine deficiency","ClinicalNotes":""},
    {"ICD10Code":"E71.50","Description":"Peroxisomal disorder, unspecified","SearchInclusion":"Disorder of peroxisomal function\nDisorder, peroxisomal","ClinicalNotes":"A group of congenital disorders of lipid metabolism, caused by loss of the normal peroxisomes. Signs and symptoms include developmental delays, mental retardation, facial abnormalities, hepatomegaly, and hypotonia.\nA heterogeneous group of inherited metabolic disorders marked by absent or dysfunctional peroxisomes. Peroxisomal enzymatic abnormalities may be single or multiple. Biosynthetic peroxisomal pathways are compromised, including the ability to synthesize ether lipids and to oxidize long-chain fatty acid precursors. Diseases in this category include zellweger syndrome; infantile refsum disease; rhizomelic chondrodysplasia (chondrodysplasia punctata, rhizomelic); hyperpipecolic acidemia; neonatal adrenoleukodystrophy; and adrenoleukodystrophy (x-linked). Neurologic dysfunction is a prominent feature of most peroxisomal disorders."},
    {"ICD10Code":"E71.510","Description":"Zellweger syndrome","SearchInclusion":"","ClinicalNotes":"A rare group of autosomal recessive inherited disorders characterized by the reduction or absence of peroxisomes in the tissues. Signs and symptoms include increased levels of iron and copper in the blood and tissues, hepatomegaly, facial abnormalities, mental retardation, seizures, and hypotonia.\nAn autosomal recessive disorder due to defects in peroxisome biogenesis which involves more than 13 genes encoding peroxin proteins of the peroxisomal membrane and matrix. Zellweger syndrome is typically seen in the neonatal period with features such as dysmorphic skull; muscle hypotonia; sensorineural hearing loss; visual compromise; seizures; progressive degeneration of the kidneys and the liver. Zellweger-like syndrome refers to phenotypes resembling the neonatal zellweger syndrome but seen in children or adults with apparently intact peroxisome biogenesis.\nAutosomal recessive peroxisomal disorder, also known as zellweger syndrome, that typically presents in the neonatal period and is usually fatal; clinical features include hypotonia, dysmorphic skull and facial bones, visual compromise, multifocal seizures, hepatomegaly, biliary dysgenesis, and swallowing difficulties; pathologically, there are migration deficits of the neocortex and degeneration of white matter tracts; zellweger-like syndrome refers to conditions that phenotypically resemble neonatal zellweger syndrome, but occur in childhood or adulthood."},
    {"ICD10Code":"E71.511","Description":"Neonatal adrenoleukodystrophy","SearchInclusion":"","ClinicalNotes":"A rare metabolic disorder that affects neonates. It is characterized by damage of the white matter in the brain and degeneration of the adrenal glands. It manifests with hyperactivity, paralysis, muscular weakness, crossed eyes, hearing loss, seizures, and coma."},
    {"ICD10Code":"E71.518","Description":"Other disorders of peroxisome biogenesis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E71.520","Description":"Childhood cerebral X-linked adrenoleukodystrophy","SearchInclusion":"Childhood cerebral x linked adrenoleukodystrophy","ClinicalNotes":""},
    {"ICD10Code":"E71.521","Description":"Adolescent X-linked adrenoleukodystrophy","SearchInclusion":"Adolescent x linked adrenoleukodystrophy","ClinicalNotes":""},
    {"ICD10Code":"E71.522","Description":"Adrenomyeloneuropathy","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E71.528","Description":"Other X-linked adrenoleukodystrophy","SearchInclusion":"Addison only phenotype adrenoleukodystrophy\nAddison-Schilder adrenoleukodystrophy","ClinicalNotes":""},
    {"ICD10Code":"E71.529","Description":"X-linked adrenoleukodystrophy, unspecified type","SearchInclusion":"Adrenoleukodystrophy\nX linked adrenoleukodystrophy, unspecified type","ClinicalNotes":"A rare metabolic disorder characterized by damage of the myelin sheaths in the nervous system and degeneration of the adrenal glands. It leads to progressive neurologic disorders, adrenal insufficiency and death.\nA syndrome combining the characteristics of adrenocortical insufficiency (addison disease) with those of cerebral sclerosis (schilder disease). Skin bronzing and sclerosis of the brain and demyelination are the principal manifestations.\nAn x-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the lysosomes of adrenal cortex and the white matter of central nervous system. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ataxia; neurobehavioral manifestations; hyperpigmentation; adrenal insufficiency; seizures; muscle spasticity; and dementia. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene abcd1 is located at xq28, and encodes the adrenoleukodystrophy protein (atp-binding cassette transporters).\nChildhood genetic disease, transmitted as an x-linked recessive trait, characterized by diffuse abnormality of cerebral white matter and adrenal atrophy; mental deterioration progresses to dementia, aphasia, apraxia, dysarthria, and loss of vision."},
    {"ICD10Code":"E71.53","Description":"Other group 2 peroxisomal disorders","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E71.540","Description":"Rhizomelic chondrodysplasia punctata","SearchInclusion":"Rhizomelic chondrodysplasia punctata syndrome","ClinicalNotes":"An autosomal recessive form of chondrodysplasia punctata characterized by defective plasmalogen biosynthesis and impaired peroxisomes. Patients have shortened proximal limbs and severely disturbed endochondral bone formation. The metabolic defects associated with the impaired peroxisomes are present only in the rhizomelic form of chondrodysplasia punctata. An autosomal recessive inherited peroxisomal disorder caused by mutations in the pex7, dhapat, and agp genes. It is characterized by short limbs, bones and cartilage abnormalities, congenital cataracts, and severe mental retardation."},
    {"ICD10Code":"E71.541","Description":"Zellweger-like syndrome","SearchInclusion":"Zellweger like syndrome","ClinicalNotes":""},
    {"ICD10Code":"E71.542","Description":"Other group 3 peroxisomal disorders","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E71.548","Description":"Other peroxisomal disorders","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E72.00","Description":"Disorders of amino-acid transport, unspecified","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E72.01","Description":"Cystinuria","SearchInclusion":"Cystinuria, type 1","ClinicalNotes":"An autosomal recessive inherited metabolic disorder caused by mutations in the slc3a1 and slc7a9 genes. It is characterized by deficient re-absorption of cystine in the proximal tubules of the kidney. It results in the formation of stones in the kidney, ureter, and urinary bladder.\nAn inherited disorder due to defective reabsorption of cystine and other basic amino acids by the proximal renal tubules. This form of aminoaciduria is characterized by the abnormally high urinary levels of cystine; lysine; arginine; and ornithine. Mutations involve the amino acid transport protein gene slc3a1.\nInherited abnormality of renal tubular transport of dibasic amino acids leading to massive urinary excretion of cystine, lysine, arginine, and ornithine."},
    {"ICD10Code":"E72.02","Description":"Hartnup's disease","SearchInclusion":"Hartnup disease\nNeutral 1 amino acid transport defect","ClinicalNotes":"An autosomal recessive disorder due to defective absorption of neutral amino acids by both the intestine and the proximal renal tubules. The abnormal urinary loss of tryptophan, a precursor of niacin, leads to a nicotinamide deficiency, pellagra-like light-sensitive rash, cerebellar ataxia, emotional instability, and aminoaciduria. Mutations involve the neurotransmitter transporter gene slc6a19.\nAn autosomal recessive inherited metabolic disorder caused by mutations in the slc6a19 gene. It is characterized by defective absorption of neutral amino acids. Signs and symptoms include skin eruptions reminiscent of pellagra, aminoaciduria, and cerebellar ataxia.\nDisorder of amino acid transport characterized by the childhood (or rarely adult) onset of photosensitive dermatitis and intermittent neurologic symptoms; ataxia, personality changes, migraine headaches, and photophobia may occur periodically; results from impaired sodium-dependent transport of neutral amino acids across the brush border membrane of the small intestine and renal tubular epithelium."},
    {"ICD10Code":"E72.03","Description":"Lowe's syndrome","SearchInclusion":"Lowe syndrome","ClinicalNotes":"A sex-linked recessive disorder affecting multiple systems including the eye, the nervous system, and the kidney. Clinical features include congenital cataract; mental retardation; and renal tubular dysfunction (fanconi syndrome; renal tubular acidosis; x-linked hypophosphatemia or vitamin-d-resistant rickets) and scoliosis. This condition is due to a deficiency of phosphatidylinositol 4,5-bisphosphate-5-phosphatase leading to defects in phosphatidylinositol metabolism and inositol signaling pathway. (from menkes, textbook of child neurology, 5th ed, p60; am j hum genet 1997 jun;60(6):1384-8)\nA syndrome of congenital cataracts, hydrophthalmia, delayed growth and mental development, vitamin d-resistant rickets, aminoaciduria, and reduced production of ammonia by the kidneys. Additional manifestations include areflexia, hypotonia, glaucoma, corneal keloid, and noninflammatory arthropathy.\nAn x-linked inherited multisystem metabolic disorder caused by mutations in the ocrl1 gene. The main manifestations of this disorder result from involvement of the eyes, nervous system and kidneys. Signs and symptoms include congenital cataracts, infantile glaucoma, intellectual disability, hypotonia, aminoaciduria and renal tubular dysfunction.\nSex-linked recessive disorder of amino acid transport which affects the eye, nervous system, and kidney; manifestations include cataract, glaucoma, aminoaciduria, hypophosphatemic rickets, developmental delay, myopathy, peripheral neuropathy, and hypotonia; associated with deficient activity of the enzyme phosphatidylinositol 4,5-bisphosphate-5-phosphatase."},
    {"ICD10Code":"E72.04","Description":"Cystinosis","SearchInclusion":"Fanconi (-de Toni) (-Debr) syndrome with cystinosis","ClinicalNotes":"A metabolic disease characterized by the defective transport of cystine across the lysosomal membrane due to mutation of a membrane protein cystinosin. This results in cystine accumulation and crystallization in the cells causing widespread tissue damage. In the kidney, nephropathic cystinosis is a common cause of renal fanconi syndrome.\nAn autosomal recessive hereditary disorder characterized by defective transportation of cystine across the lysosomal membranes and systemic deposition of cystine crystals in the body. It is associated with slight increase of the plasma cystine, cystinuria, aminoaciduria, glycosuria, polyuria, hypophosphatemia, rickets, and renal tubular dysfunction.\nLysosomal storage disorders of unknown molecular defect, characterized by widespread deposition of cystine crystals in reticuloendothelial cells."},
    {"ICD10Code":"E72.09","Description":"Other disorders of amino-acid transport","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E72.10","Description":"Disorders of sulfur-bearing amino-acid metabolism, unspecified","SearchInclusion":"Disorder of sulfur-bearing amino acid metabolism\nDisorder of sulphur bearing amino acid metabolism","ClinicalNotes":""},
    {"ICD10Code":"E72.11","Description":"Homocystinuria","SearchInclusion":"Homocystinemia                                                                                                                                                                         Cystathionine synthase deficiency","ClinicalNotes":"An autosomal recessive inherited metabolic disorder caused by mutations in the cbs, mthfr, mtr, and mtrr genes. It is characterized by abnormalities in the methionine metabolism and is associated with deficiency of cystathionine synthase. It results in the accumulation of homocysteine in the serum. It may affect the cardiovascular, musculoskeletal and the central nervous systems.\nAutosomal recessive inborn error of methionine metabolism usually caused by a deficiency of cystathionine beta-synthase and associated with elevations of homocysteine in plasma and urine. Clinical features include a tall slender habitus, scoliosis, arachnodactyly, muscle weakness, genu varus, thin blond hair, malar flush, lens dislocations, an increased incidence of mental retardation, and a tendency to develop fibrosis of arteries, frequently complicated by cerebrovascular accidents and myocardial infarction. (from Adams et al., Principles of Neurology, 6th ed, p979)\nAutosomal recessive inborn error of methionine metabolism usually caused by a deficiency of cystathionine beta-synthase and associated with elevations of homocysteine in plasma and urine; clinical features include a tall, slender habitus, scoliosis, arachnodactyly, muscle weakness, genu varis, thin blond hair, malar flush, lens dislocations, an increased incidence of mental retardation, and a tendency to develop fibrosis of arteries, frequently complicated by cerebrovascular accidents and myocardial infarction."},
    {"ICD10Code":"E72.12","Description":"Methylenetetrahydrofolate reductase deficiency","SearchInclusion":"5,10-methylenetetrahydrofolate reductase deficiency\nDeficiency, methylenetetrahydrofolate reductase\nHeterozygous methylenetetrahydrofolate reductase mutation\nHomozygous methylenetetrahydrofolate reductase mutation\nMethylenetetrahydrofolate reductase mutation","ClinicalNotes":""},
    {"ICD10Code":"E72.19","Description":"Other disorders of sulfur-bearing amino-acid metabolism","SearchInclusion":"Cystathioninuria\nMethioninemia\nSulfite oxidase deficiency","ClinicalNotes":""},
    {"ICD10Code":"E72.20","Description":"Disorder of urea cycle metabolism, unspecified","SearchInclusion":"Hyperammonemia                                                                                                               Disorder of the urea cycle metabolism\nDisorder of urea cycle metabolism","ClinicalNotes":"A genetic inborn error of metabolism characterized by the deficiency of one of the enzymes necessary for the urea cycle. It results in accumulation of ammonia in the body.\nA laboratory test result indicating increased levels of ammonia in the blood.\nElevated level of ammonia in the blood. It is a sign of defective catabolism of amino acids or ammonia to urea.\nInherited errors in the metabolic reactions occurring in the liver that convert ammonia to urea, resulting from inborn genetic mutations.\nRare congenital metabolism disorders of the urea cycle. The disorders are due to mutations that result in complete (neonatal onset) or partial (childhood or adult onset) inactivity of an enzyme, involved in the urea cycle. Neonatal onset results in clinical features that include irritability, vomiting, lethargy, seizures, neonatal hypotonia; respiratory alkalosis; hyperammonemia; coma, and death. Survivors of the neonatal onset and childhood/adult onset disorders share common risks for encephalopathies, metabolic, inborn; and respiratory alkalosis due to hyperammonemia."},
    {"ICD10Code":"E72.21","Description":"Argininemia","SearchInclusion":"Arginase deficiency\nArgininaemia","ClinicalNotes":"A rare autosomal recessive disorder of the urea cycle. It is caused by a deficiency of the hepatic enzyme arginase. Arginine is elevated in the blood and cerebrospinal fluid, and periodic hyperammonemia may occur. Disease onset is usually in infancy or early childhood. Clinical manifestations include seizures, microcephaly, progressive mental impairment, hypotonia, ataxia, spastic diplegia, and quadriparesis. \nA rare autosomal recessive metabolic disorder characterized by a deficiency of the enzyme arginase resulting in accumulation of arginine and urea in the blood and cerebrospinal fluid. Signs and symptoms include developmental delays, spasticity, ataxia, seizures and mental retardation.\nRare autosomal recessive disorder of the urea cycle; caused by a deficiency of the hepatic enzyme type i arginase; arginine is elevated in the blood and cerebrospinal fluid, and periodic hyperammonemia may occur; disease onset is usually in infancy or early childhood; clinical manifestations include seizures, microcephaly, progressive mental impairment, hypotonia, ataxia, spastic diplegia, and quadriparesis."},
    {"ICD10Code":"E72.22","Description":"Arginosuccinic aciduria","SearchInclusion":"Argininosuccinate lyase deficiency\nDeficiency, arginosuccinate lyase","ClinicalNotes":"Autosomal recessive aminoacidopathy characterized by urinary excretion of argininosuccinic acid, due to a deficiency of argininosuccinate lyase, with hyperammonemia, argininosuccinicacidemia, and citrullinemia; clinical findings include mental retardation, seizures, ataxia, hepatomegaly, and friable hair."},
    {"ICD10Code":"E72.23","Description":"Citrullinemia","SearchInclusion":"A group of diseases related to a deficiency of the enzyme argininosuccinate synthase which causes an elevation of serum levels of citrulline. In neonates, clinical manifestations include lethargy, hypotonia, and seizures. Milder forms also occur. Childhood and adult forms may present with recurrent episodes of intermittent weakness, lethargy, ataxia, behavioral changes, and dysarthria. (from menkes, textbook of child neurology, 5th ed, p49)\nA rare autosomal recessive inherited disorder caused by mutations in the ass1 and slc25a13 genes. It is characterized by a defective urea cycle, resulting in the accumulation of ammonia and other toxic substances in the blood.\nAutosomal recessive aminoacidopathy characterized by marked elevation in plasma and urine levels of citrulline, with hyperammonemia and sometimes secondary oroticaciduria; clinical findings include mental retardation and neurologic abnormalities.","ClinicalNotes":""},
    {"ICD10Code":"E72.29","Description":"Other disorders of urea cycle metabolism","SearchInclusion":"Congenital hyperammonemia, type i\nDeficiency, carbamyl phosphate synthetase\nDeficiency, n acetylglutamate synthetase\nHyperammonemia, type iii","ClinicalNotes":""},
    {"ICD10Code":"E72.3","Description":"Disorders of lysine and hydroxylysine metabolism","SearchInclusion":"Glutaric aciduria NOS\nGlutaric aciduria (type I)\nHydroxylysinemia\nHyperlysinemia                                                                                                                                     2-ketoadipic acidemia\nAciduria, ketoadipic\nDisorder of lysine and hydroxylysine metabolism\nGlutaric acidemia, type 1\nGlutaric aciduria, type 1\nLysine and hydroxylysine metabolism disorder","ClinicalNotes":"A group of inherited metabolic disorders which have in common elevations of serum lysine levels. Enzyme deficiencies of alpha-aminoadipic semialdehyde dehydrogenase and the saccharopine dehydrogenases have been associated with hyperlysinemia. Clinical manifestations include mental retardation, recurrent emesis, hypotonia, lethargy, diarrhea, and developmental delay. (from menkes, textbook of child neurology, 5th ed, p56)\nA rare autosomal recessive inherited metabolic disorder caused by deficiency of the enzyme glutaryl-coa dehydrogenase. It is characterized by abnormalities in the metabolism of lysine, hydroxylysine, and tryptophan that result in the accumulation and urinary excretion of glutaric acid. Patients present with brain atrophy, microcephaly, and acute dystonia."},
    {"ICD10Code":"E72.4","Description":"Disorders of ornithine metabolism","SearchInclusion":"Hyperammonemia-Hyperornithinemia-Homocitrullinemia syndrome\nOrnithinemia (types I, II)\nOrnithine transcarbamylase deficiency                                                                          Deficiency, ornithine transcarbamylase\nDisorder of ornithine metabolism\nHyperornithinemia hyperammonemia homocitrullinemia\nHyperornithinemia-hyperammonemia-homocitrullinuria syndrome\nOrnithine carbamoyltransferase deficiency\nOrnithine metabolism disorder","ClinicalNotes":"An inherited urea cycle disorder associated with deficiency of the enzyme ornithine carbamoyltransferase, transmitted as an x-linked trait and featuring elevations of amino acids and ammonia in the serum. Clinical features, which are more prominent in males, include seizures, behavioral alterations, episodic vomiting, lethargy, and coma. (menkes, textbook of child neurology, 5th ed, pp49-50)\nAn x-linked urea cycle metabolic disorder characterized by deficiency of ornithine carbamoyltransferase, resulting in the accumulation of amino acids and ammonia in the serum. Signs and symptoms include seizures, delayed growth, behavioral changes, ataxia, lethargy, and coma.\nAn x-linked urea cycle metabolic disorder characterized by deficiency of ornithine transcarbamylase, resulting in the accumulation of ammonia in the serum. Symptoms include vomiting, lethargy, and coma.\nInborn error of metabolism of the urea cycle due to ornithine carbomoyltransferase (e.c. 2.1.3.3) deficiency associated with hyperammonemia and accumulation of ammonia in the brain and liver. In most cases the early symptoms appear within the first three days of life and include respiratory distress, feeding difficulty, hypotonia, lethargy, and death in untreated cases. Neonatal hyperammonemic coma lasting longer than 48 hours usually results in cortical atrophy and mental retardation. In late-onset otc deficiency the symptoms appear from 2 months to 44 years with normal appearance at birth, followed by irritability, vomiting, lethargy, seizures, delayed development, ataxia, and seizures. Accumulation of ammonium in the brain and blood usually follows a protein load or intermittent infection. Otc deficient patients are particularly sensitive to toxic effects of valproate."},
    {"ICD10Code":"E72.50","Description":"Disorder of glycine metabolism, unspecified","SearchInclusion":"Disorder of glycine metabolism\nGlycine metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E72.51","Description":"Non-ketotic hyperglycinemia","SearchInclusion":"Hyperglycinemia, non ketotic","ClinicalNotes":"An autosomal recessive inherited metabolic disorder caused by mutations in the amt and gldc genes. It is characterized by abnormal accumulation of glycine in the brain and other tissues. Signs and symptoms include lethargy, feeding difficulties, hypotonia, intellectual deformities, and seizures.\nAn autosomal recessive metabolic disorder caused by deficiencies in the mitochondrial glycine cleavage system."},
    {"ICD10Code":"E72.52","Description":"Trimethylaminuria","SearchInclusion":"Primary hyperoxaluria                                                                                                                                      Oxalosis\nOxaluria","ClinicalNotes":"Excretion of an excessive amount of oxalates in the urine."},
    {"ICD10Code":"E72.53","Description":"Hyperoxaluria","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E72.59","Description":"Other disorders of glycine metabolism","SearchInclusion":"D-glycericacidemia\nHyperhydroxyprolinemia\nHyperprolinemia (types I, II)\nSarcosinemia","ClinicalNotes":""},
    {"ICD10Code":"E72.8","Description":"Other specified disorders of amino-acid metabolism","SearchInclusion":"Disorders of beta-amino-acid metabolism\nDisorders of gamma-glutamyl cycle                                                                                                           Deficiency of acetyl-coa acyltransferase\nDeficiency, beta ketothiolase\nDisorder of straight chain amino acid metabolism\nStraight chain amino acid metabolism disease","ClinicalNotes":""},
    {"ICD10Code":"E72.9","Description":"Disorder of amino-acid metabolism, unspecified","SearchInclusion":"Amino acid metabolism disorder\nAminoaciduria\nDisorder of amino acid metabolism","ClinicalNotes":"An inherited disorder that affects the metabolism of the amino acids. Representative examples include alkaptonuria, homocystinuria, tyrosinemia, and phenylketonuria.\nDisorders affecting amino acid metabolism. The majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (e.g., acidosis) and neurologic manifestations. They are present at birth, although they may not become symptomatic until later in life.\nDisorders affecting amino acid metabolism; majority of these disorders are inherited and present in the neonatal period with metabolic disturbances (for example, acidosis) and neurologic manifestations; present at birth, although they may not become symptomatic until later in life."},
    {"ICD10Code":"E73.0","Description":"Congenital lactase deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E73.1","Description":"Secondary lactase deficiency","SearchInclusion":"Acquired lactase deficiency","ClinicalNotes":""},
    {"ICD10Code":"E73.8","Description":"Other lactose intolerance","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E73.9","Description":"Lactose intolerance, unspecified","SearchInclusion":"Intestinal disaccharidase deficiency\nLactose intolerance","ClinicalNotes":"Lactose intolerance means that you cannot digest foods with lactose in them. Lactose is the sugar found in milk and foods made with milk. After eating foods with lactose in them, you may feel sick to your stomach. You may also have\ngas\ndiarrhea\nswelling in your stomach\nyour doctor may do a blood, breath or stool test to find out if your problems are due to lactose intolerance.lactose intolerance is not serious. Eating less food with lactose, or using pills or drops to help you digest lactose usually helps. You may need to take a calcium supplement if you don't get enough of it from your diet, since milk and foods made with milk are the most common source of calcium for most people.\nThe condition resulting from the absence or deficiency of lactase in the mucosa cells of the gastrointestinal tract, and the inability to break down lactose in milk for absorption. Bacterial fermentation of the unabsorbed lactose leads to symptoms that range from a mild indigestion (dyspepsia) to severe diarrhea. Lactose intolerance may be an inborn error or acquired.\nThe inability to digest or absorb lactose, a type of sugar found in milk and other dairy products."},
    {"ICD10Code":"E74.00","Description":"Glycogen storage disease, unspecified","SearchInclusion":"Glycogen storage disease\nGlycoprotein storage disorder","ClinicalNotes":"A group of inherited metabolic disorders involving the enzymes responsible for the synthesis and degradation of glycogen. In some patients, prominent liver involvement is presented. In others, more generalized storage of glycogen occurs, sometimes with prominent cardiac involvement.\nAn inherited metabolic disorder characterized either by defects in glycogen synthesis or defects in the breaking down of glycogen. It results either in the creation of abnormal forms of glycogen or accumulation of glycogen in the tissues.\nAny of a group of metabolic disorders characterized by excessive storage of glycogen."},
    {"ICD10Code":"E74.01","Description":"von Gierke disease","SearchInclusion":"Type I glycogen storage disease","ClinicalNotes":"An autosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production. Accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly. Increased concentrations of lactic acid and hyperlipidemia appear in the plasma. Clinical gout often appears in early childhood.\nAn autosomal recessive inherited type of glycogen storage disease. It is characterized by a deficiency of the enzyme glucose-6-phosphatase, resulting in the inability of the liver to produce free glucose causing severe hypoglycemia. There is abnormal accumulation of glycogen in the liver and kidneys.\nAutosomal recessive disease in which gene expression of glucose-6-phosphatase is absent, resulting in hypoglycemia due to lack of glucose production; accumulation of glycogen in liver and kidney leads to organomegaly, particularly massive hepatomegaly; increased concentrations of lactic acid and hyperlipidemia appear in the plasma; clinical gout often appears in early childhood."},
    {"ICD10Code":"E74.02","Description":"Pompe disease","SearchInclusion":"Cardiac glycogenosis\nType II glycogen storage disease                                                                                      Generalized glycogen storage disease of infants\nGlycogen storage disease, type 2","ClinicalNotes":"An autosomal recessive inherited type of glycogen storage disease caused by deficiency of the enzyme acid alpha-glucosidase. It results in the abnormal accumulation of glycogen in the heart, skeletal muscles, liver, and nervous system.\nAn autosomal recessively inherited glycogen storage disease caused by glucan 1,4-alpha-glucosidase deficiency. Large amounts of glycogen accumulate in the lysosomes of skeletal muscle (muscle, skeletal); heart; liver; spinal cord; and brain. Three forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy (cardiomyopathy, hypertrophic). The childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (from muscle nerve 1995;3:s61-9; menkes, textbook of child neurology, 5th ed, pp73-4)\nAutosomal recessively inherited glycogen storage disease caused by glucan 1,4-alpha-glucosidase deficiency; large amounts of glycogen accumulate in the lysosomes of skeletal muscle, heart, liver, spinal cord, and brain; three forms have been described: the infantile form is fatal in infancy and presents with hypotonia and a hypertrophic cardiomyopathy; the childhood form usually presents in the second year of life with proximal weakness and respiratory symptoms; the adult form consists of a slowly progressive proximal myopathy."},
    {"ICD10Code":"E74.03","Description":"Cori disease","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E74.04","Description":"McArdle disease","SearchInclusion":"Type V glycogen storage disease                                                                                              Glycogen storage disease, type 5\nGlycogen storage disease, type v","ClinicalNotes":"An autosomal recessive inherited type of glycogen storage disease caused by deficiency of myophosphorylase. It results in myalgias, muscle cramping and stiffness, and exercise intolerance.\nGlycogenosis due to muscle phosphorylase deficiency. Characterized by painful cramps following sustained exercise.\nGlycogenosis due to muscle phosphorylase deficiency; characterized by painful cramps following sustained exercise."},
    {"ICD10Code":"E74.09","Description":"Other glycogen storage disease","SearchInclusion":"Andersen disease\nHers disease\nTauri disease\nGlycogen storage disease, types 0, IV, VI-XI\nLiver phosphorylase deficiency\nMuscle phosphofructokinase deficiency                                                                             Glycogen storage disease type viii\nGlycogen storage disease, type 4\nGlycogen storage disease, type 6\nGlycogen storage disease, type 7\nGlycogen storage disease, type 8\nGlycogen storage disease, type 9\nGlycogen storage disease, type iv\nGlycogen storage disease, type ix\nGlycogen storage disease, type vi\nGlycogen storage disease, type vii","ClinicalNotes":"A hepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase (glycogen phosphorylase, liver form) activity.\nA rare inherited type of glycogen storage disease caused by deficiency of amylo-1,4-1,6 transglucosidase.\nAn autosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle (phosphofructokinase-1, muscle type) resulting in abnormal deposition of glycogen in muscle tissue. These patients have severe congenital muscular dystrophy and are exercise intolerant.\nAn autosomal recessive metabolic disorder due to a deficiency in expression of glycogen branching enzyme 1 (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches. Clinical features are muscle hypotonia and cirrhosis. Death from liver disease usually occurs before age 2.\nAutosomal recessive glycogen storage disease in which there is deficient expression of 6-phosphofructose 1-kinase in muscle resulting in abnormal deposition of glycogen in muscle tissue; patients have severe congenital muscular dystrophy and are exercise intolerant.\nAutosomal recessive metabolic disorder due to a deficiency in expression of branching enzyme (alpha-1,4-glucan-6-alpha-glucosyltransferase), resulting in an accumulation of abnormal glycogen with long outer branches; clinical features are muscle hypotonia and cirrhosis; death from liver disease usually occurs before age 2.\nHepatic glycogen storage disease in which there is an apparent deficiency of hepatic phosphorylase activity."},
    {"ICD10Code":"E74.10","Description":"Disorder of fructose metabolism, unspecified","SearchInclusion":"Fructose metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E74.11","Description":"Essential fructosuria","SearchInclusion":"Fructokinase deficiency                                                                                                       Essential benign fructosuria","ClinicalNotes":""},
    {"ICD10Code":"E74.12","Description":"Hereditary fructose intolerance","SearchInclusion":"Fructosemia                                                                                                                                Hereditary fructosuria","ClinicalNotes":"A genetic disorder characterized by the absence of the enzyme aldolase-b from the liver. This enzyme is essential for the metabolism of fructose. Signs and symptoms from fructose ingestion are evident in infancy and include vomiting, abdominal pain and hypoglycemia. Long term complications include hepatic and renal failure.\nAn autosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase (ec 2.1.2.13) activity, resulting in accumulation of fructose-1-phosphate. The accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycemia following ingestion of fructose. Prolonged fructose ingestion in infants leads ultimately to hepatic failure and death. Patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet.\nAutosomal recessive fructose metabolism disorder due to deficient fructose-1-phosphate aldolase (ec 2.1.2.13) activity, resulting in accumulation of fructose-1-phosphate; accumulated fructose-1-phosphate inhibits glycogenolysis and gluconeogenesis, causing severe hypoglycemia following ingestion of fructose; prolonged fructose ingestion in infants leads ultimately to hepatic failure and death; patients develop a strong distaste for sweet food, and avoid a chronic course of the disease by remaining on a fructose- and sucrose-free diet."},
    {"ICD10Code":"E74.19","Description":"Other disorders of fructose metabolism","SearchInclusion":"Fructose-1, 6-diphosphatase deficiency                                                                        Deficiency, fructose 1,6 diphosphatase\nFructose-biphosphatase deficiency","ClinicalNotes":"An autosomal recessive fructose metabolism disorder due to absent or deficient fructose-1,6-diphosphatase activity. Gluconeogenesis is impaired, resulting in accumulation of gluconeogenic precursors (e.g., amino acids, lactate, ketones) and manifested as hypoglycemia, ketosis, and lactic acidosis. Episodes in the newborn infant are often lethal. Later episodes are often brought on by fasting and febrile infections. As patients age through early childhood, tolerance to fasting improves and development becomes normal."},
    {"ICD10Code":"E74.20","Description":"Disorders of galactose metabolism, unspecified","SearchInclusion":"Disorder of galactose metabolism\nGalactose metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E74.21","Description":"Galactosemia","SearchInclusion":"Classical galactosemia, homozygous duarte-type\nGalactosemia (duarte)","ClinicalNotes":"A group of inherited enzyme deficiencies which feature elevations of galactose in the blood. This condition may be associated with deficiencies of galactokinase; udpglucose-hexose-1-phosphate uridylyltransferase; or udpglucose 4-epimerase. The classic form is caused by udpglucose-hexose-1-phosphate uridylyltransferase deficiency, and presents in infancy with failure to thrive; vomiting; and intracranial hypertension. Affected individuals also may develop mental retardation; jaundice; hepatosplenomegaly; ovarian failure (primary ovarian insufficiency); and cataracts. \nAn autosomal recessive inherited metabolic disorder caused by mutations in the gale, galk1, and galt genes. It is characterized by deficiency of the enzymes responsible for the metabolism of galactose. Signs and symptoms include intellectual disability, hepatomegaly, hepatic failure, and renal failure.\nGroup of inherited enzyme deficiencies which feature elevations of galactose in the blood; this condition may be associated with deficiencies of galactokinase, udp glucose-hexose-1-phosphate uridylyltransferase (classic form), or udp glucose 4-epimerase; the classic form presents in infancy with failure to thrive, vomiting, and intracranial hypertension; affected individuals also may develop mental retardation, jaundice, hepatosplenomegaly, ovarian failure and cataracts."},
    {"ICD10Code":"E74.29","Description":"Other disorders of galactose metabolism","SearchInclusion":"Galactokinase deficiency","ClinicalNotes":""},
    {"ICD10Code":"E74.31","Description":"Sucrase-isomaltase deficiency","SearchInclusion":"Sucrase isomaltase deficiency","ClinicalNotes":"Characterized by the deficiency or absence of the enzymes sucrase and isomaltase existing at, and usually before birth; this enzyme complex (sucrase-isomaltase) assists in the breakdown of a certain sugar (ie, sucrose) and certain products of starch digestion (dextrins); only evident soon after birth when sucrose or starches, such as found in modified milk formulas with sucrose or polycose, are ingested by an affected infant, breast-fed infants or those on lactose-only formula manifest no symptoms until such time as sucrose (found in fruit juices, solid foods, and/or some medications) is introduced into the diet."},
    {"ICD10Code":"E74.39","Description":"Other disorders of intestinal carbohydrate absorption","SearchInclusion":"Disorder of intestinal carbohydrate absorption NOS\nGlucose-galactose malabsorption\nSucrase deficiency                                                                                                                  Glucose malabsorption\nMalabsorption of glucose","ClinicalNotes":""},
    {"ICD10Code":"E74.4","Description":"Disorders of pyruvate metabolism and gluconeogenesis","SearchInclusion":"Deficiency of phosphoenolpyruvate carboxykinase\nDeficiency of pyruvate carboxylase\nDeficiency of pyruvate dehydrogenase                                                                       Deficiency, pyruvate carboxylase\nDeficiency, pyruvate deshydrogenase\nPyruvate carboxylase deficiency\nPyruvate dehydrogenase complex deficiency\nPyruvate metabolism and gluconeogenesis disorder","ClinicalNotes":"A rare autosomal recessive inherited metabolic disorder caused by mutations in the pc gene. It results in the accumulation of lactic acid and other toxic substances in the blood. Signs and symptoms appear early in life and include failure to thrive, mental and growth retardation, motor disturbances, seizures, and lactic acidosis.\nA very rare, autosomal recessive inherited disorder caused by deficiency of the enzyme phosphoenolpyruvate carboxykinase, which is involved in gluconeogenesis. It presents with hypoglycemia, failure to thrive, metabolic acidosis, muscle weakness, and hepatomegaly.\nAn autosomal recessive metabolic disorder caused by absent or decreased pyruvate carboxylase activity, the enzyme that regulates gluconeogenesis, lipogenesis, and neurotransmitter synthesis. Clinical manifestations include lactic acidosis, seizures, respiratory distress, marked psychomotor delay, periodic hypoglycemia, and hypotonia. The clinical course may be similar to leigh disease.\nAn inborn error of metabolism in which deficiency of pyruvate dehydrogenase complex is complicated by variable metabolic and neurological disorders. Neonatal lactic acidosis is usually associated with slow physical and mental development, microcephaly, dysgenesis and atrophic changes in the brain, cerebellar ataxia, seizures, and spasticity. Pyruvate dehydrogenase phosphatase (ec 3.1.3.43) deficiency has been found to occur in leigh syndrome.\nAn inherited metabolic disorder caused by deficient enzyme activity in the pyruvate dehydrogenase complex, resulting in deficiency of acetyl coa and reduced synthesis of acetylcholine. Two clinical forms are recognized: neonatal and juvenile. The neonatal form is a relatively common cause of lactic acidosis in the first weeks of life and may also feature an erythematous rash. The juvenile form presents with lactic acidosis, alopecia, intermittent ataxia; seizures; and an erythematous rash. autosomal recessive and x-linked forms are caused by mutations in the genes for the three different enzyme components of this multisubunit pyruvate dehydrogenase complex. One of the mutations at xp22.2-p22.1 in the gene for the e1 alpha component of the complex leads to leigh disease."},
    {"ICD10Code":"E74.8","Description":"Other specified disorders of carbohydrate metabolism","SearchInclusion":"Glycosuria, renal\nRenal glycosuria                                                                                                                                                  Essential pentosuria\nRenal glycosuria","ClinicalNotes":"An autosomal inherited disorder due to defective reabsorption of glucose by the proximal renal tubules. The urinary loss of glucose can reach beyond 50 g/day. It is attributed to the mutations in the sodium-glucose transporter 2 encoded by the slc5a2 gene."},
    {"ICD10Code":"E74.9","Description":"Disorder of carbohydrate metabolism, unspecified","SearchInclusion":"Carbohydrate transport disorder\nDisorder of carbohydrate transport","ClinicalNotes":"An inherited or acquired disorder that affects the metabolism of the carbohydrates. Representative examples include diabetes mellitus, glycogen storage disease, mucopolysaccharidoses, and lactose intolerance."},
    {"ICD10Code":"E75.00","Description":"GM2 gangliosidosis, unspecified","SearchInclusion":"Gm>2< gangliosidosis\nGm2 gangliosidosis","ClinicalNotes":"A group of recessively inherited diseases characterized by the intralysosomal accumulation of g(m2) ganglioside in the neuronal cells. Subtypes include mutations of enzymes in the beta-n-acetylhexosaminidases system or g(m2) activator protein leading to disruption of normal degradation of gangliosides, a subclass of acidic glycosphingolipids."},
    {"ICD10Code":"E75.01","Description":"Sandhoff disease","SearchInclusion":"","ClinicalNotes":"An autosomal recessive inherited lysosomal storage disorder caused by mutations in the hexb gene. It is characterized by deficiency of the enzyme hexosaminidase, resulting in the accumulation of gangiosides in the central nervous system and other body tissues. Signs and symptoms include progressive motor and mental deterioration, early blindness, macrocephaly, seizures, and hepatosplenomegaly.\nAn autosomal recessive neurodegenerative disorder characterized by an accumulation of g(m2) ganglioside in neurons and other tissues. It is caused by mutation in the common beta subunit of hexosaminidase a and hexosaminidase b. Thus this disease is also known as the o variant since both hexosaminidase a and b are missing. Clinically, it is indistinguishable from tay-sachs disease.\nAutosomal inherited disease caused by deficiency of the enzymes hexosaminidase a and b which leads to an accumulation of gm2 ganglioside and the sphingolipid globoside in neurons and other organs; clinical manifestations resemble tay-sachs disease."},
    {"ICD10Code":"E75.02","Description":"Tay-Sachs disease","SearchInclusion":"","ClinicalNotes":"A rare, fatal, autosomal recessive lipid storage disorder caused by mutations in the hexa gene. It is characterized by deficiency of beta-hexosaminidase a, resulting in accumulation of gangliosides in the neurons of the brain and spinal cord. Signs and symptoms include progressive deterioration of the mental and physical abilities early in life, accompanied by blindness, deafness, muscle atrophy, and paralysis.\nAn autosomal recessive neurodegenerative disorder characterized by the onset in infancy of an exaggerated startle response, followed by paralysis, dementia, and blindness. It is caused by mutation in the alpha subunit of the hexosaminidase a resulting in lipid-laden ganglion cells. It is also known as the b variant (with increased hexosaminidase b but absence of hexosaminidase a) and is strongly associated with ashkenazic jewish ancestry.\nAutosomal recessive inherited gangliosidosis characterized by the onset in the first 6 months of life of an exaggerated startle response, delay in psychomotor development, hypotonia (followed by spasticity), visual loss, and a macular cherry red spot; hexosaminidase a is deficient, leading to the accumulation of gm2 ganglioside in neurons of the central nervous system and retina; this condition is strongly associated with ashkenazic jewish ancestry.\nTay-sachs disease is a rare, inherited disorder. It causes too much of a fatty substance to build up in tissues and nerve cells of the brain. This buildup destroys the nerve cells, causing mental and physical problems. Infants with tay-sachs disease appear to develop normally for the first few months of life. Then, as nerve cells become distended with fatty material, mental and physical abilities deteriorate. The child becomes blind, deaf, and unable to swallow. Muscles begin to atrophy and paralysis sets in. Even with the best of care, children with tay-sachs disease usually die by age 4.tay-sachs is most common in eastern european ashkenazi jews. A blood test can determine if you carry or have the disease. There is no cure. Medicines and good nutrition can help some symptoms. Some children need feeding tubes."},
    {"ICD10Code":"E75.09","Description":"Other GM2 gangliosidosis","SearchInclusion":"Adult GM2 gangliosidosis\nJuvenile GM2 gangliosidosis","ClinicalNotes":""},
    {"ICD10Code":"E75.10","Description":"Unspecified gangliosidosis","SearchInclusion":"Gangliosidosis NOS","ClinicalNotes":"A group of autosomal recessive lysosomal storage disorders marked by the accumulation of gangliosides. They are caused by impaired enzymes or defective cofactors required for normal ganglioside degradation in the lysosomes. Gangliosidoses are classified by the specific ganglioside accumulated in the defective degradation pathway.\nGroup of often fatal inherited diseases marked by the accumulation of gangliosides in lysosomes secondary to enzymatic deficiency states; gangliosidoses include tay-sachs disease, gangliosidosis gm1, gangliosidoses gm2, and sandhoff disease; which share the infantile or childhood onset of central nervous system deterioration."},
    {"ICD10Code":"E75.11","Description":"Mucolipidosis IV","SearchInclusion":"Ganglioside sialidase deficiency","ClinicalNotes":"An autosomal recessive lysosomal storage disease caused by mutations in the mcoln1 gene. It is characterized by psychomotor developmental delays and ophthalmologic abnormalities."},
    {"ICD10Code":"E75.19","Description":"Other gangliosidosis","SearchInclusion":"GM1 gangliosidosis\nGM3 gangliosidosis","ClinicalNotes":"A ganglioside biosynthesis disorder caused by (n-acetylneuraminyl)-galactosylglucosylceramide n-acetyl transferase (e.c. 2.4.192) deficiency with excessive accumulation of ganglioside gm3 in the liver and brain tissue and absence of higher ganglioside homologs. Clinical features include limpness, retarded psychomotor development, coarsening of facial features, macroglossia, gingival hypertrophy, hepatosplenomegaly, inguinal hernia, and stubby hands and feet. Most patients die in infancy.\nA ganglioside storage disorder due to beta-galactosidase (ec 3.2.1.23) deficiency and abnormal accumulation of gm1 ganglioside in neurons and in hepatic, splenic and other histiocytes and in renal glomerular epithelium due. The symptoms appear shortly after birth; they include retarded psychomotor development, failure to thrive, startle reaction to sounds, feeding difficulty, hepatosplenomegaly, hurler (gargoyle-like) facies (coarse facial features, macrocephaly, broad nose, frontal bossing, long philtrum, prominent maxilla, and macroglossia), bone defects similar to those seen in hurler syndrome (mainly dysostosis multiplex and long bone and vertebral anomalies), and other abnormalities. Severe cerebral degeneration follows with death in the first two years of life usually due to bronchopneumonia. The affected infants are often blind, deaf, and quadriplegic.\nAn autosomal recessive lysosomal storage disease characterized by deficiency of the enzyme acid beta-galactosidase, resulting in the accumulation of acid lipids in the nervous system. Signs and symptoms include neurologic disturbances, muscle atrophy, dystonia, eye abnormalities, and formation of angiokeratomas.\nAn autosomal recessive neurodegenerative disorder caused by the absence or deficiency of beta-galactosidase. It is characterized by intralysosomal accumulation of g(m1) ganglioside and oligosaccharides, primarily in neurons of the central nervous system. The infantile form is characterized by muscle hypotonia, poor psychomotor development, hirsutism, hepatosplenomegaly, and facial abnormalities. The juvenile form features hyperacusis; seizures; and psychomotor retardation. The adult form features progressive dementia; ataxia; and muscle spasticity. (from menkes, textbook of child neurology, 5th ed, pp96-7)\nForm of gangliosidosis characterized by accumulation of g(m1) ganglioside and oligosaccharides in lysosomes caused by an absence or severe deficiency of the enzyme beta-galactosidase (type a1); three phenotypes of this disorder are infantile (generalized), juvenile, and adult; the infantile form is characterized by skeletal abnormalities, hypotonia, poor psychomotor development, hirsutism, hepatosplenomegaly, and facial abnormalities; the juvenile form features hyperacusis, seizures, and psychomotor retardation; the adult form features progressive intellectual deterioration, involuntary movements, ataxia, and spasticity."},
    {"ICD10Code":"E75.21","Description":"Fabry (-Anderson) disease                                                                                                                                                                                                                                       Y","SearchInclusion":"Fabry's disease\nFabrys disease","ClinicalNotes":"A rare x-linked inherited lysosomal storage disorder characterized by deficiency of the enzyme alpha-galactosidase a. It results in the accumulation of glycolipids in the blood vessels and tissues. Signs and symptoms include hypertension, cardiomyopathy, angiokeratomas, neuropathy, hypohidrosis, keratopathy, proteinuria, and renal failure.\nAn x-linked inherited metabolic disease caused by a deficiency of lysosomal alpha-galactosidase a. It is characterized by intralysosomal accumulation of globotriaosylceramide and other glycosphingolipids in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.\nX-linked lysosomal storage disease of glycosphingolipid catabolism, resulting from a deficiency of alpha-galactosidase a and leading to accumulation of ceramide trihexoside in the cardiovascular and renal systems."},
    {"ICD10Code":"E75.22","Description":"Gaucher disease                                                                                                                                                                                                                                                 Y","SearchInclusion":"Gaucher's disease\nGauchers disease","ClinicalNotes":"An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (glucosylceramidase) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the mononuclear phagocyte system. The characteristic gaucher cells, glycosphingolipid-filled histiocytes, displace normal cells in bone marrow and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.\nAn inherited lysosomal storage disease caused by deficiency of the enzyme glucocerebrosidase. It results in the accumulation of a fatty substance called glucocerebroside in mononuclear cells in the bone marrow, liver, spleen, brain, and kidneys. Signs and symptoms include hepatomegaly, splenomegaly, neurologic disorders, lymphadenopathy, skeletal disorders, anemia and thrombocytopenia.\nAutosomal recessive disorder caused by deficiency of the enzyme glucocerebrosidase featuring the pathological storage of glycosylceramide in mononuclear phagocytes; the most common subtype is the non-neuronopathic form, a slowly progressive condition characterized by hepatosplenomegaly and skeletal deformities; the neuronopathic forms are divided into infantile and juvenile forms; the infantile form presents at 4-5 months of age with anemia, loss of cognitive gains, neck retraction, dysphagia, and hepatosplenomegaly; the juvenile form features a slowly progressive loss of intellect, hepatosplenomegaly, ataxia, myoclonic seizures, and spasticity; the neuronopathic forms are characterized by neuronal loss with neuronophagia, and accumulation of glucocerebroside in neurons.\nGaucher's disease is a rare, inherited disorder that causes too much of a substance called glucocerebroside to build up in your spleen, liver, lungs, bones and sometimes in your brain. The buildup prevents these organs from working properly.there are three types:\ntype 1, the most common form, causes liver and spleen enlargement, bone pain and broken bones, and, sometimes, lung and kidney problems. It does not involve the brain. It can occur at any age.\ntype 2, which causes severe brain damage, appears in infants. Most children who have it die by age 2.\nin type 3, there may be liver and spleen enlargement, and signs of brain involvement appear gradually.\ngaucher's disease has no cure. Treatment options for types 1 and 3 include medicine and enzyme replacement therapy, which is usually very effective. There is no good treatment for the brain damage of type 2."},
    {"ICD10Code":"E75.23","Description":"Krabbe disease","SearchInclusion":"Galactosylceramide beta-galactosidase deficiency\nGloboid cell leukodystrophy, late onset\nKrabbes disease","ClinicalNotes":"A degenerative disease of the central and peripheral nervous system caused by abnormal breakdown and turnover of myelin and marked by reduced galacosylceramide beta-galactosidase activity (ec 3.2.1.46). Two types based on the age of onset are recognized: infantile-onset krabbe disease is marked by the appearance of symptoms at ages 3-6 months, which include irritability, frequent crying, and increase of muscle tonus. They are followed by opisthotonos, less of tendon reflexes, visual failure, elevated cerebrospinal fluid proteins, and delayed nerve conduction velocity. Most infants die during the second year of life. Late-onset krabbe disease (lokd) has first symptoms at ages 5 to 10 years, consisting of focal neurological signs, hemiparesis, cerebellar ataxia, cortical blindness, and spastic paraplegia, followed by mental and physical deterioration. Some patients survive into adulthood.\nA rare inherited neurodegenerative disorder that belongs to the group of leukodystrophies. It is characterized by myelin destruction, gliosis in the brain, and the presence of multinucleated globoid cells. Signs and symptoms include irritability, mental and motor developmental disturbances, muscle weakness, seizures, blindness, and deafness.\nAn autosomal recessive metabolic disorder caused by a deficiency of galactosylceramidase leading to intralysosomal accumulation of galactolipids such as galactosylceramides and psychosine. It is characterized by demyelination associated with large multinucleated globoid cells, predominantly involving the white matter of the central nervous system. The loss of myelin disrupts normal conduction of nerve impulses.\nInherited, demyelinating, human lipid storage disease caused by a deficiency of galactosylceramidase; manifestations include convulsions, quadriplegia, blindness, deafness, and mental retardation."},
    {"ICD10Code":"E75.240","Description":"Niemann-Pick disease type A                                                                                                                                                                                                                                     Y","SearchInclusion":"Niemann pick disease type a\nNiemann-pick disease, type a","ClinicalNotes":"The classic infantile form of niemann-pick disease, caused by mutation in sphingomyelin phosphodiesterase. It is characterized by accumulation of sphingomyelins in the cells of the mononuclear phagocyte system and other cell throughout the body leading to cell death. Clinical signs include jaundice, hepatosplenomegaly, and severe brain damage."},
    {"ICD10Code":"E75.241","Description":"Niemann-Pick disease type B                                                                                                                                                                                                                                     Y","SearchInclusion":"Niemann pick disease type b\nNiemann-pick disease, type b","ClinicalNotes":"An allelic disorder of type a niemann-pick disease, a late-onset form. It is also caused by mutation in sphingomyelin phosphodiesterase but clinical signs involve only visceral organs (non-neuropathic type)."},
    {"ICD10Code":"E75.242","Description":"Niemann-Pick disease type C                                                                                                                                                                                                                                     Y","SearchInclusion":"Niemann pick disease type c\nNiemann-pick disease, type c","ClinicalNotes":"An autosomal recessive inherited lysosomal storage disease caused by mutations in the npc1 and npc2 genes. It is characterized by progressive neurologic deterioration manifested with ataxia, dementia, seizures, and dystonia. Other signs and symptoms include hepatosplenomegaly, jaundice, and respiratory failure.\nAn autosomal recessive lipid storage disorder that is characterized by accumulation of cholesterol and sphingomyelins in cells of the viscera and the central nervous system. Type c (or c1) and type d are allelic disorders caused by mutation of gene (npc1) encoding a protein that mediate intracellular cholesterol transport from lysosomes. Clinical signs include hepatosplenomegaly and chronic neurological symptoms. Type d is a variant in people with a nova scotia ancestry."},
    {"ICD10Code":"E75.243","Description":"Niemann-Pick disease type D                                                                                                                                                                                                                                     Y","SearchInclusion":"Niemann pick disease type d\nNiemann-pick disease, type d","ClinicalNotes":""},
    {"ICD10Code":"E75.248","Description":"Other Niemann-Pick disease                                                                                                                                                                                                                                      Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E75.249","Description":"Niemann-Pick disease, unspecified                                                                                                                                                                                                                               Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E75.25","Description":"Metachromatic leukodystrophy","SearchInclusion":"","ClinicalNotes":"An autosomal recessive inherited disorder characterized by abnormalities in the development of the myelin sheaths. It is caused by a deficiency of the enzyme arylsulfatase a. There are three forms of this disease: late infantile, juvenile, and adult. In the late infantile form symptoms include muscle weakness and rigidity, gait disturbances, developmental delays, and seizures. In the juvenile form symptoms include gait disturbances, mental deterioration and seizures. The adult form is characterized by psychotic symptoms and dementia.\nAn autosomal recessive metabolic disease caused by a deficiency of cerebroside-sulfatase leading to intralysosomal accumulation of cerebroside sulfate (sulfoglycosphingolipids) in the nervous system and other organs. Pathological features include diffuse demyelination, and metachromatically-staining granules in many cell types such as the glial cells. There are several allelic and nonallelic forms with a variety of neurological symptoms.\nAutosomal recessive lysosomal storage disease caused by a deficiency of cerebroside sulfatase leading to an accumulation of cerebroside sulfate in the nervous system and other organs."},
    {"ICD10Code":"E75.29","Description":"Other sphingolipidosis","SearchInclusion":"Farber's syndrome\nSulfatase deficiency\nSulfatide lipidosis                                                                                                                         Canavan disease\nLeukodystrophy\nPelizaeus merzbacher disease\nSpongy degeneration of central nervous system","ClinicalNotes":"An autosomal recessive inherited disorder characterized by abnormalities in the development of the myelin sheaths. It is caused by a deficiency of the enzyme arylsulfatase a. There are three forms of this disease: late infantile, juvenile, and adult. In the late infantile form symptoms include muscle weakness and rigidity, gait disturbances, developmental delays, and seizures. In the juvenile form symptoms include gait disturbances, mental deterioration and seizures. The adult form is characterized by psychotic symptoms and dementia.\nAn autosomal recessive metabolic disease caused by a deficiency of cerebroside-sulfatase leading to intralysosomal accumulation of cerebroside sulfate (sulfoglycosphingolipids) in the nervous system and other organs. Pathological features include diffuse demyelination, and metachromatically-staining granules in many cell types such as the glial cells. There are several allelic and nonallelic forms with a variety of neurological symptoms.\nAutosomal recessive lysosomal storage disease caused by a deficiency of cerebroside sulfatase leading to an accumulation of cerebroside sulfate in the nervous system and other organs."},
    {"ICD10Code":"E75.3","Description":"Sphingolipidosis, unspecified                                                                                                                                                                                                                                   Y","SearchInclusion":"Sphingolipidosis","ClinicalNotes":"A group of inherited metabolic disorders characterized by the intralysosomal accumulation of sphingolipids primarily in the central nervous system and to a variable degree in the visceral organs. They are classified by the enzyme defect in the degradation pathway and the substrate accumulation (or storage). Clinical features vary in subtypes but neurodegeneration is a common sign.\nLysosomal storage diseases characterized by abnormal storage of spingolipids."},
    {"ICD10Code":"E75.4","Description":"Neuronal ceroid lipofuscinosis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E75.5","Description":"Other lipid storage disorders                                                                                                                                                                                                                                   Y","SearchInclusion":"Cholesterol ester storage disease\nNeutral lipid storage disorder\nTendon xanthoma\nTriglyceride storage disease with ichthyosis\nXanthoma tendinosum                                                                                                     Cerebrotendinous cholesterosis [van Bogaert-Scherer-Epstein]\nWolman's disease","ClinicalNotes":"A very rare, autosomal recessive inherited lysosomal storage disease caused by mutations in the lipa gene. Signs and symptoms appear in infancy and include developmental delay, vomiting, abdominal distention, hepatosplenomegaly, jaundice, anemia, steatorrhea, and calcification of the adrenal glands.\nSevere infantile form of inherited lysosomal lipid storage disease due to deficiency of acid lipase; results in accumulation of neutral lipids, particularly cholesterol esters, within cells.\nThe severe infantile form of inherited lysosomal lipid storage diseases due to deficiency of acid lipase (sterol esterase). It is characterized by the accumulation of neutral lipids, particularly cholesterol esters in leukocytes, fibroblasts, and hepatocytes. It is also known as wolman's xanthomatosis and is an allelic variant of cholesterol ester storage disease."},
    {"ICD10Code":"E75.6","Description":"Lipid storage disorder, unspecified                                                                                                                                                                                                                             Y","SearchInclusion":"Cerebral degeneration associated with generalized lipidosis\nCerebral degeneration in lipidoses\nChemically-induced lipidosis\nLipidosis, chemically induced\nLipoidosis\nRetinal dystrophy\nRetinal dystrophy in cerebroretinal lipidosis","ClinicalNotes":"Conditions characterized by abnormal lipid deposition due to disturbance in lipid metabolism, such as hereditary diseases involving lysosomal enzymes required for lipid breakdown. They are classified either by the enzyme defect or by the type of lipid involved.\nDisturbance of lipid metabolism with abnormal deposit of lipids in the cells."},
    {"ICD10Code":"E76.01","Description":"Hurler's syndrome","SearchInclusion":"Mucopolysaccharidosis, mps-i-h","ClinicalNotes":"An autosomal recessive inherited disorder of mucopolysaccharide metabolism. It is the most severe form of mucopolysaccharidosis type i. It is characterized by deficiency of the enzyme alpha-l-iduronidase resulting in the accumulation of mucopolysaccharides in the tissues."},
    {"ICD10Code":"E76.02","Description":"Hurler-Scheie syndrome","SearchInclusion":"Mucopolysaccharidosis, mps-i-h/s","ClinicalNotes":""},
    {"ICD10Code":"E76.03","Description":"Scheie's syndrome","SearchInclusion":"Mucopolysaccharidosis mps-i-s","ClinicalNotes":"An autosomal recessive disorder representing the milder form of mucopolysaccharidosis type i. It is characterized by deficiency of the enzyme alpha-l-iduronidase. Signs and symptoms include broad mouth with full lips, cloudy cornea which may lead to blindness, stiff joints, and hirsutism."},
    {"ICD10Code":"E76.1","Description":"Mucopolysaccharidosis, type II","SearchInclusion":"Mucopolysaccharidosis 2\nMucopolysaccharidosis, mps-ii","ClinicalNotes":"A syndrome with variable manifestations exhibiting mainly microcephaly, characteristic facies, mental retardation, short stature, acral skeletal anomalies with occasional craniosynostosis and congenital heart defects.\nAn inborn mucopolysaccharide metabolism disorder with iduronate-2-sulfatase deficiency. Clinical characteristics are similar to those in mps i, except for the absence of corneal clouding and slower progression of the course of disease and central nervous system deterioration. Retinal degeneration may occur, but the cornea usually remains clear. Appearance is normal at birth with excessive growth taking place during first two years of life. Two types are recognized: a severe form (mps iia) which is characterized mainly by mental retardation and progressive physical deterioration and early death, and a mild form (mps iib) in which patients may survive into adulthood. Mps iia usually occurs between 2 and 4 years of age with progressive deterioration, chronic diarrhea, recurrent ear infections, hearing impairment, communicating hydrocephalus with increased intracranial pressure, and death at about 10 and 15 years. Obstructive airway disease, cardiac valvular dysfunction, myocardial thickening, pulmonary hypertension, coronary disease, and myocardial infarction may be superimposed. Mps iib is milder with preservation of intelligence. The symptoms usually include hearing impairment, carpal tunnel syndrome, joint stiffness, discrete corneal opacities, and papilledema. Death may occur in early adulthood, usually from airway obstruction or cardiac failure.\nAn x-linked, inherited lysosomal storage disease caused by the deficiency of the enzyme iduronate sulfatase that is responsible for the degradation of mucopolysaccharides. It nearly always affects males and is characterized by the accumulation of mucopolysaccharides in various organs, resulting in mental dysfunction, enlarged abdomen, hearing loss, obstructive airway disease, heart disease, and hepatosplenomegaly.\nLysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of l-sulfoiduronate sulfatase; this disease differs from muchopolysaccharidosis i by slower progression, lack of corneal clouding, and x-linked rather than autosomal recessive inheritance.\nSystemic lysosomal storage disease marked by progressive physical deterioration and caused by a deficiency of l-sulfoiduronate sulfatase. This disease differs from mucopolysaccharidosis i by slower progression, lack of corneal clouding, and x-linked rather than autosomal recessive inheritance. The mild form produces near-normal intelligence and life span. The severe form usually causes death by age 15."},
    {"ICD10Code":"E76.210","Description":"Morquio A mucopolysaccharidoses","SearchInclusion":"Classic Morquio syndrome\nMorquio syndrome A\nMucopolysaccharidosis, type IVA","ClinicalNotes":"A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme galactosamine-6-sulfatase. It is characterized by skeletal and central nervous system deficits."},
    {"ICD10Code":"E76.211","Description":"Morquio B mucopolysaccharidoses","SearchInclusion":"Morquio-like mucopolysaccharidoses\nMorquio-like syndrome\nMorquio syndrome B\nMucopolysaccharidosis, type IVB                                                                            Mucopolysaccharidosis mps-iv-b","ClinicalNotes":"A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme beta galactosidase. It is characterized by skeletal dysplasia and short stature."},
    {"ICD10Code":"E76.219","Description":"Morquio mucopolysaccharidoses, unspecified","SearchInclusion":"Morquio syndrome\nMucopolysaccharidosis, type IV                                                                                                                             Morquio syndrome\nMucopolysaccharidosis mps-iv-a\nMucopolysaccharidosis mps-iv-b","ClinicalNotes":"A rare autosomal recessive lysosomal storage disease characterized by abnormal skeletal developments, dwarfism, heart disorders, and central nervous system deficits.\nAn inborn error of metabolism characterized by faulty degradation of keratan sulfate with lysosomal accumulation and mucopolysaccharidosis, keratansulfaturia. Clinical features include short trunk dwarfism, dysostosis multiplex, progressive spinal deformity, short neck, pectus carinatum, genu valgum, pes planus, and odontoid hypoplasia with varying degrees of severity. Mental development is usually normal but progressive intellectual deterioration was reported in type b. Two types are recognized according to the enzymes involved: type a: synonyms: morquio syndrome a galactosamine-4-sulfatase (galns) deficiency mucopolysaccharidosis (mps) iv a this type is caused by galactosamine-6-sulfate sulfatase (ec 3.16.4) and is more severe than type b. It is marked by shortness and hyperextension of the neck causing the head to appear as if it were resting directly on the shoulders, short trunk, long extremities with excessive joint mobility, kyphosis or kyphoscoliosis, pectus carinatum, the sternum extending from clavicular junction and angling downward in midsection, spinal cord compression associated with atlantoaxial dislocation and thoracolumbar gibbus, protruding abdomen, and clouding of the cornea type b: synonyms: morquio syndrome b morquio-like syndrome beta-galactosidase deficiency mucopolysaccharidosis (mps) iv b this type is caused by beta-galactosidase (ec 3.2.1.23) deficiency and is marked a milder phenotype consisting of dysostosis multiplex, pectus carinatum, odontoid hypoplasia, kyphosis, genua valga, platyspondyly, and corneal clouding.\nGenetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate.\nGenetic disorder of mucopolysaccharide metabolism characterized by skeletal abnormalities, joint instability, development of cervical myelopathy, and excessive urinary keratan sulfate. There are two biochemically distinct forms, each due to a deficiency of a different enzyme."},
    {"ICD10Code":"E76.22","Description":"Sanfilippo mucopolysaccharidoses","SearchInclusion":"Mucopolysaccharidosis, type III (A) (B) (C) (D)\nSanfilippo A syndrome\nSanfilippo B syndrome\nSanfilippo C syndrome\nSanfilippo D syndrome                                                                                                                                                                    Sanfilippo syndrome","ClinicalNotes":"A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme acetyl-coa:alpha-glucosaminide acetyltransferase. It is characterized by behavioral changes, sleep disturbances, and mental developmental delays.\nA rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme heparan sulfate sulfatase. It is characterized by behavioral changes, sleep disturbances, mental developmental delays and seizures.\nA rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme n-acetyl-alpha-d-glucosaminidase. It is characterized by behavioral changes, sleep disturbances, and mental developmental delays.\nA rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme n-acetylglucosamine-6-sulfatase. It is characterized by behavioral changes, sleep disturbances and mental developmental delays."},
    {"ICD10Code":"E76.29","Description":"Other mucopolysaccharidoses","SearchInclusion":"beta-Glucuronidase deficiency\nMaroteaux-Lamy (mild) (severe) syndrome\nMucopolysaccharidosis, types VI, VII                                                                                   Maroteaux lamy syndrome","ClinicalNotes":"A rare autosomal recessive lysosomal storage disease caused by deficiency of the enzyme beta-glucuronidase. It is characterized by hepatosplenomegaly, skeletal deformities, enlarged head, and mental retardation.\nAn inborn error of metabolism characterized by beta-glucuronidase (ec 3.2.1.31) deficiency with abnormal storage of mucopolysaccharides in various tissues. The phenotype consists mainly of short stature, hepatosplenomegaly, dysostosis multiplex, and mild mental retardation. Type i is the most severe with hydrops fetalis, coarse facies with hypertelorism and depressed nasal bridge, cloudy corneae, and onset of symptoms at birth. Type ii has a less severe course with moderate huurler facies and hypertelorism and onset at 2 to 3 years. Type iii has the mildest symptoms with onset during adolescence.\nMucopolysaccharidosis characterized by excessive dermatan and heparan sulfates in the urine and hurler-like features. It is caused by a deficiency of beta-glucuronidase."},
    {"ICD10Code":"E76.3","Description":"Mucopolysaccharidosis, unspecified","SearchInclusion":"Mucopolysaccharidosis","ClinicalNotes":"A group of autosomal recessive or x-linked inherited lysosomal storage disorders affecting the metabolism of mucopolysaccharides, resulting in the accumulation of mucopolysaccharides in the body. Signs and symptoms include organomegaly, mental retardation, abnormal skeletal development, heart disorders, hearing loss, and central nervous system deficiencies.\nAny of a group of lysosomal storage diseases resulting from defects in degradation of glycosaminoglycans, which are excreted in urine and accumulate in tissue.\nGroup of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). The diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency."},
    {"ICD10Code":"E76.8","Description":"Other disorders of glucosaminoglycan metabolism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E76.9","Description":"Glucosaminoglycan metabolism disorder, unspecified","SearchInclusion":"Disorder of glycosaminoglycan metabolism\nGlucosaminoglycan metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E77.0","Description":"Defects in post-translational modification of lysosomal enzymes                                                                                                                                                                                                 Y","SearchInclusion":"Mucolipidosis II [I-cell disease]\nMucolipidosis III [pseudo-Hurler polydystrophy]                                                                                                              I-cell disease\nPseudo-hurler polydystrophy","ClinicalNotes":""},
    {"ICD10Code":"E77.1","Description":"Defects in glycoprotein degradation                                                                                                                                                                                                                             Y","SearchInclusion":"Aspartylglucosaminuria\nFucosidosis\nMannosidosis\nSialidosis [mucolipidosis I]                                                                                                  Fucosidosis\nMannosidosis\nSialidosis","ClinicalNotes":"A rare autosomal recessive lysosomal disorder characterized by deficiency of n-aspartyl-beta-glucosaminidase. It is characterized by developmental delays during childhood.\nA rare autosomal recessive lysosomal storage disease characterized by a deficient activity of the enzymes alpha-d-mannosidase or beta-mannosidase. Clincal signs and symptoms include hepatomegaly, splenomegaly, hearing loss, mental retardation, skeletal abnormalities, and recurrent respiratory infections.\nA recessively inherited, progressive lysosomal storage disease caused by a deficiency of glycosylasparaginase activity. The lack of this enzyme activity results in the accumulation of n-acetylglucosaminylasparagine (the linkage unit of asparagine-linked glycoproteins) in lysosomes.\nAn autosomal recessive lysosomal storage disease caused by a deficiency of alpha-l-fucosidase activity resulting in an accumulation of fucose containing sphingolipids; glycoproteins, and mucopolysaccharides (glycosaminoglycans) in lysosomes. The infantile form (type i) features psychomotor deterioration, muscle spasticity, coarse facial features, growth retardation, skeletal abnormalities, visceromegaly, seizures, recurrent infections, and macroglossia, with death occurring in the first decade of life. Juvenile fucosidosis (type ii) is the more common variant and features a slowly progressive decline in neurologic function and angiokeratoma corporis diffusum. Type ii survival may be through the fourth decade of life. (from menkes, textbook of child neurology, 5th ed, p87; am j med genet 1991 jan;38(1):111-31)\nAn autosomal recessive lysosomal storage disease characterized by a defective alpha-l-fucosidase. It results in accumulation of fucose in the tissues. Signs and symptoms include psychomotor retardation, dysostosis multiplex, and neural disturbances.\nAn inborn error of metabolism caused by deficient activity of the enzyme aspartylglucosaminidase. Clinical manifestations consist of psychomotor retardation, coarse facies, hepatosplenomegaly, ventral hernia, and skeletal abnormalities.\nDiseases caused by the loss of one or more enzymes involved in the hydrolysis of mannoside linkages (mannosidases). The defects in enzyme activity are primarily associated with genetic mutation of the genes that codes for a particular mannosidase isoenzyme.\nLysosomal storage disease caused by defective alpha-l-fucosidase and accumulation of fucose containing glycoconjugates; clinical symptoms include psychomotor deterioration, growth retardation, hepatosplenomegaly, cardiomegaly, and seizures.\nLysosomal storage disease due to defective alpha-mannosidase with resultant oligosaccharide accumulation.\nLysosome storage disease due to alpha-l-fucosidase (e.c. 3.2.1.51) deficiency in leukocytes manifested by abnormal accumulation in tissues and urinary excretion of partially catabolized oligosaccharides, glycoasparagines, and glycolipids with alpha-linked fucose at the nonreducing end of the glycogen chain. The phenotype is variable and may include delayed growth and mental development, progressive neurological deterioration, hurler-like (mucopolysaccharidosis i-h) coarse facies, recurrent infections, visceromegaly, skeletal abnormalities, joint contractures, deafness, and angiokeratoma corporis diffusum. Several types are recognized by different researchers. The form exhibiting a longer survival, mild neurological manifestations, and angiokeratoma is sometimes referred to as fucosidosis type ii. In a different scheme, three different types are recognized according to their age of onset. Types i and ii are the most severe and have their onsets at 10 and 18 months, respectively with life expectancy of 6 years. Type iii represents a juvenile form which is marked by a milder form of psychomotor retardation and a slower deterioration of neurological activities. Hurler-like (gargyloid) facies occur mainly in types i and ii and is less commonly in type iii."},
    {"ICD10Code":"E77.8","Description":"Other disorders of glycoprotein metabolism                                                                                                                                                                                                                      Y","SearchInclusion":"Carbohydrate deficiency glycoprotein syndrome\nCarbohydrate-deficient glycoprotein syndrome","ClinicalNotes":""},
    {"ICD10Code":"E77.9","Description":"Disorder of glycoprotein metabolism, unspecified                                                                                                                                                                                                                Y","SearchInclusion":"Disorder of glycoprotein metabolism\nGlycoprotein metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E78.0","Description":"Pure hypercholesterolemia                                                                                                                                                                                                                                       Y","SearchInclusion":"Fredrickson's hyperlipoproteinemia, type IIa\nHyperbetalipoproteinemia\nLow-density-lipoprotein-type [LDL] hyperlipoproteinemia\n(Pure) hypercholesterolemia NOS","ClinicalNotes":""},
    {"ICD10Code":"E78.00","Description":"Pure hypercholesterolemia, unspecified","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E78.01","Description":"Familial hypercholesterolemia","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E78.1","Description":"Pure hyperglyceridemia                                                                                                                                                                                                                                          Y","SearchInclusion":"Elevated fasting triglycerides\nEndogenous hyperglyceridemia\nFredrickson's hyperlipoproteinemia, type IV\nHyperlipidemia, group B\nHyperprebetalipoproteinemia\nVery-low-density-lipoprotein-type [VLDL]                                                              hyperlipoproteinemia                                                                                  Hyperlipoproteinemia, type i\nHypertriglyceridemia\nHypertriglyceridemia (high blood fats)\nHypertriglyceridemia, endogenous\nHypertriglyceridemia, primary\nPrimary hypertriglyceridemia","ClinicalNotes":"A hypertriglyceridemia disorder, often with autosomal dominant inheritance. It is characterized by the persistent elevations of plasma triglycerides, endogenously synthesized and contained predominantly in very-low-density lipoproteins (pre-beta lipoproteins). In contrast, the plasma cholesterol and phospholipids usually remain within normal limits.\nCharacterized by an isolated elevation in the plasma level of endogenously synthesized triglyceride carried in vldl; considered to be an autosomal dominant trait."},
    {"ICD10Code":"E78.2","Description":"Mixed hyperlipidemia                                                                                                                                                                                                                                            Y","SearchInclusion":"Broad- or floating-betalipoproteinemia\nCombined hyperlipidemia NOS\nElevated cholesterol with elevated triglycerides NEC\nFredrickson's hyperlipoproteinemia, type IIb or III\nHyperbetalipoproteinemia with prebetalipoproteinemia\nHypercholesteremia with endogenous hyperglyceridemia\nHyperlipidemia, group C\nTubo-eruptive xanthoma\nXanthoma tuberosum                                                                                                           Diabetes type 1 with hyperliidemia\nDiabetes type 2 with hyperlipidemia\nEruptive xanthoma\nHyperlipidemia, mixed (high blood fats)\nMixed hyperlipidemia associated with type 1 diabetes mellitus\nMixed hyperlipidemia associated with type 2 diabetes mellitus\nMixed hyperlipidemia due to type 1 diabetes mellitus\nMixed hyperlipidemia due to type 2 diabetes mellitus\nTuberous xanthoma\nXanthoma tuberosum","ClinicalNotes":"A disorder of lipoprotein metabolism characterized by high levels of cholesterol and triglycerides in the blood. It is caused by elevation of low density and very low density lipoproteins.\nA type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma cholesterol and/or triglycerides. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (upstream stimulatory factors) on chromosome 1.\nType iib hyperlipoproteinemia is caused by mutation in the receptor-binding domain of apolipoprotein b-100 which is a major component of low-density lipoproteins and very-low-density lipoproteins resulting in reduced clearance of these lipoproteins. It is characterized by both hypercholesterolemia and hypertriglyceridemia (combined hyperlipidemia)."},
    {"ICD10Code":"E78.3","Description":"Hyperchylomicronemia                                                                                                                                                                                                                                            Y","SearchInclusion":"Chylomicron retention disease\nFredrickson's hyperlipoproteinemia, type I or V\nHyperlipidemia, group D\nMixed hyperglyceridemia                                                                                                            Familial lipoprotein lipase deficiency","ClinicalNotes":"A genetic disorder of lipoprotein metabolism caused by mutations in the lpl and apolipoprotein (apo) c-ii genes. It is characterized by increased levels of chylomicrons and triglycerides in the blood.\nAn inherited condition due to a deficiency of either lipoprotein lipase or apolipoprotein c-ii (a lipase-activating protein). The lack of lipase activities results in inability to remove chylomicrons and triglycerides from the blood which has a creamy top layer after standing.\nIntestinal fat transport defect with hypobetalipoproteinemia and accumulation of apolipoprotein b-like protein in intestinal cells, deficient blood apolipoproteins, and avitaminosis e manifested by malnutrition, steatorrhea, and growth and mental retardation. Some clinical (but not biochemical) manifestations may disappear later in life.\nRare familial condition characterized by massive chylomicronemia and decreased levels of other lipoproteins; due to deficiency of lipoprotein lipase, an alkaline triglyceride hydrolase which catalyzes an important step in the extrahepatic removal of triglyceride-rich lipoproteins from the blood."},
    {"ICD10Code":"E78.4","Description":"Other hyperlipidemia                                                                                                                                                                                                                                            Y","SearchInclusion":"Diabetes type 1 with hyperlipidemia\nFamilial combined hyperlipidemia\nFamilial hyperalphalipoproteinemia\nHyperalphalipoproteinemia, familial\nHyperlipidemia due to type 1 diabetes mellitus\nHyperlipidemia, familial combined","ClinicalNotes":"A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma cholesterol and/or triglycerides. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (upstream stimulatory factors) on chromosome 1."},
    {"ICD10Code":"E78.5","Description":"Hyperlipidemia, unspecified                                                                                                                                                                                                                                     Y","SearchInclusion":"Complex dyslipidemia\nDiabetes type 1 with dyslipidemia\nDiabetes type 1 with hyperlipidemia\nDiabetes type 2 low hdl and high triglyceride\nDiabetes type 2 with hyperlipidemia\nDyslipidemia\nDyslipidemia (high blood cholesterol/triglycerides)\nDyslipidemia due to type 1 diabetes mellitus\nDyslipidemia with high density lipoprotein below reference range and triglyceride above reference range due to type 2 diabetes mellitus\nDyslipidemia, complex\nElevated fasting lipid profile\nElevated lipid profile fasting\nHyperlipidemia\nHyperlipidemia (high blood fats)\nHyperlipidemia due to steroid\nHyperlipidemia due to type 1 diabetes mellitus\nHyperlipidemia due to type 2 diabetes mellitus\nHyperlipidemia, long term steroid use\nHyperlipoproteinemia\nNutrition therapy for hyperlipidemia done\nNutritional therapy for hyperlipidemia (cholesterol problem)","ClinicalNotes":"Conditions with excess lipids in the blood.\nExcess of lipids in the blood."},
    {"ICD10Code":"E78.6","Description":"Lipoprotein deficiency                                                                                                                                                                                                                                          Y","SearchInclusion":"Abetalipoproteinemia\nFamilial hypoalphalipoproteinemia\nFamilial hypobetalipoproteinemia\nFamilial lipoprotein lipase deficiency\nHigh density lipoid deficiency\nHigh density lipoprotein (hdl) deficiency\nHigh density lipoprotein deficiency\nHypo-beta-lipoproteinemia\nHypoalphalipoproteinemia, familial\nHypobetalipoproteinemia\nHypobetalipoproteinemia, familial\nLipoprotein deficiency disorder                                                                         Abetalipoproteinemia\nDepressed HDL cholesterol\nHigh-density lipoprotein deficiency\nHypoalphalipoproteinemia\nHypobetalipoproteinemia (familial)\nLecithin cholesterol acyltransferase deficiency\nTangier disease","ClinicalNotes":"A disorder of lipoprotein metabolism caused by mutations in the lcat gene. It is characterized by deficiency of the enzyme lecithin cholesterol acyltransferase. It is manifested with corneal opacity, hemolytic anemia, and proteinuria.\nA metabolic disorder characterized by deficiency of high density (alpha) lipoprotein in the blood.\nA rare, autosomal recessive inherited disorder of cholesterol transport, resulting in severe reduction of the amount of high density lipoprotein in the plasma and accumulation of cholesterol esters in the tissues. Signs and symptoms include large tonsils, hepatosplenomegaly, lymphadenopathy, and hypocholesterolemia.\nAn autosomal recessive disorder characterized by defective absorption of dietary fat, cholesterol and fat-soluble vitamins. It results in multiple vitamin deficiencies. Signs and symptoms include failure to thrive, diarrhea, steatorrhea, acanthocytosis and ataxia.\nAn autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (triglycerides; cholesterol esters; phospholipids) and is required in the secretion of beta-lipoproteins (low density lipoproteins or ldl). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent ldl.\nAn autosomal recessively inherited disorder caused by mutation of atp-binding cassette transporters involved in cellular cholesterol removal (reverse-cholesterol transport). It is characterized by near absence of alpha-lipoproteins (high-density lipoproteins) in blood. The massive tissue deposition of cholesterol esters results in hepatomegaly; splenomegaly; retinitis pigmentosa; large orange tonsils; and often sensory polyneuropathy. The disorder was first found among inhabitants of tangier island in the chesapeake bay, md.\nAn autosomal recessively inherited disorder caused by mutation of lecithin cholesterol acyltransferase that facilitates the esterification of lipoprotein cholesterol and subsequent removal from peripheral tissues to the liver. This defect results in low hdl-cholesterol level in blood and accumulation of free cholesterol in tissue leading to a triad of corneal opacity, hemolytic anemia (anemia, hemolytic), and proteinuria.\nAutosomal recessive disorder of lipoprotein and lipid metabolism characterized by absence in plasma of normal high-density lipoprotein, deficiency of apolipoproteins ai and aii, low to normal low-density lipoproteins, high triglycerides and accumulation in body tissues of cholesteryl esters.\nConditions with abnormally low levels of alpha-lipoproteins (high-density lipoproteins) in the blood. Hypoalphalipoproteinemia can be associated with mutations in genes encoding apolipoprotein a-i; lecithin cholesterol acyltransferase; and atp-binding cassette transporters.\nConditions with abnormally low levels of lipoproteins in the blood. This may involve any of the lipoprotein subclasses, including alpha-lipoproteins (high-density lipoproteins); beta-lipoproteins (low-density lipoproteins); and prebeta-lipoproteins (very-low-density lipoproteins).\nDisease characterized by abnormally low levels of plasma lecithin cholesterol acyl transferase; clinical manifestations include corneal opacity, anemia, and proteinuria.\nDisorder of lipid metabolism inherited as an autosomal recessive trait characterized by the near absence of apolipoprotein b and apob containing lipoproteins in plasma; microsomal triglyceride transfer protein is deficient or absent in enterocytes; clinical and laboratory findings include acanthocytosis, hypocholesterolemia, peripheral neuropathy, posterior column degeneration, ataxia, and steatorrhea; intellectual abilities may also be impaired.\nPresence of abnormally low levels of lipoproteins in the serum."},
    {"ICD10Code":"E78.70","Description":"Disorder of bile acid and cholesterol metabolism, unspecified                                                                                                                                                                                                   Y","SearchInclusion":"Bile acid and cholesterol metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E78.71","Description":"Barth syndrome","SearchInclusion":"3-methylglutaconic aciduria type 2","ClinicalNotes":"A rare x-linked syndrome caused by mutations in taz1 gene. Signs and symptoms include cardiomyopathy, neutropenia, muscle weakness and atrophy, growth delay, cardiolipin deficiency and 3-methylglutaconic aciduria.\nRare congenital x-linked disorder of lipid metabolism. Barth syndrome is transmitted in an x-linked recessive pattern. The syndrome is characterized by muscular weakness, growth retardation, dilated cardiomyopathy, variable neutropenia, 3-methylglutaconic aciduria (type ii) and decreases in mitochondrial cardiolipin level. Other biochemical and morphological mitochondrial abnormalities also exist."},
    {"ICD10Code":"E78.72","Description":"Smith-Lemli-Opitz syndrome","SearchInclusion":"Smith lemli opitz syndrome","ClinicalNotes":"A rare, autosomal recessive syndrome caused by mutations in the dhcr7 gene. It is characterized by deficiency of the enzyme 3 beta-hydroxysterol-delta 7-reductase resulting in defects in the cholesterol synthesis. It is manifested with multiple congenital malformations, including facial abnormalities, microcephaly, and syndactyly. Behavioral abnormalities may also be present.\nA syndrome with variable characteristics marked mainly by short stature, mental deficiency, microcephaly, postaxial polydactyly, cleft palate, cardiovascular defects, genital malformations, and other abnormalities associated with defective cholesterol metabolism. The fundamental biochemical abnormality appears to be a primary or secondary deficiency of 7-dhc-reductase (3-beta-hydroxysteroid-delta7-reductase causing deficient synthesis of cholesterol. Two types are recognized: type i comprising the milder manifestations. Type ii representing severe forms, consisting of male pseudohermaphroditism, polydactyly with frequent early lethality. The designation rsh represents initials of the surnames of the first three patients in whom the syndrome was first observed.\nAn autosomal recessive disorder of cholesterol metabolism. It is caused by a deficiency of 7-dehydrocholesterol reductase, the enzyme that converts 7-dehydrocholesterol to cholesterol, leading to an abnormally low plasma cholesterol. This syndrome is characterized by multiple congenital abnormalities, growth deficiency, and intellectual disability.\nAutosomal recessive disorder characterized by multiple congenital anomalies including microcephaly, mental retardation, unusual facies, and genital abnormalities; the biochemical defect is a lack of 7-dehydrocholesterol-delta-7-reductase, resulting in abnormally high levels of 7-dehydrocholesterol and low levels of cholesterol."},
    {"ICD10Code":"E78.79","Description":"Other disorders of bile acid and cholesterol metabolism                                                                                                                                                                                                         Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E78.81","Description":"Lipoid dermatoarthritis                                                                                                                                                                                                                                         Y","SearchInclusion":"","ClinicalNotes":"A rare disease where skin rashes containing lipid are associated with arthritis\nA systemic disease, often associated with arthritis, fever, and weight loss. The cutaneous lesions consist of histiocytes, which are usually confined to the dermis. A large number of patients develop malignant tumors (carcinomas, sarcomas, and lymphomas)."},
    {"ICD10Code":"E78.89","Description":"Other lipoprotein metabolism disorders                                                                                                                                                                                                                          Y","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E78.9","Description":"Disorder of lipoprotein metabolism, unspecified                                                                                                                                                                                                                 Y","SearchInclusion":"Abnormal lipid deposits\nCholesterol, abnormal\nDisorder of lipid metabolism\nLipid metabolism disorder\nSerum cholesterol abnormal","ClinicalNotes":""},
    {"ICD10Code":"E79.0","Description":"Hyperuricemia without signs of inflammatory arthritis and tophaceous disease","SearchInclusion":"Asymptomatic hyperuricemia\nHyperuricemia\nHyperuricemia (high uric acid in blood)","ClinicalNotes":""},
    {"ICD10Code":"E79.1","Description":"Lesch-Nyhan syndrome","SearchInclusion":"Lesch nyhan syndrome","ClinicalNotes":"An inborn error of metabolism resulting from a deficiency of hypoxanthine-guanine phosphoribosyltransferase (ec 2.4.2.8) with increased conversion of glycine to uric acid with excessive purine synthesis and hyperuricemia. Patients are normal at birth but begin to show hypertonicity at about 4 months and irritability and other neurological symptoms become apparent during the second year of life, the child becoming gradually more aggressive and self-destructive, banging his head, biting the lower lip and, less commonly, the upper lip, cheeks, fingers, and hands, sometimes using the fingers to mutilate his ears and nose. Associated disorders include spastic cerebral palsy, choreoathetosis, renal uric acid calculi, gouty tophi, and uric acid nodules. Mental retardation is common but normal intelligence occurs in some cases.\nAn inherited disorder transmitted as a sex-linked trait and caused by a deficiency of an enzyme of purine metabolism; hypoxanthine phosphoribosyltransferase. Affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures. Self-destructive behaviors such as biting of fingers and lips are seen frequently. Intellectual impairment may also occur but is typically not severe. Elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis.\nAn x-linked inherited syndrome caused by mutations in the gene that encodes the enzyme hypoxanthine-guanine phosphoribosyltransferase, resulting in accumulation of uric acid in the body. It affects males and is characterized by neurologic defects, moderate mental retardation, muscle hypotonia, and a tendency for self-mutilation (self-biting of lips, tongue, and fingertips).\nRare x-linked disorder of purine metabolism, due to deficiency of hypoxanthine phosphoribosyltransferase; affected individuals are normal in the first year of life and then develop psychomotor retardation, extrapyramidal movement disorders, progressive spasticity, and seizures; self-destructive behaviors such as biting of fingers and lips are seen frequently; intellectual impairment may also occur but is typically not severe; elevation of uric acid in the serum leads to the development of renal calculi and gouty arthritis."},
    {"ICD10Code":"E79.2","Description":"Myoadenylate deaminase deficiency","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E79.8","Description":"Other disorders of purine and pyrimidine metabolism","SearchInclusion":"Hereditary xanthinuria","ClinicalNotes":""},
    {"ICD10Code":"E79.9","Description":"Disorder of purine and pyrimidine metabolism, unspecified","SearchInclusion":"Disorder of purine and pyrimidine metabolism\nPurine and pyrimidine metabolism disorder","ClinicalNotes":"Condition in which there is a deviation or interruption in the processing of purine or pyrmidine in the body: its absorption, transport, storage, and utilization."},
    {"ICD10Code":"E80.0","Description":"Hereditary erythropoietic porphyria","SearchInclusion":"Congenital erythropoietic porphyria\nErythropoietic protoporphyria                                                                                                                    Congenital erythropoietic porphyria","ClinicalNotes":"A rare congenital metabolic disorder characterized by an inborn error of porphyrin-heme biosynthesis. It is caused by deficiency of the enzyme ferrochelatase. Signs and symptoms include painful cutaneous photosensitivity leading to blistering and scarring of the exposed skin areas, erythrodontia, red discoloration of urine, hemolytic anemia, and splenomegaly.\nA rare congenital metabolic disorder characterized by an inborn error of porphyrin-heme biosynthesis. It is caused by deficiency of the enzyme uroporphyrinogen iii cosynthetase. It results in cutaneous photosensitivity leading to blistering and scarring of the exposed skin areas.\nAn autosomal dominant porphyria that is due to a deficiency of ferrochelatase (heme synthetase) in both the liver and the bone marrow, the last enzyme in the 8-enzyme biosynthetic pathway of heme. Clinical features include mainly neurological symptoms, rarely cutaneous lesions, and elevated levels of protoporphyrin and coproporphyrins in the feces.\nAn autosomal recessive porphyria that is due to a deficiency of uroporphyrinogen iii synthase in the bone marrow; also known as congenital erythropoietic porphyria. This disease is characterized by splenomegaly; anemia; photosensitivity; cutaneous lesions; accumulation of hydroxymethylbilane; and increased excretion of uroporphyrins and coproporphyrins.\nAutosomal dominant disorder due to partial deficiency of ferrochelatase, characterized by an excess of protoporphyrin and a wide variety of photosensitive skin changes.\nAutosomal recessive porphyria characterized by splenomegaly, photosensitivity, hemolytic anemia, and the appearance of red urine in early infancy; results from increased synthesis of uroporphyrinogen i relative to uroporphyrinogen iii in bone marrow normoblasts."},
    {"ICD10Code":"E80.1","Description":"Porphyria cutanea tarda","SearchInclusion":"","ClinicalNotes":"An autosomal dominant or acquired porphyria due to a deficiency of uroporphyrinogen decarboxylase in the liver. It is characterized by photosensitivity and cutaneous lesions with little or no neurologic symptoms. Type i is the acquired form and is strongly associated with liver diseases and hepatic toxicities caused by alcohol or estrogenic steroids. Type ii is the familial form."},
    {"ICD10Code":"E80.20","Description":"Unspecified porphyria","SearchInclusion":"Disorder of porphyrin metabolism\nPorphyria\nPorphyrin metabolism disorder\nPorphyrinuria\nPorphyruria                                                                                                                                                           Porphyria NOS","ClinicalNotes":"A disease characterized by the presence of large amounts of porphyrins in the blood and urine\nA diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of heme in the liver, the bone marrow, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.\nA group of genetic or acquired metabolic disorders characterized by defects in the enzymes that are involved in the heme synthesis.\nGroup of disorders characterized by the excessive production of porphyrins or their precursors that arises from abnormalities in the regulation of the porphyrin-heme pathway; acquired porphyrias, which are due to inhibition of enzymes in the metabolic pathway by a drug, toxin or abnormal metabolite, are more common than those which are inherited.\nPorphyrias are a group of genetic disorders caused by problems with how your body makes a substance called heme. Heme is found throughout the body, especially in your blood and bone marrow, where it carries oxygen. Porphyrias affect the skin or the nervous system. People with the skin type develop blisters, itching, and swelling of their skin when it is exposed to sunlight. The nervous system type is called acute porphyria. Symptoms include pain in the chest or abdomen, vomiting, and diarrhea or constipation. During an attack, symptoms can include muscle numbness, tingling, paralysis, cramping, and personality or mental changes. Certain triggers can cause an attack, including some medicines, smoking, drinking alcohol, infections, stress and sun exposure. Attacks develop over hours or days. They can last for days or weeks. Porphyria can be hard to diagnose. It requires blood, urine and stool tests. Each type has a different treatment. It usually involves medicine, treatment with heme or drawing blood."},
    {"ICD10Code":"E80.21","Description":"Acute intermittent (hepatic) porphyria","SearchInclusion":"Acute intermittent porphyria","ClinicalNotes":""},
    {"ICD10Code":"E80.29","Description":"Other porphyria","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E80.3","Description":"Defects of catalase and peroxidase","SearchInclusion":"Acatalasia (takahara's disease)","ClinicalNotes":""},
    {"ICD10Code":"E80.4","Description":"Gilbert syndrome","SearchInclusion":"Gilbert's syndrome\nGilberts syndrome","ClinicalNotes":"A benign familial disorder, transmitted as an autosomal dominant trait. It is characterized by low-grade chronic hyperbilirubinemia with considerable daily fluctuations of the bilirubin level.\nAn autosomal recessive inherited disorder characterized by unconjugated hyperbilirubinemia, resulting in harmless intermittent jaundice."},
    {"ICD10Code":"E80.5","Description":"Crigler-Najjar syndrome","SearchInclusion":"Crigler najjar syndrome","ClinicalNotes":"A familial form of congenital hyperbilirubinemia transmitted as an autosomal recessive trait. It is characterized by icterus and brain damage caused by a glucuronyl transferase deficiency in the liver and faulty bilirubin conjugation.\nA rare autosomal recessive inherited syndrome characterized by abnormalities in the metabolism of bilirubin. It results in the development of jaundice. It may cause brain damage in infancy."},
    {"ICD10Code":"E80.6","Description":"Other disorders of bilirubin metabolism","SearchInclusion":"Dubin-Johnson syndrome\nRotor's syndrome                                                                                                                                                  Bilirubin excretion disorder\nDisorders of bilirubin excretion\nDubin johnson syndrome\nRotor syndrome","ClinicalNotes":"A benign, autosomally recessive inherited hyperbilirubinemia characterized by the presence of a dark pigment in the centrilobular region of the liver cells. There is a functional defect in biliary excretion of bilirubin, cholephilic dyes, and porphyrins. Affected persons may be asymptomatic or have vague constitutional or gastrointestinal symptoms. The liver may be slightly enlarged, and oral and intravenous cholangiography fails to visualize the biliary tract.\nAn inherited autosomal recessive disorder characterized by the presence of mild jaundice due to abnormalities in the bilirubin transportation from the liver parenchyma to the biliary system."},
    {"ICD10Code":"E80.7","Description":"Disorder of bilirubin metabolism, unspecified","SearchInclusion":"Bilirubin metabolism disorder\nDisorder of bilirubin metabolism\nElevated total bilirubin\nTotal bilirubin, elevated","ClinicalNotes":""},
    {"ICD10Code":"E83.00","Description":"Disorder of copper metabolism, unspecified","SearchInclusion":"Copper metabolism disorder\nDisorder of copper metabolism","ClinicalNotes":""},
    {"ICD10Code":"E83.01","Description":"Wilson's disease","SearchInclusion":"Bilateral kayser-fleischer rings\nKayser-fleischer ring, both eyes\nLeft kayser-fleischer ring\nLeft kayser-fleischer ring (eye condition)\nRight kayser-fleischer ring\nWilsons disease","ClinicalNotes":"A rare autosomal recessive disease characterized by the deposition of copper in the brain; liver; cornea; and other organs. It is caused by defects in the atp7b gene encoding copper-transporting atpase 2 (ec 3.6.3.4), also known as the wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as liver cirrhosis; tremor; ataxia and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years.\nA rare autosomal recessive inherited disorder caused by mutations in the atp7b gene. It is characterized by copper accumulation in the tissues, particularly brain and liver. It results in liver failure, neurologic, and psychotic manifestations.\nRare autosomal recessive disease characterized by the deposition of copper in the brain, liver, cornea and other organs; clinical features include liver cirrhosis, liver failure, splenomegaly, tremor, bradykinesia, dysarthria, chorea, muscle rigidity, kayser-fleischer rings (pigmented corneal lesions), ataxia and intellectual deterioration; hepatic dysfunction may precede neurologic dysfunction by several years.\nWilson disease is a rare inherited disorder that prevents your body from getting rid of extra copper. You need a small amount of copper from food to stay healthy. Too much copper is poisonous.normally, your liver releases extra copper into bile, a digestive fluid. With wilson disease, the copper builds up in your liver, and it releases the copper directly into your bloodstream. This can cause damage to your brain, kidneys, and eyes.wilson disease is present at birth, but symptoms usually start between ages 5 and 35. It first attacks the liver, the central nervous system or both. The most characteristic sign is a rusty brown ring around the cornea of the eye. A physical exam and laboratory tests can diagnose it.treatment is with drugs to remove the extra copper from your body. You need to take medicine and follow a low-copper diet for the rest of your life. Don't eat shellfish or liver, as these foods may contain high levels of copper. At the beginning of treatment, you'll also need to avoid chocolate, mushrooms, and nuts. Have your drinking water checked for copper content and don't take multivitamins that contain copper.with early detection and proper treatment, you can enjoy good health."},
    {"ICD10Code":"E83.09","Description":"Other disorders of copper metabolism","SearchInclusion":"Menkes kinky-hair syndrome\nMenkes syndrome","ClinicalNotes":""},
    {"ICD10Code":"E83.10","Description":"Disorder of iron metabolism, unspecified","SearchInclusion":"Disorder of iron metabolism\nIron metabolism disorder","ClinicalNotes":"Condition in which there is a deviation or interruption in the processing of iron in the body: its absorption, transport, storage, and utilization.\nDisorders in the processing of iron in the body: its absorption, transport, storage, and utilization."},
    {"ICD10Code":"E83.110","Description":"Hereditary hemochromatosis","SearchInclusion":"Bronzed diabetes\nPigmentary cirrhosis (of liver)\nPrimary (hereditary) hemochromatosis                                                       Hemochromatosis, hereditary","ClinicalNotes":"A condition in which the body takes up and stores more iron than it needs. The extra iron is stored in the liver, heart, and pancreas, which may cause liver disease, heart problems, organ failure, and cancer. It may also cause bronze skin, diabetes, pain in the joints and abdomen, tiredness, and impotence. Hemochromatosis may be inherited, or it may be caused by blood transfusions.\nA disorder due to the deposition of hemosiderin in the parenchymal cells, causing tissue damage and dysfunction of the liver, pancreas, heart, and pituitary. Full development of the disease in women is restricted by menstruation, pregnancy, and lower dietary intake of iron. Acquired hemochromatosis may be the result of blood transfusions, excessive dietary iron, or secondary to other disease. Idiopathic or genetic hemochromatosis is an autosomal recessive disorder of metabolism associated with a gene tightly linked to the a locus of the hla complex on chromosome 6. (from Dorland, 27th ed)\nAn inherited metabolic disorder characterized by iron accumulation in the tissues.\nCondition in which there is a deviation or interruption in the storage of iron in the body.\nDisorder due to the deposition of hemosiderin in the parenchymal cells, causing tissue damage and dysfunction of the liver, pancreas, heart, and pituitary; full development of the disease in women is restricted by menstruation, pregnancy, and lower dietary intake of iron; an autosomal recessive disorder of metabolism associated with a gene tightly linked to the a locus of the hla complex on chromosome 6.\nHemochromatosis is an inherited disease in which too much iron builds up in your body. It is one of the most common genetic diseases in the United States. iron is a mineral found in many foods. Your body normally absorbs about 10 percent of the iron in the food you eat. If you have hemochromatosis, you absorb more iron than you need. Your body has no natural way to get rid of the extra iron. It stores it in body tissues, especially the liver, heart and pancreas. The extra iron can damage your organs. Without treatment, it can cause your organs to fail. The most common treatment is to remove some blood, just like when you donate blood. This is called therapeutic phlebotomy. Medicines may also help remove the extra iron. Your doctor might suggest some changes in your diet.\nWhat: hemochromatosis: hemochromatosis: a disorder of iron metabolism characterized by excess deposition of iron in the tissues, especially the liver. It is characterized by pigmentation of the skin, hepatic cirrhosis, decreased carbohydrate tolerance, cardiomyopathy and endocrinopathy (especially hypogonadism). Mainly seen in men over the age of 40 years. It has an associated arthropathy distinguished by involvement of the metacarpophalangeal joints (particularly the second and third), wrists, knees, shoulders, and hips. There is often an associated chondrocalcinosis. Why: hemochromatosis is an autosomal recessive disease that produces an arthritis similar to osteoarthritis or pseudogout. How: hemochromatosis is diagnosed by the typical physical and radiographic findings supported by elevated serum iron concentrations and high transferrin saturations. Serum ferritin is also markedly elevated. Confirmation of the diagnosis can be done by demonstrating hepatic iron deposition on liver biopsy."},
    {"ICD10Code":"E83.111","Description":"Hemochromatosis due to repeated red blood cell transfusions","SearchInclusion":"Iron overload due to repeated red blood cell transfusions\nTransfusion (red blood cell) associated hemochromatosis  Hemochromatosis due to red blood cell transfusions\nHemochromatosis due to repeated red blood cell transfusion\nTransfusion hemosiderosis\nTransfusion induced iron overload","ClinicalNotes":""},
    {"ICD10Code":"E83.118","Description":"Other hemochromatosis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E83.119","Description":"Hemochromatosis, unspecified","SearchInclusion":"Hemochromatosis","ClinicalNotes":"A condition in which the body takes up and stores more iron than it needs. The extra iron is stored in the liver, heart, and pancreas, which may cause liver disease, heart problems, organ failure, and cancer. It may also cause bronze skin, diabetes, pain in the joints and abdomen, tiredness, and impotence. Hemochromatosis may be inherited, or it may be caused by blood transfusions.\nA disorder due to the deposition of hemosiderin in the parenchymal cells, causing tissue damage and dysfunction of the liver, pancreas, heart, and pituitary. Full development of the disease in women is restricted by menstruation, pregnancy, and lower dietary intake of iron. Acquired hemochromatosis may be the result of blood transfusions, excessive dietary iron, or secondary to other disease. Idiopathic or genetic hemochromatosis is an autosomal recessive disorder of metabolism associated with a gene tightly linked to the a locus of the hla complex on chromosome 6. (from Dorland, 27th ed)\nAn inherited metabolic disorder characterized by iron accumulation in the tissues.\nCondition in which there is a deviation or interruption in the storage of iron in the body.\nHemochromatosis is an inherited disease in which too much iron builds up in your body. It is one of the most common genetic diseases in the United States. iron is a mineral found in many foods. Your body normally absorbs about 10 percent of the iron in the food you eat. If you have hemochromatosis, you absorb more iron than you need. Your body has no natural way to get rid of the extra iron. It stores it in body tissues, especially the liver, heart and pancreas. The extra iron can damage your organs. Without treatment, it can cause your organs to fail. The most common treatment is to remove some blood, just like when you donate blood. This is called therapeutic phlebotomy. Medicines may also help remove the extra iron. Your doctor might suggest some changes in your diet.\nWhat: hemochromatosis: hemochromatosis: a disorder of iron metabolism characterized by excess deposition of iron in the tissues, especially the liver. It is characterized by pigmentation of the skin, hepatic cirrhosis, decreased carbohydrate tolerance, cardiomyopathy and endocrinopathy (especially hypogonadism). Mainly seen in men over the age of 40 years. It has an associated arthropathy distinguished by involvement of the metacarpophalangeal joints (particularly the second and third), wrists, knees, shoulders, and hips. There is often an associated chondrocalcinosis. Why: hemochromatosis is an autosomal recessive disease that produces an arthritis similar to osteoarthritis or pseudogout. How: hemochromatosis is diagnosed by the typical physical and radiographic findings supported by elevated serum iron concentrations and high transferrin saturations. Serum ferritin is also markedly elevated. Confirmation of the diagnosis can be done by demonstrating hepatic iron deposition on liver biopsy."},
    {"ICD10Code":"E83.19","Description":"Other disorders of iron metabolism","SearchInclusion":"Hemosiderosis\nIdiopathic pulmonary hemosiderosis\nPulmonary hemosiderosis, idiopathic","ClinicalNotes":""},
    {"ICD10Code":"E83.2","Description":"Disorders of zinc metabolism","SearchInclusion":"Disorder of zinc metabolism\nZinc metabolism disorder","ClinicalNotes":"Severe human skin and gastrointestinal disease inherited as a recessive autosomal trait that is characterized by the symptoms of zinc deficiency and clears up when zinc is added to the diet."},
    {"ICD10Code":"E83.30","Description":"Disorder of phosphorus metabolism, unspecified","SearchInclusion":"Disorder of phosphorus metabolism\nDisorders of phosphorus metabolism","ClinicalNotes":""},
    {"ICD10Code":"E83.31","Description":"Familial hypophosphatemia","SearchInclusion":"Vitamin D-resistant osteomalacia\nVitamin D-resistant rickets                                                                                                   Familial x-linked hypophosphatemic vitamin d refractory rickets\nRickets, hypophosphatemic vit d refractory, familial","ClinicalNotes":"An inherited condition of abnormally low serum levels of phosphates (below 1 mg/liter) which can occur in a number of genetic diseases with defective reabsorption of inorganic phosphorus by the proximal renal tubules. This leads to phosphaturia, hypophosphatemia, and disturbances of cellular and organ functions such as those in x-linked hypophosphatemic rickets; osteomalacia; and fanconi syndrome."},
    {"ICD10Code":"E83.32","Description":"Hereditary vitamin D-dependent rickets (type 1) (type 2)","SearchInclusion":"25-hydroxyvitamin D 1-alpha-hydroxylase deficiency\nPseudovitamin D deficiency\nVitamin D receptor defect                                                                                        Hereditary vitamin d dependent rickets type 2\nVitamin d-dependent rickets, type 2","ClinicalNotes":""},
    {"ICD10Code":"E83.39","Description":"Other disorders of phosphorus metabolism","SearchInclusion":"Acid phosphatase deficiency\nHypophosphatasia                                                                                                                                       Hyperphosphatemia\nHyperphosphatemia (high phosphate level)\nHypophosphatasia\nHypophosphatemia\nHypophosphatemia (low phosphorus level)\nRickets, hypophosphatasia","ClinicalNotes":"A genetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia. Clinical manifestations include severe skeletal defects resembling vitamin d-resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes. (from Dorland, 27th ed)\nA rare, serious metabolic disorder caused by mutations in the gene encoding tissue non-specific alkaline phosphatase (tnsalp) activity. It is characterized by low activity of tnsalp in the serum. The signs and symptoms vary significantly and include death in utero, failure to thrive, premature loss of deciduous teeth, early loss of the adult dentition, hypercalcemia, osteomalacia, skeletal defects, renal stones, and movement disorders.\nGenetic metabolic disorder resulting from serum and bone alkaline phosphatase deficiency leading to hypercalcemia, ethanolamine phosphatemia, and ethanolamine phosphaturia; manifestations include severe skeletal defects resembling vitamin d resistant rickets, failure of the calvarium to calcify, dyspnea, cyanosis, vomiting, constipation, renal calcinosis, failure to thrive, disorders of movement, beading of the costochondral junction, and rachitic bone changes."},
    {"ICD10Code":"E83.40","Description":"Disorders of magnesium metabolism, unspecified","SearchInclusion":"Disorder of magnesium metabolism\nMagnesium metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E83.41","Description":"Hypermagnesemia","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E83.42","Description":"Hypomagnesemia","SearchInclusion":"\nHypomagnesemia (low magnesium level)","ClinicalNotes":"A disorder characterized by laboratory test results that indicate a low concentration of magnesium in the blood.\nLower than normal levels of magnesium in the circulating blood."},
    {"ICD10Code":"E83.49","Description":"Other disorders of magnesium metabolism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E83.50","Description":"Unspecified disorder of calcium metabolism","SearchInclusion":"Calcium metabolism disorder\nDisorder of calcium metabolism\nHypercalciuria\nHypercalciuria (excess calcium in urine)","ClinicalNotes":"Disorders in the processing of calcium in the body: its absorption, transport, storage, and utilization."},
    {"ICD10Code":"E83.51","Description":"Hypocalcemia","SearchInclusion":"Hypocalcemia (low calcium level)","ClinicalNotes":"A disorder characterized by laboratory test results that indicate a low concentration of calcium in the blood.\nLower than normal levels of calcium in the circulating blood.\nReduction of the blood calcium below normal. Manifestations include hyperactive deep tendon reflexes, chvostek's sign, muscle and abdominal cramps, and carpopedal spasm. (Dorland, 27th ed)\nReduction of the blood calcium below normal; manifestations include hyperactive deep tendon reflexes, muscle and abdominal cramps, and carpopedal spasm."},
    {"ICD10Code":"E83.52","Description":"Hypercalcemia","SearchInclusion":"Hypercalcemia (excess calcium in blood)\nHypocalciuric hypercalcemia                                                                                              Familial hypocalciuric hypercalcemia","ClinicalNotes":"A disorder characterized by laboratory test results that indicate an elevation in the concentration of calcium in blood.\nAbnormally high concentration of calcium in the peripheral blood.\nAbnormally high level of calcium in the blood.\nAbnormally high level of calcium in the blood; manifestations include fatigability, muscle weakness, depression, anorexia, nausea, and constipation.\nHigh level of calcium in the blood\nHigher than normal levels of calcium in the blood. Some types of cancer increase the risk of hypercalcemia."},
    {"ICD10Code":"E83.59","Description":"Other disorders of calcium metabolism","SearchInclusion":"Calcinosis\nCalciphylaxis\nNephrocalcinosis\nNephrocalcinosis (excess calcium in kidneys)\nSubcutaneous calcification\nSubcutaneous calcinosis                                                                                                                                     Idiopathic hypercalciuria","ClinicalNotes":""},
    {"ICD10Code":"E83.81","Description":"Hungry bone syndrome","SearchInclusion":"Hungry bones syndrome","ClinicalNotes":""},
    {"ICD10Code":"E83.89","Description":"Other disorders of mineral metabolism","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E83.9","Description":"Disorder of mineral metabolism, unspecified","SearchInclusion":"Disorder of mineral metabolism\nMineral metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E84.0","Description":"Cystic fibrosis with pulmonary manifestations","SearchInclusion":"Cystic fibrosis of the lung\nCystic fibrosis, pulmonary","ClinicalNotes":""},
    {"ICD10Code":"E84.11","Description":"Meconium ileus in cystic fibrosis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E84.19","Description":"Cystic fibrosis with other intestinal manifestations","SearchInclusion":"Distal intestinal obstruction syndrome                                                                              Cystic fibrosis with intestinal manifestation\nCystic fibrosis with intestinal manifestations","ClinicalNotes":""},
    {"ICD10Code":"E84.8","Description":"Cystic fibrosis with other manifestations","SearchInclusion":"Cystic fibrosis related to diabetes\nCystic fibrosis related to liver dis\nDiabetes mellitus due to cystic fibrosis\nLiver disease due to cystic fibrosis","ClinicalNotes":""},
    {"ICD10Code":"E84.9","Description":"Cystic fibrosis, unspecified","SearchInclusion":"Cystic fibrosis","ClinicalNotes":"A common hereditary disease in which exocrine (secretory) glands produce abnormally thick mucus. This mucus can cause problems in digestion, breathing, and body cooling.\nA congenital metabolic disorder affecting the exocrine glands, inherited as an autosomal trait. The secretions of exocrine glands are abnormal, resulting in excessively viscid mucus production which causes obstruction of passageways (including pancreatic and bile ducts, intestines, and bronchi). The sweat sodium and chloride content are increased. Symptoms usually appear in childhood and include meconium ileus, poor growth despite good appetite, malabsorption and foul bulky stools, chronic bronchitis with cough, recurrent pneumonia, bronchiectasis, emphysema, clubbing of the fingers, and salt depletion in hot weather.\nAn autosomal recessive genetic disease of the exocrine glands. It is caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator expressed in several organs including the lung, the pancreas, the biliary system, and the sweat glands. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in airway obstruction; chronic respiratory infections; pancreatic insufficiency; maldigestion; salt depletion; and heat prostration.\nCystic fibrosis (cf) is an inherited disease of the mucus and sweat glands. It affects mostly your lungs, pancreas, liver, intestines, sinuses and sex organs. Cf causes your mucus to be thick and sticky. The mucus clogs the lungs, causing breathing problems and making it easy for bacteria to grow. This can lead to problems such as repeated lung infections and lung damage. The symptoms and severity of cf vary widely. Some people have serious problems from birth. Others have a milder version of the disease that doesn't show up until they are teens or young adults. Although there is no cure for cf, treatments have improved greatly in recent years. Until the 1980s, most deaths from cf occurred in children and teenagers. Today, with improved treatments, some people who have cf are living into their forties, fifties, or older.\nMost common potentially lethal autosomal recessive disease affecting caucasians; characterized by chronic pulmonary, intestinal, liver, pancreatic, and exocrine gland dysfunction; caused by mutations of the cftr chloride channel."},
    {"ICD10Code":"E85.0","Description":"Non-neuropathic heredofamilial amyloidosis","SearchInclusion":"Hereditary amyloid nephropathy                                                                                             Familial mediterranean fever\nFamilial non-neuropathic amyloidosis\nNonneuropathic heredofamilial amyloidosis","ClinicalNotes":"A group of hereditary autoinflammation diseases, characterized by recurrent fever, abdominal pain, headache, rash, pleurisy; and arthritis. Orchitis; benign meningitis; and amyloidosis may also occur. Homozygous or compound heterozygous mutations in marenostrin gene result in autosomal recessive transmission; simple heterozygous, autosomal dominant form of the disease.\nA usually autosomal recessive inherited inflammatory disorder caused by mutations in the mefv gene. It is characterized by recurrent painful inflammatory attacks in the abdomen, joints, and chest. The inflammatory attacks are associated with fever."},
    {"ICD10Code":"E85.1","Description":"Neuropathic heredofamilial amyloidosis","SearchInclusion":"Familial amyloid polyneuropathy","ClinicalNotes":"A rare inherited neuropathy characterized by deposition of amyloid in the peripheral nerves.\nInherited disorders of the peripheral nervous system associated with the deposition of amyloid in nerve tissue. The different clinical types based on symptoms correspond to the presence of a variety of mutations in several different proteins including transthyretin (prealbumin); apolipoprotein a-i; and gelsolin."},
    {"ICD10Code":"E85.2","Description":"Heredofamilial amyloidosis, unspecified","SearchInclusion":"Heredofamilial amyloidosis","ClinicalNotes":""},
    {"ICD10Code":"E85.3","Description":"Secondary systemic amyloidosis","SearchInclusion":"Hemodialysis-associated amyloidosis","ClinicalNotes":""},
    {"ICD10Code":"E85.4","Description":"Organ-limited amyloidosis","SearchInclusion":"Cardiac amyloidosis\nCerebral amyloid angiopathy\nCutaneous amyloidosis\nLichen amyloidosis\nOrgan limited amyloidosis\nSenile cardiac amyloidosis","ClinicalNotes":"Localized amyloidosis\nTransthyretin-related (ATTR) familial amyloid cardiomyopathy"},
    {"ICD10Code":"E85.81","Description":"Light chain (AL) amyloidosis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E85.82","Description":"Wild-type transthyretin-related (ATTR) amyloidosis","SearchInclusion":"Senile systemic amyloidosis (SSA)","ClinicalNotes":""},
    {"ICD10Code":"E85.89","Description":"Other amyloidosis","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E85.9","Description":"Amyloidosis, unspecified","SearchInclusion":"Amyloidosis","ClinicalNotes":"A disorder characterized by the localized or diffuse accumulation of amyloid protein in various anatomic sites. It may be primary, due to clonal plasma cell proliferations; secondary, due to long standing infections, chronic inflammatory disorders, or malignancies; or familial. It may affect the nerves, skin, tongue, joints, heart, liver, spleen, kidneys and adrenal glands.\nA group of diseases in which protein builds up in certain organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis may be either primary (with no known cause), secondary (caused by another disease, including some types of cancer, such as multiple myeloma), or hereditary (passed down from parents to children). Many organs are affected by amyloidosis. The organs affected may depend on whether the amyloidosis is the primary, secondary, or hereditary form.\nA group of diseases in which protein is deposited in specific organs (localized amyloidosis) or throughout the body (systemic amyloidosis). Amyloidosis may be either primary (plasma cell neoplasm) or secondary (caused by a long standing infection or another disease or some types of cancer). Generally, primary amyloidosis affects the nerves, skin, tongue, joints, heart, and liver; secondary amyloidosis often affects the spleen, kidneys, liver, and adrenal glands.\nA group of diseases in which protein is deposited in specific organs or throughout the body.\nA group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of amyloid. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.\nAmyloidosis occurs when abnormal proteins build up and form deposits. The deposits can collect in organs such as the kidney and heart. This can cause the organs to become stiff and unable to work the way they should. There are three main types of amyloidosis:\nprimary - with no known cause\nsecondary - caused by another disease, including some types of cancer\nfamilial - passed down through genes\ntreatment depends on the type of amyloidosis you have.\nAny disease manifested by the pathogenic accumulation of amyloid in organs and tissues."},
    {"ICD10Code":"E86.0","Description":"Dehydration","SearchInclusion":"Dehydration due to radiation\nDehydration hypernatremic\nDehydration secondary to radiation\nDehydration, mild\nDehydration, moderate\nDehydration, severe\nHypernatremic dehydration\nMild dehydration\nModerate dehydration\nSevere dehydration","ClinicalNotes":"A condition caused by the loss of too much water from the body. Severe diarrhea or vomiting can cause dehydration.\nA condition resulting from the excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.\nA disorder characterized by excessive loss of water from the body. It is usually caused by severe diarrhea, vomiting or diaphoresis.\nCondition that results from excessive loss of water from a living organism.\nDecreased intravascular, interstitial, and/or intracellular fluid. This refers to dehydration, water loss alone without change in sodium.\nState of excessively reduced body water or water deficit.\nThe condition that results from excessive loss of water from a living organism.\nWhen you're dehydrated, your body doesn't have enough fluid to work properly. An average person on an average day needs about 3 quarts of water. But if you're out in the hot sun, you'll need a lot more than that. Most healthy bodies are very good at regulating water. Elderly people, young children and some special cases - like people taking certain medications - need to be a little more careful.signs of dehydration in adults include\nbeing thirsty\nurinating less often than usual\ndark-colored urine\ndry skin\nfeeling tired\ndizziness and fainting\nsigns of dehydration in babies and young children include a dry mouth and tongue, crying without tears, no wet diapers for 3 hours or more, a high fever and being unusually sleepy or drowsy.if you think you're dehydrated, drink small amounts of water over a period of time. Taking too much all at once can overload your stomach and make you throw up. For people exercising in the heat and losing a lot of minerals in sweat, sports drinks can be helpful. Avoid any drinks that have caffeine."},
    {"ICD10Code":"E86.1","Description":"Hypovolemia","SearchInclusion":"Depletion of volume of plasma","ClinicalNotes":"Abnormally decreased volume of circulating fluid (plasma) in body.\nAbnormally decreased volume of circulating fluid (plasma) in the body.\nAn abnormally low volume of blood circulating through the body. It may result in hypovolemic shock (see shock)."},
    {"ICD10Code":"E86.9","Description":"Volume depletion, unspecified","SearchInclusion":"Hypovolemia\nVolume depletion","ClinicalNotes":"Abnormally decreased volume of circulating fluid (plasma) in body.\nAbnormally decreased volume of circulating fluid (plasma) in the body.\nAn abnormally low volume of blood circulating through the body. It may result in hypovolemic shock (see shock)."},
    {"ICD10Code":"E87.0","Description":"Hyperosmolality and hypernatremia","SearchInclusion":"Sodium [Na] excess\nSodium [Na] overload                                                                                                                                                                         Dehydration hypernatremic\nDiabetes type 1 with hyperosmolarity\nHypernatremia\nHypernatremia (high sodium level)\nHypernatremic dehydration\nHyperosmolality\nHyperosmolality with hypernatremia\nHyperosmolarity\nHyperosmolarity due to type 1 diabetes mellitus","ClinicalNotes":"Excessive amount of sodium in the blood.\nExcessive amount of sodium in the blood"},
    {"ICD10Code":"E87.1","Description":"Hypo-osmolality and hyponatremia","SearchInclusion":"Hyponatremia\nHyponatremia (low sodium level)\nHyposmolality                                                                                                                                                           Sodium [Na] deficiency","ClinicalNotes":"A disorder characterized by laboratory test results that indicate a low concentration of sodium in the blood.\nAbnormally low blood sodium level.\nAbnormally low sodium levels in the blood; salt depletion.\nDeficiency of sodium in the blood; salt depletion.\nLower than normal levels of sodium in the circulating blood."},
    {"ICD10Code":"E87.2","Description":"Acidosis","SearchInclusion":"Acidosis NOS\nLactic acidosis\nMetabolic acidosis\nRespiratory acidosis                                                                                                                                Alcoholic ketoacidosis\nDiabetes, type 2 with ketoacidosis\nKetoacidosis due to acute alcohol intoxication\nKetoacidosis in type 2 diabetes mellitus\nKetoacidosis in type ii diabetes mellitus\nLactic acidosis\nMetabolic acidosis\nMetabolic acidosis, increased anion gap (iag)\nRespiratory acidosis","ClinicalNotes":"A condition in which the blood is too acidic. It may be caused by severe illness or sepsis (bacteria in the bloodstream).\nA disorder characterized by abnormally high acidity (high hydrogen-ion concentration) of the blood and other body tissues.\nA pathologic condition of acid accumulation or depletion of base in the body. The two main types are respiratory acidosis and metabolic acidosis, due to metabolic acid build up.\nA state due to excess retention of carbon dioxide in the body.\nAcid base imbalance resulting from an accumulation of carbon dioxide secondary to hypoventilation.\nAcidosis caused by accumulation of lactic acid more rapidly than it can be metabolized. It may occur spontaneously or in association with diseases such as diabetes mellitus, leukemia, or liver failure.\nAcidosis caused by accumulation of lactic acid more rapidly than it can be metabolized; may occur spontaneously or in association with diseases such as diabetes mellitus, leukemia, or liver failure.\nAn abnormal increase in the acidity of the body's fluids\nAn abnormally high acidity (excess hydrogen-ion concentration) of the blood and other body tissues.\nAn abnormally high acidity of the blood and other body tissues. Acidosis can be either respiratory or metabolic.\nExcess retention of carbon dioxide in the body resulting from ventilatory impairment.\nIncreased acidity in the blood secondary to acid base imbalance. Causes include diabetes, kidney failure and shock.\nMetabolic acidosis characterized by the accumulation of lactate in the body. It is caused by tissue hypoxia.\nPathologic condition resulting from accumulation of acid or depletion of the alkaline reserve (bicarbonate) content of the blood and body tissues, and characterized by an increase in hydrogen ion concentration (decrease in ph).\nRespiratory retention of carbon dioxide. It may be chronic or acute."},
    {"ICD10Code":"E87.3","Description":"Alkalosis","SearchInclusion":"Alkalosis NOS\nMetabolic alkalosis\nRespiratory alkalosis                                                                                                                  Acute respiratory alkalosis\nAlkalosis, acute respiratory\nMetabolic alkalosis","ClinicalNotes":"A disorder characterized by abnormally high alkalinity (low hydrogen-ion concentration) of the blood and other body tissues.\nA pathologic condition resulting from accumulation of base, or from loss of acid without comparable loss of base in the body fluids, and characterized by decrease in hydrogen ion concentration.\nA pathological condition that removes acid or adds base to the body fluids.\nA state due to excess loss of carbon dioxide from the body. \nAn abnormally high alkalinity (low hydrogen-ion concentration) of the blood and other body tissues.\nCondition characterized by excessive loss of carbon dioxide from the body, often as a result of hyperventilation due to psychogenic or physical factors.\nPathological condition that removes acid or adds base to the body fluids."},
    {"ICD10Code":"E87.4","Description":"Mixed disorder of acid-base balance","SearchInclusion":"Hypercapnia with mixed acid base disorder\nMixed acid base balance disorder","ClinicalNotes":""},
    {"ICD10Code":"E87.5","Description":"Hyperkalemia","SearchInclusion":"Potassium [K] excess\nPotassium [K] overload                                                                                                                                                 Drug-induced hyperkalemia\nHyperkalemia (high potassium level)\nHyperkalemia due to angiotensin-converting enzyme inhibitor\nHyperkalemia, ace inhibitor induced\nHyperkalemia, drug induced\nPotassium intoxication","ClinicalNotes":"A disorder characterized by laboratory test results that indicate an elevation in the concentration of potassium in the blood; associated with kidney failure or sometimes with the use of diuretic drugs.\nAbnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated t waves and depressed p waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. \nAbnormally high potassium concentration in the blood, most often due to defective renal excretion; characterized clinically by electrocardiographic abnormalities; in severe cases, weakness and flaccid paralysis may occur.\nHigher than normal levels of potassium in the circulating blood; associated with kidney failure or sometimes with the use of diuretic drugs."},
    {"ICD10Code":"E87.6","Description":"Hypokalemia","SearchInclusion":"Potassium [K] deficiency                                                                                                       Chronic hypokalemia\nHypokalemia (low potassium level)\nHypokalemia chronic\nHypokalemic alkalosis due to diarrhea\nVerner morrison syndrome","ClinicalNotes":"A disorder characterized by laboratory test results that indicate a low concentration of potassium in the blood.\nAbnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the t wave and elevation of the u wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed)\nAbnormally low potassium concentration in the blood; may result from excessive potassium loss by the renal or gastrointestinal route, from decreased intake, or from transcellular shifts; manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities, and by renal and gastrointestinal disorders.\nHypokalemia; lower than normal levels of potassium in the circulating blood.\nLower than normal levels of potassium in the circulating blood."},
    {"ICD10Code":"E87.70","Description":"Fluid overload, unspecified","SearchInclusion":"Hypervolemia\nHypervolemia (fluid overload)","ClinicalNotes":"Abnormal increase in the volume of circulating fluid (plasma) in the body.\nFluid retention, overload, or edema\nIncreased isotonic fluid retention"},
    {"ICD10Code":"E87.71","Description":"Transfusion associated circulatory overload","SearchInclusion":"Fluid overload due to transfusion (blood) (blood components)\nTACO                                                                                                                                                 Circulatory overload due to transfusion\nTransfusion reaction due to excess volume","ClinicalNotes":""},
    {"ICD10Code":"E87.79","Description":"Other fluid overload","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E87.8","Description":"Other disorders of electrolyte and fluid balance, not elsewhere classified","SearchInclusion":"Electrolyte imbalance NOS\nHyperchloremia\nHypochloremia                                                                                                                                                       Electrolyte imbalance\nFluid volume disorder","ClinicalNotes":"Abnormally low level of chloride in the blood.\nHigher or lower body electrolyte levels\"\nHigher or lower than normal values for the serum electrolytes; usually affecting na, k, chl, co2, glucose, bun."},
    {"ICD10Code":"E88.01","Description":"Alpha-1-antitrypsin deficiency","SearchInclusion":"Alpha 1 antitrypsin deficiency                                                                                                                                       AAT deficiency","ClinicalNotes":"A genetic disorder characterized by decreased alpha-1 antitrypsin activity in the lungs and blood and deposition of alpha-1 antitrypsin protein in the hepatocytes. These abnormalities result from defective production of alpha-1 antitrypsin and lead to the development of emphysema, cirrhosis, and liver failure.\nAlpha-1 antitrypsin deficiency is an inherited disorder that can cause lung disease in adults and liver disease in adults and children. Alpha-1 antitrypsin (aat) is a protein that protects the lungs. The liver usually makes the protein, and releases it into the bloodstream. Because of a gene problem, some people have little or none of it. Not having enough aat puts you at risk of emphysema or liver problems. If you smoke, you increase your risk. Children with aat deficiency can develop liver problems that last their whole lives. Aat deficiency can be treated but not cured. One treatment involves adding to or replacing the missing protein. A lung transplant may be an option if you are seriously ill. Staying away from cigarette smoke is crucial.a blood test can tell if you have the deficiency. If you have it, your family members should also take the blood test.\nAutosomal recessive trait leading to destruction of lung tissue by neutrophil elastase and eventual emphysema; second only to cystic fibrosis as most common lethal genetic disorder among caucasians of northern european ancestry.\nDeficiency of the protease inhibitor alpha 1-antitrypsin that manifests primarily as pulmonary emphysema and liver cirrhosis."},
    {"ICD10Code":"E88.09","Description":"Other disorders of plasma-protein metabolism, not elsewhere classified","SearchInclusion":"Bisalbuminemia                                                                                                                                Atypical pseudocholinesterase deficiency\nDyscrasia, plasma cell\nHypoalbuminemia\nHypoalbuminemia (low blood albumin level)\nHypoalbuminemia due to protein calorie malnutrition\nLight chain nephropathy due to plasma cell dyscrasia\nPlasma cell neoplasm\nPlasma protein metabolism disorder\nProtein-calorie malnutrition with hypoalbuminemia\nPseudocholinesterase deficiency","ClinicalNotes":""},
    {"ICD10Code":"E88.1","Description":"Lipodystrophy, not elsewhere classified","SearchInclusion":"Congenital lipodystrophy\nFamilial partial lipodystrophy\nHiv lipoatrophy\nLipoatrophy due to hiv infection and treatment\nLipodystrophy\nLipodystrophy of face\nLipodystrophy, congenital\nLipodystrophy, facial","ClinicalNotes":"A collection of heterogenous conditions resulting from defective lipid metabolism and characterized by adipose tissue atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.\nA congenital or acquired disorder characterized by abnormal loss or redistribution of the adipose tissue in the body.\nCollection of rare conditions resulting from defective fat metabolism and characterized by atrophy of the subcutaneous fat; includes total, congenital or acquired, partial, abdominal infantile, and localized lipodystrophy."},
    {"ICD10Code":"E88.2","Description":"Lipomatosis, not elsewhere classified","SearchInclusion":"Lipomatosis NOS\nLipomatosis (Check) dolorosa [Dercum]                                                                           Benign familial lipomatosis\nFamilial multiple lipomata\nLipomatosis","ClinicalNotes":"A disorder characterized by the accumulation of encapsulated or unencapsulated tumor-like fatty tissue resembling lipoma.\nA rare disease characterized by multiple tumor-like fatty deposits that press on nerves in various sites causing pain and weakness. Often these lipoma-like structures are located on the trunk and limbs but sparing the face and hands.\nA rare genetic disorder characterized by the development of painful lipomas during adulthood, especially in menopausal women. Associated symptoms include fatigue, obesity, confusion and depression."},
    {"ICD10Code":"E88.3","Description":"Tumor lysis syndrome","SearchInclusion":"Tumor lysis syndrome (spontaneous)\nTumor lysis syndrome following antineoplastic drug chemotherapy","ClinicalNotes":"A condition of metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells. Tumor lysis syndrome typically occurs in aggressive, rapidly proliferating lymphoproliferative disorders. Burkitt lymphoma and t cell acute lymphoblastic leukemia are commonly associated with this syndrome. Metabolic abnormalities include hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia and may result in renal failure, multiple organ failure, and death.\nA condition that can occur after treatment of a fast-growing cancer, especially certain leukemias and lymphomas (cancers of the blood). As tumor cells die, they break apart and release their contents into the blood. This causes a change in certain chemicals in the blood, which may cause damage to organs, including the kidneys, heart, and liver.\nA disorder characterized by metabolic abnormalities that result from a spontaneous or therapy-related cytolysis of tumor cells.\nA syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia."},
    {"ICD10Code":"E88.40","Description":"Mitochondrial metabolism disorder, unspecified","SearchInclusion":"Defect, mitochondrial metabolism\nMitochondrial metabolism defect\nMitochondrial mutation","ClinicalNotes":""},
    {"ICD10Code":"E88.41","Description":"MELAS syndrome","SearchInclusion":"Juvenile myopathy, encephalopathy, lactic acidosis and stroke\nMitochondrial encephalopathy, lactic acidosis, stroke","ClinicalNotes":"A mitochondrial disorder characterized by focal or generalized seizures, episodes of transient or persistent neurologic dysfunction resembling strokes, and ragged-red fibers on muscle biopsy. Affected individuals tend to be normal at birth through early childhood, then experience growth failure, episodic vomiting, and recurrent cerebral insults resulting in visual loss and hemiparesis. The cortical lesions tend to occur in the parietal and occipital lobes and are not associated with vascular occlusion. Vascular headache is frequently associated and the disorder tends to be familial."},
    {"ICD10Code":"E88.42","Description":"MERRF syndrome","SearchInclusion":"Myoclonus epilepsy and ragged red fibers\nMyoclonus epilepsy and ragged red fibers syndrome","ClinicalNotes":"A mitochondrial encephalomyopathy characterized clinically by a mixed seizure disorder, myoclonus, progressive ataxia, spasticity, and a mild myopathy. Dysarthria, optic atrophy, growth retardation, deafness, and dementia may also occur. This condition tends to present in childhood and to be transmitted via maternal lineage. Muscle biopsies reveal ragged-red fibers and respiratory chain enzymatic defects. (from Adams et al., Principles of Neurology, 6th ed, p986)\nA very rare mitochondrial abnormality characterized by myoclonic epilepsy and the microscopic finding of ragged-red fibers in muscle tissues."},
    {"ICD10Code":"E88.49","Description":"Other mitochondrial metabolism disorders","SearchInclusion":"Disorder of mitochondrial respiratory chain complexes\nMitochondrial disorder, respiratory chain","ClinicalNotes":""},
    {"ICD10Code":"E88.81","Description":"Metabolic syndrome","SearchInclusion":"Dysmetabolic syndrome X                                                                                                                                                      Drug resistance to insulin\nDysmetabolic syndrome x\nInsulin resistance\nMetabolic syndrome x","ClinicalNotes":"A cluster of metabolic risk factors for cardiovascular diseases and type 2 diabetes mellitus. The major components of metabolic syndrome x include excess abdominal fat; atherogenic dyslipidemia; hypertension; hyperglycemia; insulin resistance; a proinflammatory state; and a prothrombotic (thrombosis) state. \nA collection of metabolic risk factors in one individual. The root causes of metabolic syndrome are overweight / obesity, physical inactivity, and genetic factors. Various risk factors have been included in metabolic syndrome. Factors generally accepted as being characteristic of this syndrome include abdominal obesity, atherogenic dyslipidemia, raised blood pressure, insulin resistence with or without glucose intolerance, prothrombotic state, and proinflammatory state.\nA condition is marked by extra fat around the abdomen, high levels of blood glucose (sugar) when not eating, high levels of triglycerides (a type of fat) in the blood, low levels of high-density lipoproteins (a type of protein that carries fats) in the blood, and high blood pressure. People with metabolic syndrome are at increased risk of diabetes mellitus and diseases of the heart and blood vessels.\nA multifaceted syndrome characterized by clustering of insulin resistance and hyperinsulinemia, associated with dyslipidemia, essential hypertension, abdominal obesity, glucose intolerance or noninsulin dependent diabetes mellitus, and an increased risk of cardiovascular events.\nA term referring to a combination of medical conditions that, when present, increase the risk of heart attack, stroke, and diabetes mellitus. It includes the following medical conditions: increased blood pressure, central obesity, abnormal cholesterol levels, and elevated fasting glucose.\nMetabolic syndrome is a group of conditions that put you at risk for heart disease and diabetes. These conditions are\nhigh blood pressure\nhigh blood sugar levels\nhigh levels of triglycerides, a type of fat, in your blood\nlow levels of hdl, the good cholesterol, in your blood\ntoo much fat around your waist\nnot all doctors agree on the definition or cause of metabolic syndrome. The cause might be insulin resistance. Insulin is a hormone your body produces to help you turn sugar from food into energy for your body. If you are insulin resistant, too much sugar builds up in your blood, setting the stage for disease."},
    {"ICD10Code":"E88.89","Description":"Other specified metabolic disorders","SearchInclusion":"Launois-Bensaude adenolipomatosis                                                                                                             Disorder of lysosomal enzyme\nDisorder of organic acid metabolism\nKetosis\nLysosomal enzyme defect\nLysosomal storage disease\nOrganic acid metabolism disorder","ClinicalNotes":""},
    {"ICD10Code":"E88.9","Description":"Metabolic disorder, unspecified","SearchInclusion":"Arthropathy assoc w metabolic disorder\nArthropathy due to a metabolic disorder\nArthropathy due to metabolic disorder\nArthropathy with metabolic disorder\nBilateral corneal deposits in metabolic disorders\nCardiomyopathy, metabolic\nCorneal deposit associated with metabolic disorder\nCorneal deposits in metabolic disorders\nCorneal deposits in metabolic disorders, both eyes\nEnzymopathy\nInborn error of metabolism\nLeft corneal deposits in metabolic disorders\nMetabolic cardiomyopathy\nMetabolic disease\nMetabolism disorder\nMultiple carboxylase deficiency\nRight corneal deposits in metabolic disorders","ClinicalNotes":"A condition in which normal metabolic processes are disrupted, usually because of a missing enzyme.\nA congenital (due to inherited enzyme abnormality) or acquired (due to failure of a metabolic important organ) disorder resulting from an abnormal metabolic process.\nCondition in which there is a deviation from or caused by an abnormal metabolic process; can be congenital due to inherited enzyme abnormality (inborn metabolism disorder) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver.\nGeneric term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (metabolism, inborn errors) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver.\nMetabolism is the process your body uses to get or make energy from the food you eat. Food is made up of proteins, carbohydrates and fats. Chemicals in your digestive system break the food parts down into sugars and acids, your body's fuel. Your body can use this fuel right away, or it can store the energy in your body tissues, such as your liver, muscles and body fat.a metabolic disorder occurs when abnormal chemical reactions in your body disrupt this process. When this happens, you might have too much of some substances or too little of other ones that you need to stay healthy. You can develop a metabolic disorder when some organs, such as your liver or pancreas, become diseased or do not function normally. diabetes is an example."},
    {"ICD10Code":"E89.0","Description":"Postprocedural hypothyroidism","SearchInclusion":"Postirradiation hypothyroidism\nPostsurgical hypothyroidism                                                                                                                                  History of thyroidectomy\nHistory of thyroidectomy (removal of thyroid)\nHistory of total thyroidectomy\nHypothyroidism (low thyroid) after radioiodine therapy\nHypothyroidism (low thyroid), after ablation\nHypothyroidism (low thyroid), after surgery\nHypothyroidism following radioiodine therapy\nPostablative hypothyroidism\nPostoperative hypothyroidism","ClinicalNotes":""},
    {"ICD10Code":"E89.1","Description":"Postprocedural hypoinsulinemia","SearchInclusion":"Postpancreatectomy hyperglycemia\nPostsurgical hypoinsulinemia                                                                                                                             Hypoinsulinemia, postsurgical\nPost-surgical hypoinsulinemia","ClinicalNotes":""},
    {"ICD10Code":"E89.2","Description":"Postprocedural hypoparathyroidism","SearchInclusion":"Parathyroprival tetany                                                                                                                                                                     Post-surgical hypoparathyroidism\nPostoperative hypoparathyroidism","ClinicalNotes":""},
    {"ICD10Code":"E89.3","Description":"Postprocedural hypopituitarism","SearchInclusion":"Postirradiation hypopituitarism                                                                                                          Hypopituitarism due to pituitary tumor surgery\nHypopituitarism due to radiotherapy\nIatrogenic pituitary disorder\nPituitary disorder, iatrogenic\nRadiotherapy-induced hypopituitarism","ClinicalNotes":""},
    {"ICD10Code":"E89.40","Description":"Asymptomatic postprocedural ovarian failure","SearchInclusion":"Postprocedural ovarian failure NOS                                                                                                                  Ovarian failure, postablative\nOvarian failure, postchemotherapy\nPost-chemotherapy ovarian failure\nPostablative ovarian failure\nPostprocedural asymptomatic ovarian failure","ClinicalNotes":""},
    {"ICD10Code":"E89.41","Description":"Symptomatic postprocedural ovarian failure","SearchInclusion":"Symptoms such as flushing, sleeplessness, headache, lack of concentration, associated with postprocedural menopause","ClinicalNotes":""},
    {"ICD10Code":"E89.5","Description":"Postprocedural testicular hypofunction","SearchInclusion":"Post-chemotherapy testicular hypofunction\nPostablative testicular hypofunction\nPostsurgical testicular hypofunction\nTesticular hypofunction, postablative\nTesticular hypofunction, postchemotherapy","ClinicalNotes":""},
    {"ICD10Code":"E89.6","Description":"Postprocedural adrenocortical (-medullary) hypofunction","SearchInclusion":"History of adrenalectomy\nHistory of removal of adrenal gland\nPostprocedural adrenocortical hypofunction\nPostprocedural adrenocortical(-medullary) hypofunction","ClinicalNotes":""},
    {"ICD10Code":"E89.810","Description":"Postprocedural hemorrhage of an endocrine system organ or structure following an endocrine system procedure","SearchInclusion":"Hemorrhage and/or hematoma of endocrine structure after procedure on endocrine system\nHemorrhage of endocrine structure after procedure on endocrine system","ClinicalNotes":""},
    {"ICD10Code":"E89.811","Description":"Postprocedural hemorrhage of an endocrine system organ or structure following other procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E89.820","Description":"Postprocedural hematoma of an endocrine system organ or structure following an endocrine system procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E89.821","Description":"Postprocedural hematoma of an endocrine system organ or structure following other procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E89.822","Description":"Postprocedural seroma of an endocrine system organ or structure following an endocrine system procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E89.823","Description":"Postprocedural seroma of an endocrine system organ or structure following other procedure","SearchInclusion":"","ClinicalNotes":""},
    {"ICD10Code":"E89.89","Description":"Other postprocedural endocrine and metabolic complications and disorders","SearchInclusion":"","ClinicalNotes":""}
    ]